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(Poly)phenols are the most widely distributed secondary metabolites, in plants, 
and, therefore, are regular constituents of human food products. The regular 
ingestion of (poly)phenol-containing foods has been associated with a reduced 
risk of acquiring chronic diseases and many studies are currently trying  to 
corroborate this theory. However, the precise contribution of (poly)phenols to 
disease prevention is still unknown. For understanding how (poly)phenols act on 
human health it is essential to acknowledge their bioavailability. After ingestion, 
compounds undergo several transformations in the gastrointestinal tract and also 
after absorption into the blood. Additionally, a great proportion of non-absorbed 
compounds reach the colon where they are catabolised by the colon microflora, 
resulting in simple phenolics which can also be absorbed and metabolized. 
However, these events are not fully understood and many questions can be posed 
during the entire process and many metabolites remain to be discovered. 
In this study, we aimed to identify some of the most abundant bioavailable 
metabolites after the ingestion of dietary (poly)phenols from a mixture of berries 
and to predict their importance for human health.  
 
The first goal of this work was to identify and quantify the compounds present in 
selected varieties of commercial blueberries, raspberries and blackberries, and 
two wild berries, strawberry tree fruit and Portuguese crowberry, since the latter 
hasnnever been analyzed. A methodology consisting on the hydrolysis of 
glycosides and esters of quinic acid and analysis of the resulting aglycones was 
developed by combination of enzymes obtained from Aspergillus niger. The 
selected berries were demonstrated to be a good source of some classes of 
(poly)phenols. These fruits, therefore, were chemically diverse and abundant in 
certain (poly)phenols, being ideal to be used in an intervention study. 
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In the second part of the work, the analysed berries were ground in the form of a 
puree and administered for breakfast to healthy human volunteers in a 
bioavailability study. Bioavailability studies are vital to understand the events 
that (poly)phenols undergo in the gastrointestinal tract and determine the 
metabolites that circulate in the blood stream. Based on the existing literature, an 
in silico library of potential bioavailable metabolites was constructed and used as 
reference for a preliminary search in urine collected from the volunteers using a 
LC-Orbitrap mass spectrometer. The metabolites preliminarily identified on the 
basis of their exact mass were then confirmed in urine by comparison with 
chemically or enzymatically synthesized standard compounds using LC-MS/MS. 
Several metabolites were positively confirmed in urine samples, mainly in 
conjugated form, as methyl, glucuronides and sulfates, some being identified in 
human samples for the first time.  
For the third part of the work, the (poly)phenol metabolites previously identified 
in urine were quantified in plasma and their provenance from the ingested 
(poly)phenols was verified through to a crossover intervention with ingestion of 
fruit puree and a standard (poly)phenol-free meal by the volunteers. Standard 
compounds of sulfated phenolics were chemically synthesized for quantification 
purposes. Our results confirmed the presence of several phenolic sulfated and 
methylated-metabolites in plasma resulting from the ingestion of a (poly)phenol-
rich berry fruit puree by humans and particularly  emphasized the importance of 
the colonic catabolism. Nevertheless, some of the metabolites previously 
identified in urine did not fully result from the ingestion of (poly)phenols. 
 
After identifying the phenolic metabolites circulating in the blood and 
determining their physiological concentration, it becomes possible to investigate 
their role in the human body. One of the relevant areas of (poly)phenols activity 
in humans is related with their effects in the brain and particularly at the level of 
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the blood-brain barrier, which controls the entrance of substances in the brain. In 
the final part of this work, confluent monolayers of brain microvascular 
endothelial cells (HBMEC) were used as an in vitro model of the blood-brain 
barrier for testing the effects of the sulfated-metabolites previously synthesized. 
The metabolites were tested for toxicity in HBMEC at physiological 
concentrations, and subsequently their ability to cross the cells was assessed 
suggesting the possibility of entering the brain. Nevertheless, the compounds 
were also assayed for a protective effect on HBMEC against injury induced by 
H2O2, suggesting a possible protective role at the level of the endothelial cells 
constituting the blood-brain barrier and without requiring entering the brain. 
Finally, no effect on the expression and activity of the efflux transporter P-
glycoprotein (P-gp) in HBMEC was observed. 
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Os (poli)fenóis são o grupo de metabolitos secundários com maior 
dispersão nas plantas e são, portanto, constituintes normais da 
alimentação humana. A ingestão regular de alimentos contendo 
(poli)fenóis tem sido associada a um menor risco de desenvolver doenças 
crónicas e muitos estudos estão a tentar corroborar esta teoria. No entanto, 
a contribuição exata dos (poli)fenóis para a prevenção de doenças ainda é 
desconhecida. Para melhor compreender como atuam os (poli)fenóis na 
saúde humana é essencial compreende a sua biodisponibilidade. Depois 
da ingestão, os compostos sofrem diversas transformações no trato 
gastrointestinal, bem como depois da sua absorção para a corrente 
sanguínea. Além disso, uma grande quantidade de compostos que não são 
absorvidos chegam ao cólon onde são catabolizados pela microbiota aí 
presente, resultando em fenóis mais simples que ainda podem ser 
absorvidos e metabolizados. No entanto, estes eventos não estão 
totalmente compreendidos e várias questões podem ser colocadas acerca 
todo o processo, bem como existem diversos metabolitos que ainda não 
foram descobertos. 
Neste estudo pretendemos identificar os metabolitos biodisponíveis mais 
abundantes após a ingestão de (poli)fenóis dos alimentos e prever a sua 
importância para a saúde humana. 
 
O primeiro objetivo deste trabalho foi identificar e quantificar os 
compostos presentes em variedades selecionadas de mirtilos, amoras e 
framboesas comerciais bem como de dois frutos selvagens, o medronho e 
a camarinha, sendo que este último nunca foi anteriormente analisado. Foi 
Resumo 
 
xx 
desenvolvida uma metodologia consistindo na hidrólise dos glicósidos e 
ésteres de ácido quínico, através da combinação de enzimas obtidas de 
Aspergillus niger, com posterior análise das aglíconas resultantes dos 
(poli)fenóis. Estes pequenos frutos demonstraram ser uma boa fontes de 
algumas classes de (poli)fenóis. Por serem quimicamente diversos e 
abundantes em (poli)fenóis, estes frutos são ideais para serem usados num 
estudo de intervenção. 
 
Na segunda parte do trabalho, os pequenos frutos analisados foram 
moídos na forma de um puré e administrados ao pequeno almoço a 
voluntários humanos saudáveis num estudo de biodisponibilidade. Os 
estudos de biodisponibilidade são vitais para compreender os eventos 
pelos quais os (poli)fenóis passam no trato digestivo e determinar os 
metabolitos que circulam na corrente sanguínea. Com base na literatura 
existente, foi construída um biblioteca in silico dos potenciais metabolitos 
biodisponíveis e usada como referência para uma procura preliminar em 
amostras de urina colhidas dos voluntários. As amostras foram analisadas 
por cromatografia líquida associada a um espectrómetro de massa 
Orbitrap. Os metabolitos preliminarmente identificados com base na sua 
massa exata foram então confirmados na urina por comparação com 
compostos padrão sintetizados química ou enzimaticamente, por 
intermédio de LC-MS/MS. Vários metabolitos foram positivamente 
confirmados nas amostras de urina, muitos deles na forma conjugada com 
grupos metilo, ácido glucurónico e sulfato, sendo que alguns foram 
mesmo identificados em amostras humanas pela primeira vez.  
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Na terceira parte do trabalho, os metabolitos de (poli)fenóis anteriormente 
identificados nas amostras de urina foram quantificados no plasma e a sua 
origem a partir dos (poli)fenóis ingeridos foi verificada através de um 
estudo de intervenção cruzado, em que os voluntários humanos 
alternaram entre a ingestão do puré de  pequenos frutos e um pequeno 
almoço livre de polifenóis. Compostos padrão de fenóis-sulfatados foram 
sintetizados quimicamente para auxiliar na quantificação dos metabolitos. 
Os resultados confirmaram a presença no plasma de diversos metabolitos 
fenólicos conjugados com grupos sulfato e metilo, após a ingestão de um 
puré de pequenos frutos ricos em (poli)fenóis e enfatizou particularmente 
a importância do catabolismo no cólon. No entanto, houve alguns 
metabolitos previamente identificados na urina que não resultaram da 
ingestão de (poli)fenóis. 
 
Após identificar os metabolitos fenólicos presentes na corrente sanguínea 
e determinar a sua concentração fisiológica, torna-se assim possível 
investigar o seu papel no corpo humano. Uma das área mais importantes 
no estudo da atividade dos (poli)fenóis em humanos está relacionada com 
os seus efeitos no cérebro e particularmente ao nível da barreira 
hematoencefálica, que controla o fluxo de substâncias para dentro e fora 
do cérebro. Na última parte deste trabalho, células endoteliais 
microvasculares de cérebro humano (HBMEC) foram utilizadas como 
modelo in vitro da barreira hematoencefálica para testar os efeitos dos 
metabolitos sulfatados, sintetizados anteriormente. A toxicidade destes 
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metabolitos foi testada nestas células em concentrações determinadas 
como fisiológicas. De seguida, a sua capacidade para atravessar estas 
células foi também determinada como uma indicação do seu potencial 
para penetrar a barreira hematoencefálica e entrar no cérebro. 
Adicionalmente, o efeito protetor destes compostos contra o dano causado 
por H2O2 nestas células foi também determinado, de forma a verificar um 
papel protetor ao nível do endotélio que compõe a barreira 
hematoencefálica ainda antes de entrar no cérebro. Por fim, também foi 
testado o seu efeito na expressão e atividade do transportador de efluxo P-
glicoproteína nas HBMEC, que se verificou negativo.  
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This Dissertation is divided in six chapters. 
 
Chapter one consists of a general introduction concerning (poly)phenols. It briefly 
describes the chemical diversity of compounds and their abundance in human 
foods. The functions of (poly)phenols in plants and their effects in animals are 
also addressed, particularly some of the proposed beneficial effects in humans. 
This chapter also focus on what is currently known about the bioavailability of 
(poly)phenols in humans.  
This content of chapter is planned to be included in a review publication. 
  
Chapter two focuses on the identification and quantification of (poly)phenols in 
berry fruits. From this work resulted a publication in Journal of Agricultural and 
Food Chemistry in which the author of this dissertation was the first author.   
 
Chapter three describes the work on the identification of the bioavailable 
(poly)phenol-metabolites in urine of human volunteers after an intervention 
study where a puree made of berries was ingested. From this work several 
metabolites were identified and some of them were even identified in humans 
and associated with the consumption of (poly)phenols for the first time. From this 
work resulted a publication in Molecular Nutrition & Food Research in which the 
author of this dissertation was first author.  
 
Chapter four consists in the confirmation and quantification in plasma of the 
previously identified bioavailable (poly)phenol-metabolites. The physiological 
concentration of the metabolites in the blood was therefore obtained. From this 
work resulted a paper submitted to The British Journal of Nutrition which is under 
revision and where the author of this dissertation will be first author. 
Thesis Outline 
 
xxv 
In chapter five, the potential effects of the bioavailable (poly)phenol-metabolites 
on human  brain microvascular endothelial cells were addressed in vitro. The 
results suggest the possibility of these metabolites to cross the blood-brain barrier 
as well as a protective effect against chemical insult at the level of the endothelial 
cells that compose this barrier. These results will be used in a future publication.  
 
To finalize, chapter six consists of an integrated discussion of the global results 
obtained during this dissertation, focusing on the novelties achieved in this work   
and includes future perspectives. 
 
 
 
 
 
 
 
 
 
 
 
xxvi 
 
 
 
 
 
 
 
 
Abbreviations List 
 
 
 
 
  
 
 
 
AbbreviationsList 
 
xxviii 
 
Abbreviation Full form 
(Poly)phenols Flavonoids, phenolic acids and their phenolic 
metabolites 
4-MeCat 4-Methylcatechol 
4-MeGA 4-Methylgallic acid 
ACN Acetonitrile 
BBB Blood-brain barrier 
BHT Butylated hydroxytoluene 
CA Caffeic acid 
Cat Catechol 
CBG Cytosolic β-glucosidase 
cGMP Cyclic guanosine mono phosphate 
COMT Catechol O-methyltransferase 
CYP450 Cytochrome C P450 
DAD Diode array detection 
DAPI 4',6-Diamidino-2-phenylindole 
DHCA Dihydrocaffeic acid 
DHFA Dihydroferulic acid 
DMSO Dimethyl sulfoxide 
EDTA Ethylenediaminetetraacetic acid 
FA Ferulic acid 
Abbreviations List 
 
xxix 
FBS Fetal bovine serum 
Fig. Figure 
GA Gallic acid 
GAE Gallic acid equivalents 
Glcrnd Glucuronide 
GLUTs Glucose transporters 
Glycsd Glycoside 
HBMEC Brain microvascular endothelial cells 
HPLC High performance liquid chromatography 
IS Internal standard 
LC-MS Liquid Chromatography-mass spectrometry 
LOD Limit of detection 
LOQ Limit of quantitation 
LPH Lactase phlorizin hydrolase 
MEM Minimum essential medium 
MePyr Methylpyrogallol 
MRM Multiple reaction monitoring 
NEAA Non-essential amino acids 
NMR Nuclear magnetic resonance 
NO Nitric oxide 
ORAC Oxygen Radical Absorbance Capacity 
PA Protocatechuic acid 
AbbreviationsList 
 
xxx 
PAPS 3'-Phosphoadenosine-5'-phosphosulfate 
Pe Permeability coefficient 
P-gp P-glycoprotein 
PTFE Polytetrafluoroethylene 
Pyr Pyrogallol 
R123 Rhodamine 123 
RPMI Basal medium Roswell Park Memorial Institute 
SGLT1 Sodium dependent glucose transporter 1 
SGLts Sodium-glucose transporters 
SLC Solute carry family 
SSc Soluble solids content 
Sulf Sulfate 
SULTs Sulfotransferases 
TAc Titratable acidity 
TE Trolox equivalents 
TEER Transendothelial electrical resistance 
UDPGA Uridine 5′-diphosphoglucuronic acid trisodium salt 
UGTs Uridine diphospho-glucuronosyltransferases 
VA Vanillic acid 
 
 
 
 
 
 
 
Chapter 1 
 
  
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RP wrote this chapter based on the referred bibliography.  
Chapter 1 
 
3 
 
 
Contents 
(Poly)phenols – structure and chemical classes .................................. 4 
(Poly)phenols content in food and dietary intake ............................. 9 
(Poly)phenols functions ........................................................................ 14 
Importance of polyphenols for human nutrition ............................. 18 
Prevention of diabetes ................................................................................................ 19 
Prevention of cardiovascular diseases ..................................................................... 20 
Hormone replacement therapy substitutes ............................................................. 21 
Prevention of neurodegenerative diseases and aging ........................................... 22 
Bioavailability of (poly)phenols .......................................................... 23 
Metabolism in the proximal gastrointestinal tract ................................................. 24 
Metabolism in the colon ............................................................................................. 27 
Biotransformation reactions of (poly)phenols ........................................................ 30 
Phase III – elimination of (poly)phenols .................................................................. 34 
Aims and scope of the thesis ................................................................ 37 
References ................................................................................................ 40 
 
 
 
 
 
 
Introduction 
 
4 
(POLY)PHENOLS – STRUCTURE AND CHEMICAL CLASSES 
Plants produce a great variety of secondary metabolites which can be 
classified according to their structural characteristics and biosynthetic 
pathways. Phenolic compounds, generically called (poly)phenols, are the 
most widely distributed secondary metabolites, ubiquitously present in 
plant kingdom 1. They are a group of secondary metabolites characterized 
by the presence of at least one hydroxyl group attached to an aromatic 
ring. Their biosynthetic  pathways are particularly complex with, in many 
cases, multiple alternative metabolic fates 2. All plant phenolics are 
synthesized from the shikimate/phenylpropanoid pathway, which 
directly provides phenylpropanoids, or the “polyketide” acetate/malonate 
pathway, which can produce both monomeric and polymeric structures 3. 
(Poly)phenols constitute an extremely diversified group not only in terms 
of chemical structure but also biological roles. They usually occur in 
conjugated form with sugars, carboxylic and organic acids, amines, lipids 
and other phenols and can be classified into different groups according to 
the number of phenol rings and on the basis of structural elements that 
bind these rings 4. The main classes are represented in Fig. 1.  
Simple phenolics are substituted phenols, where one or more hydroxyl 
groups are introduced in ortho, meta and para positions in relation to the 
benzene ring 5. They include compounds such as catechol, resorcinol, 
pyrogallol or phloroglucinol. 
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Phenolic acids include two different groups, hydroxybenzoic acids and 
hydroxycinnamic acids. Hydroxybenzoic acids can be found both free and 
esterified in plants. They include gallic acid, which is present in fruits, 
herbs, tea and wine, and it is also the base unit of more complex 
compounds, such as ellagic acid and hydrolysable tannins, including 
gallotannins and ellagitannins, found in rubus fruits, pomegranate and 
cereal grains  6, 7.  Hydroxycinnamic acids consist mainly of p-coumaric, 
caffeic, ferulic and sinapic acids which are usually found glycosylated or 
conjugated with quinic, shikimic and tartaric acids 4, 6. Chlorogenic acid, 
an ester of caffeic and quinic acids, can be found in several fruits and 
vegetables and is highly abundant in coffee. Ferulic acid is abundant in 
cereal grains 6.  
Coumarins, with a C6-C3 skeleton, derive from the fusion of benzene and 
 -pyrone rings. They can be found in free form or conjugated with sugars 
and although they are distributed throughout all parts of the plant, 
including essential oils, coumarins occur at the highest levels in the  
fruits 1, 8.   
Flavonoids constitute the biggest group of phenolic compounds in  
plants 1. Structurally, they are based on a fifteen-carbon skeleton 
consisting of two benzene rings (A and B rings, Fig. 2) linked via a 
heterocyclic pyrane ring (C ring). They can be divided into several classes 
according to the level of oxidation and pattern of substitution of the C 
ring, while individual compounds within a class differ in the pattern of 
substitution of A and B rings 9. The main classes of flavonoids are 
flavonols, flavones, flavanones, isoflavones, flavanols and anthocyanins.  
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Figure 2. Representation of the general structure of flavonoids. 
 
Flavonols are highly distributed in superior plants, although usually 
present at relatively low concentrations and in glycosilated form. 
Kaempferol and quercetin are the main representatives of this class, being 
found in fruits of the Rosaceae family, onions, leek, broccoli, etc. 2, 6, 10. 
Flavones such as apigenin are much less common in fruits and vegetables. 
The main edible sources of flavones are oregano, parsley and celery and 
some cereals such as millet and wheat. Large quantities of 
polymethoxylated flavones have been found on the skin of citrus  
fruits 6, 11. Flavanones such as hesperetin and naringenin are generally 
found glycosylated by a disaccharide in position 7, either a 
neohesperidose, which confers bitter taste, or a rutinoside, which is 
flavourless. They can be found in high concentrations in citrus fruits and 
in smaller concentrations in tomatoes and aromatic plants such as mint 6. 
Isoflavones, having a similar molecular conformation to mammalian 
estrogens, are considered phytoestrogens. Worldwide, soybeans and its 
processed products are the almost exclusive dietary source of isoflavones, 
with genistein, daidzein and glycitein being the main aglycones 12. 
Flavanols share in common with anthocyanins the lack of an oxygen 
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group at the 4-position of the heterocyclic C-ring (Fig. 1) 13.  Monomers of 
flavanols (catechins), such as (+)-catechin and (-)-epicatechin, can be found 
relatively abundantly in fruits, wine, chocolate and green tea 6, 13. Unlike 
other (poly)phenols they are found as aglycones in plants 2. Dimers, 
oligomers and polymers of catechins constitute the proanthocyanidins 
(also known as condensed tannins) which can be found in fruits such as 
apples and grapes, in drinks such as wine, cider, tea and beer, and also in 
cocoa, being responsible for their astringency 14. Anthocyanins are 
glycosylated pigments located in the vacuole of cells, responsible for the 
shiny orange, pink, red, violet and blue colours in the flowers and fruits of 
some plants. They can also be present in vegetative tissues.  Glycosides of 
cyanidin, delphinidin and pelargonidin are the most common in nature 15.  
Lignans are diphenolic compounds formed by 2 phenylpropane units 4, 6. 
Several lignans, such as secoisolariciresinol, are considered 
phytoestrogens 4. They can be found in fruits, cereals, grains and certain 
vegetables although the main dietary source is linseed 6.  
Stilbenes contain two phenyl moieties connected by a two-carbon 
methylene bridge 4. They are commonly found in the roots, barks, 
rhizomes and leaves. However, the stilbenes are often in plants that are 
not routinely consumed for food, or in the non-edible tissue. One 
exception is resveratrol, found in grapes and in red wine in low 
concentrations 16. 
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(POLY)PHENOLS CONTENT IN FOOD AND DIETARY INTAKE 
(Poly)phenols are present in virtually all parts of plants but the 
quantitative distribution varies between different organs of the plant and 
within different populations of the same plant species. These differences 
can be attributed to many factors including genetics, maturity, climate, 
agricultural practices, etc 2. However, these differences make it difficult to 
standardize the amount of (poly)phenols present in food.  
Quantification of (poly)phenols in food products has been done mainly by 
two approaches: the total amount of (poly)phenols in a certain food is 
usually estimated by colorimetric redox assays, based on the reducing 
properties of the phenolic groups, the Folin method, developed by 
Singleton and Rossi 17, being the most common one 18; and 
chromatographic techniques, most commonly HPLC linked with several 
possible detection systems, are used not only for total estimates of 
(poly)phenols, but also for determining individual compounds in samples 
with great sensitivity 19.  
The in vitro measurement of the antioxidant activity of (poly)phenols was 
initially considered as indicative of the potential biological activity of 
compounds, and for a while, (poly)phenols were regarded as a very 
important source of exogenous antioxidant defences 20.  However, recently 
this view has lost some credibility among the scientific community 21 and 
the measurement of the antioxidant activity can be considered nowadays 
more as a simple but rough alternative quantification method of 
(poly)phenols in food samples. 
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 There are several sources of the (poly)phenolic content of foods and 
beverages, and the main ones are the United States Department of 
Agriculture (USDA) and the Phenol-explorer database (Table 1) 18. These 
databases are very useful for research studies and for calculating the 
amount of ingested (poly)phenols by populations, required for predicting 
the health effects of compounds studied in epidemiology. It is thus 
important to calculate the dietary intake of (poly)phenols. 
 Estimation of the dietary intake of (poly)phenols has been, however, a 
very difficult task for several reasons: there are numerous food products 
where phenolic compounds have not yet been quantified;  there are many 
(poly)phenols not yet identified in foods products due to many factors, 
such as the great variety of compounds in plants (and the lack of 
standards for their correct identification), which are obviously 
unaccounted for in quantification; and the intake is usually determined by 
diet histories, food frequency questionnaires or diet diaries, which are 
self-reporting and where accuracy is often uncertain 19. Nonetheless, food 
frequency questionnaires are a good way of measuring long-term intake 
of food, being relatively inexpensive, substantially less time-consuming 
than other methods and can be self-administered. Due to reduced cost and 
time saving, online nutritional interventions and electronic methodologies 
for collecting dietary intake data are also being explored nowadays 22.  
Although the richest sources of (poly)phenols are usually seasonings 
(Table 1), they are generally consumed in very low amounts. When 
considering the highest sources of (poly)phenols in our diet taking into 
consideration how much of that food we regularly ingest, the most 
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relevant sources are black and green tea, coffee, dark chocolate, walnuts, 
sesame oil and fruits such as blueberries, orange and grapefruit (Table 2).  
Berry fruits are a particularly rich source of (poly)phenols and their 
importance to the total consumption of (poly)phenols can be considerable. 
They are some of the richest sources in anthocyanins, flavonols and 
phenolic acids. In a recent study it was demonstrated that berry fruits 
have a low consumption by the Portuguese population in comparison to 
what is described for northern countries populations. Nonetheless, 
although berries account for only 9% of the total ingestion of fruits, they 
are responsible for 14% of the ingestion of (poly)phenols attributed to 
fruits and are the main dietary source of anthocyanins 22. 
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Table 1. (Poly)phenols content in the top thirty richest foods (mg per 100g ) 
Rank Food Food type (Poly)phenols 
content 
1 Cloves Seasonings 15 188 
2 Peppermint, dried Seasonings 11 960 
3 Star anise Seasonings 5460 
4 Cocoa powder Cocoa products 3448 
5 Mexican oregano, dried Seasonings 2319 
6 Celery seed Seasonings 2094 
7 Black chokeberry Fruits 1756 
8 Dark chocolate Cocoa products 1664 
9 Flaxseed meal Seeds 1528 
10 Black elderberry Fruits 1359 
11 Chestnut Seeds 1215 
12 Common sage, dried Seasonings 1207 
13 Rosemary, dried Seasonings 1018 
14 Spearmint, dried Seasonings 956 
15 Common thyme, dried Seasonings 878 
16 Lowbush blueberry Fruits 836 
17 Blackcurrant Fruits 758 
18 Capers Seasonings 654 
19 Black olive Vegetables 569 
20 Highbush blueberry Fruits 560 
21 Hazelnut Seeds 495 
22 Pecan nut Seeds 493 
23 Soy flour Seeds 466 
24 Plum Fruits 377 
25 Green olive Vegetables 346 
26 Sweet basil, dried Seasonings 322 
27 Curry, powder Seasonings 285 
28 Sweet cherry Fruits 274 
29 Globe artichoke heads Vegetables 260 
30 Blackberry Fruits 260 
Adapted from Pérez-Jiménez 18 
 
Chapter 1 
 
13 
 
 
T
ab
le
 2
. (
P
o
ly
)p
h
en
o
ls
 c
o
n
te
n
t 
in
 f
o
o
d
s 
 
A
d
ap
te
d
 f
ro
m
  M
an
ac
h
 e
t 
al
. 6
 a
n
d
 T
an
g
n
ey
 e
t 
al
. 
11
   
(P
o
ly
)p
h
e
n
o
l
c
la
ss
(P
o
ly
)p
h
e
n
o
l 
su
b
c
la
ss
E
x
a
m
p
le
 
c
o
m
p
o
u
n
d
s
D
ie
ta
r
y
 s
o
u
r
c
e 
(m
g
/s
er
v
in
g
)
<
2
5
2
5
-5
0
5
0
-1
0
0
>
1
0
0
P
h
e
n
o
li
c
a
c
id
s
H
y
d
ro
x
y
b
e
n
z
o
ic
a
c
id
s
; 
H
y
d
ro
x
y
ci
n
n
a
m
ic
a
c
id
s
G
a
ll
ic
 a
c
id
, 
e
ll
a
g
ic
a
c
id
, 
v
a
n
il
li
c
a
c
id
; 
c
a
ff
e
ic
a
c
id
, 
fe
ru
li
c
a
c
id
, 
c
h
lo
ro
g
e
n
ic
a
c
id
G
ra
p
e
 j
u
ic
e
, 
R
e
d
 
w
in
e
, 
R
o
s
e
m
ar
y
, 
G
ra
p
e
fr
u
it
, 
D
a
rk
 
c
h
o
c
o
la
te
, W
h
it
e
 
w
in
e
, 
O
re
g
a
n
o
, 
R
o
ll
e
d
 o
a
ts
F
la
x
s
e
e
d
, 
B
la
c
k
 t
e
a
, 
G
re
e
n
 o
li
v
e
s,
 
B
la
c
k
 b
e
a
n
s
,
P
lu
m
, 
K
iw
i,
 
C
h
ic
o
ry
C
o
ff
e
e
, 
W
a
ln
u
t,
 
B
lu
e
b
e
rr
y
, 
C
h
e
rr
y
, 
A
u
b
e
rg
in
e
F
la
v
o
n
o
id
s
F
la
v
o
n
o
ls
Q
u
e
rc
e
ti
n
, 
K
a
e
m
p
fe
ro
l,
 
m
y
ri
c
e
ti
n
B
la
c
k
 t
e
a
, 
W
a
ln
u
ts
, 
B
la
c
k
 b
e
a
n
s
, D
a
rk
 
c
h
o
c
o
la
te
, R
e
d
 
w
in
e
, 
A
lm
o
n
d
s,
 
W
h
it
e
 w
in
e
S
p
in
a
c
h
, 
P
lu
m
, 
O
n
io
n
, 
B
lu
e
b
e
rr
y
C
a
p
e
rs
, 
C
u
rl
y
 
K
a
le
F
la
v
a
n
o
n
es
N
a
ri
n
g
e
n
in
, 
h
e
s
p
re
ti
n
R
e
d
 w
in
e
L
e
m
o
n
 j
u
ic
e
G
ra
p
e
fr
u
it
, 
O
ra
n
g
e
F
la
v
o
n
e
s
A
p
ig
e
n
in
, 
lu
te
o
li
n
O
re
g
a
n
o
Is
o
fl
a
v
o
n
e
s
D
a
id
z
e
in
, 
g
e
n
is
te
in
T
o
fu
, 
T
e
m
p
eh
S
o
y
 b
e
a
n
s,
 S
o
y
 
fl
o
u
r
F
la
v
a
n
o
ls
C
a
te
c
h
in
, 
e
p
ic
a
te
c
h
in
, 
e
p
ig
a
ll
o
c
a
te
c
h
in
g
a
ll
a
te
, 
p
ro
c
y
an
id
in
G
ra
p
e
 j
u
ic
e
, 
P
lu
m
, 
W
h
it
e
 w
in
e
, 
A
lm
o
n
d
s,
 
B
lu
e
b
e
rr
y
R
e
d
 w
in
e
, 
C
o
c
o
a
D
a
rk
 c
h
o
c
o
la
te
, 
B
e
a
n
s
B
la
c
k
 t
e
a
, 
G
re
e
n
 
te
a
A
n
th
o
c
y
an
in
s
C
y
a
n
id
in
, 
D
e
lp
h
in
id
in
, 
P
e
la
rg
o
n
id
in
R
e
d
 w
in
e
B
la
c
k
 b
e
a
n
s
, 
P
lu
m
, 
R
e
d
 
c
a
b
b
a
g
e
S
tr
a
w
b
e
rr
y
B
lu
e
b
e
rr
y
, 
B
la
c
k
b
e
rr
y
, 
B
la
c
k
c
u
rr
an
t,
  
A
u
b
e
rg
in
e
, 
C
h
e
rr
y
, 
R
h
u
b
ar
b
, 
B
la
c
k
 g
ra
p
e
L
ig
n
a
n
s
L
a
ri
c
ir
e
s
in
o
l,
 
s
e
c
o
is
o
la
ri
c
ir
es
in
o
l
F
la
x
s
e
e
d
S
e
s
a
m
e
 o
il
S
ti
lb
e
n
e
s
R
e
s
v
e
ra
tr
o
l
R
e
d
 w
in
e
, 
W
h
it
e
 
w
in
e
O
th
e
r 
(p
o
ly
)p
h
en
o
ls
T
y
ro
s
o
ls
O
li
v
e
 o
il
, 
R
e
d
 
w
in
e
, 
W
h
it
e
 w
in
e
G
re
e
n
 o
li
v
e
s
C
u
rc
u
m
in
o
id
s
T
u
m
e
ri
c
Introduction 
 
14 
(Poly)phenols functions 
As non-movable organisms, plants had to develop mechanisms for 
surviving in the different ecological niches on Earth.  Evolution and 
development of the phenolic biosynthetic pathways was a key event for 
the adaptation of plants to terrestrial environment. Simple phenolics are 
structural units for the formation of lignin which provide mechanical 
support but also of cutin and suberin which are essential in transport and 
storage of water 23. As secondary metabolites, phenolic compounds have 
defensive roles (against pathogens, herbivorous predators and other 
competitor plants), they act as signalling molecules, and protect against 
UV radiation 24, 25 or oxidative stress 26, 27.   
(Poly)phenols were described to affect communication between plants, a 
phenomenon called allelopathy which can be detrimental or beneficial to 
the receiving plant, and accumulation in soils can influence the 
availability of soil nutrients and rates of nutrient cycling 28, 29. 
(Poly)phenols also act as attractants of pollinators and seed dispersers. 
Red colours provided by anthocyanins are attractants of birds while 
yellow flavonoids contribute to insect attraction. Non-pigmented 
phenolics may also act as attractants, being detected by soil bacteria and 
fungi which can either be beneficial or prejudicial 23, 28.  
Phenolic compounds, among other plant secondary metabolites, have also 
an important function in the defence system of plants against the attack of 
herbivores or pathogens such as fungi and bacteria. Defensive metabolites 
can be either produced constitutively and stored as inactive forms 
(phytoanticipins) or induced in response to the attackers (phytoalexins) 30. 
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Phytoanticipins are mainly activated by β-glucosidases during attack, 
which removes the glycosides and releases the biocidal aglycone 
metabolites 30.  Examples of phytoalexins are vitiferins, stilbenic 
polyphenols, dimers, trimers and tetramers of resveratrol which are 
produced in Vitaceae when infected by fungal pathogens. These 
compounds are thought to interfere with the activity of the fungi to 
prevent the disease process 31. 
 (Poly)phenols, as other classes of plant secondary metabolites ingested by 
animals, are xenobiotics which can exert beneficial or adverse reactions 
depending on their structure and concentrations in foodstuffs 32. Human 
dietary (poly)phenols are usually non-toxic, at least in the normally 
ingested amounts, but there are thousands of toxic phytochemicals which 
taken together can affect virtually any function in a living organism 33. 
Knowledge of their effects in animals can provide important information 
on their possible effects in humans. 
With the function of deterring predator herbivores, (poly)phenols can act 
in many different ways. (Poly)phenols are substrates of peroxidases and 
polyphenol oxidases, enzymes present in plants, which generate semi-
quinone free radicals and quinones using plant phenolics when there is 
herbivore or pathogen-damaging of foliage. These radicals can react with 
proteins and amino acids in plant cells, thus reducing their nutritional 
quality 34, 35. Semi-quinone free radicals can also be generated by plant 
peroxidases in the mid-guts of larvae predators, decreasing larval 
performance 35.  The ability of plant compounds to influence the behaviour 
and fitness of predator herbivores has been well documented.  Insect 
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larvae exposed to salycilates from Salix species grow slowly and consume 
less plant material. On the other hand, insects can use phenolics to 
increase their fitness. Sequestering of dietary flavonoids by larvae of 
Polyommatus icarus results in more attractive butterflies for the opposite 
sex 36. 
To reduce foraging, plants can produce bitter compounds to make them 
unpalatable. Humans and other animals tend to reject foods excessively 
bitter, an instinct that for long has been useful since many of these bitter 
plants possess toxic and possibly fatal compounds. Several (poly)phenol 
compounds are responsible for the bitter taste of plants. In general, low-
molecular-weight phenolics tend to be bitter whereas high-molecular-
weight polymers tend to be more astringent. The flavanones tangeretin 
and nobiletin, the flavonol quercetin and flavanone naringin, the 
isoflavones genistein and daidzein and monomers and polymers of 
flavanols are responsible for bitter taste in foods 37. Although humans 
have selected plants varieties with reduced bitterness, there are still 
several food products with distinctive bitterness such as red wine, tea, 
beer and chocolate 38. On the other hand, changes in the structure of 
flavonoids can produce differences in palatability ranging from bitter to 
tasteless to extremely sweet. As was observed for flavanones, a rutinoside 
or a neohesperidoside attached to the position 7 in naringenin can 
produce, respectively tasteless and bitter compounds, whereas the 
chalcone and dihydrochalcone corresponding to naringenin-7-
neohesperidoside (naringin) are extremely sweet  39. 
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Some compounds designated by phytoestrogens have structures similar to 
mammalian estrogens and exhibit estrogenic or anti-estrogenic  
activities 40. Phytoestrogens have relatively weak activity compared to 
animal estrogens; however, exposure to high dietary levels may result in 
biological responses in humans and animals, with favourable or 
unfavourable consequences 40. These include compounds such as 
isoflavones, coumestans and lignans. Lignans such as enterolactone and 
enterodiol occur widely in Leguminosae and are found in woody portion of 
plants, in seeds and cereal grains, being particularly high in flaxseed 16, 40. 
Coumestans such as coumestrol and isoflavones such as genistein, 
daidzein and glycitein can also be found in legumes. Alfalfa, white clover 
and Medicago spp. contain basal reduced levels of coumestan 
phytoestrogens, which increase when attacked by aphids and fungal 
pathogens. Isoflavones are present in subterranean clover, red clover and 
soy, important in animal feeds 41. In cattle, phytoestrogens were shown to 
cause infertility accompanied by visible signs of estrogenism including 
mammary development, swelling of the vulva, cystic ovaries and 
behaviour abnormalities. In sheep, infertility was also observed and in 
ewes infertility may be temporary and accompanied or not by visible 
signs. However, infertility can become permanent upon prolonged 
exposures to phytoestrogens 41. In humans, soy and soy derived products 
are the main sources of pytoestrogens; no adverse effects have been 
observed by soy consumption and, in contrast, consumption of soy 
isoflavones may be advantageous for humans, as they were described to 
relieve menopausal symptoms among other health effects 40.  
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Tannins are very abundant (poly)phenols in plants, commonly ranging 
from 5 to 10% dry weight of leaves. They have the ability to bind proteins, 
and are thought to decrease the protein utilization by mammalian 
herbivores. Binding to plants cellular proteins is thought to reduce their 
digestibility and limit nitrogen supply and binding to salivary proteins 
would also decrease digestion efficiency 42, 43. It is the ability of tannins to 
bind to proteins that transmit the feeling of astringency and possibly  the 
cause of tannins acting as feeding deterrents 44. Additionally, they can 
inhibit the growth and activity of ruminal microflora 43. A toxic effect in 
some herbivorous insects has been observed upon ingestion of tannins 
which being oxidised cause lesions in the gut 42. 
 
IMPORTANCE OF POLYPHENOLS FOR HUMAN NUTRITION 
Although dietary (poly)phenols do not usually present any risk at normal 
intake, they are also not classically essential for humans nor even 
considered nutrients. However, (poly)phenols may have a positive impact 
on human nutrition. Their wide dispersion in plant products and 
abundance in certain foods makes them very good candidates as being 
responsible for the protective effects associated with vegetable and fruit-
rich diets. In an attempt to verify this idea, several epidemiological studies 
have been conducted to evaluate the effects to human health of a long 
term ingestion of (poly)phenol-containing foods. And although some 
positive correlations were found in some studies, some of the results are 
controversial and contradictory 45, 46. Most of the studies only regarded 
some of flavonoid sub-classes, neglecting others. Although many studies 
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do not actually observe no positive correlation between ingestion of 
(poly)phenols and prevention of diseases or reduced mortality, they 
cannot be comparable due to variability in the assessed flavonoid classes, 
demographic characteristics of the populations, outcomes assessed, and 
length of follow-up 46., Additionally, although some studies show positive 
results and others show no effect, the studies suggesting a negative effect 
of (poly)phenols are almost non-existing. Some epidemiological studies 
fail in indicating which components of fruit and vegetables may be 
responsible for the effects and that is also related with an insufficient 
characterization and variable quantification of (poly)phenols contents in 
food 23. Positive results from epidemiological studies should also be 
confirmed by clinical trials which can be very expensive. Therefore, 
experimental studies with animals and in vitro tests are important to 
search for evidence for the effects of (poly)phenols in humans and to 
verify their mechanisms of action. Nonetheless, all these different studies 
contribute with pieces of evidence which support that a continuous and 
prolonged intake of (poly)phenol-rich foods may help in prevention of 
several degenerative pathologies such as diabetes, cardiovascular 
diseases, neurodegenerative diseases and cancer, and to prevent 
symptoms associated to aging and menopause 47, 48. 
 
Prevention of diabetes 
Consumption of (poly)phenol-containing foods has been negatively 
correlated with glycemic index and therefore associated with prevention 
of developing type 2 diabetes and its metabolic disorders. Diabetes-
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associated hyperglycemia is caused by insulin resistance and impaired 
carbohydrate metabolism, characterized by altered digestion and 
absorption of carbohydrates, depletion of glycogen storage, increased 
gluconeogenesis and over output of hepatic glucose 49. Epidemiological 
studies have proposed that (poly)phenols can have an effect in reducing 
the risk of type 2 diabetes, and instead of being attributed to a single 
compound this effect would be correlated with the ingestion of 
(poly)phenol–rich foods 50, 51. There are several possible mechanisms of 
action of (poly)phenols in reducing the risk of developing diabetes 50. It is 
thought that they can inhibit α-glucosidase and α-amylase, important 
enzymes for digestion of carbohydrates into glucose 52. There is also 
evidence that (poly)phenols can inhibit the absorption of sugars by 
interacting with sugar transporters from GLUTs (glucose transporters) 
and SGLTs (sodium-glucose transporters) families 53. Additionally,  it was 
shown that some flavonoids (anthocyanins) can modulate post-prandial 
glycaemia by decreasing GLUT expression in human intestinal Caco-2 
cells 54. Moreover, ingestion of (poly)phenols such as isoflavones can 
stimulate insulin production by pancreatic β-cells 55 and increase insulin 
sensitivity in peripheral tissues, thus requiring smaller amounts of  
insulin 56.  
 
Prevention of cardiovascular diseases 
There are several epidemiological studies associating the consumption of 
(poly)phenol-containing foods with a reduced risk of hypertension, 
stroke, coronary heart disease and myocardial infarction 57-60. Although a 
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substantial amount of research has been dedicated to the subject, it is still 
not clear which (poly)phenols are more active against cardiovascular 
disorders and what are the mechanisms of action. It was proposed that 
soy and cocoa flavonoids have the most beneficial effect on reducing 
cardiovascular risk, based on clinical trials 61. There are several possible 
mechanisms by which (poly)phenols might act in prevention of 
cardiovascular diseases. They can act via a vasodilatory effect, mediated 
by nitric oxide (NO) production and increase of cyclic guanosine 
monophosphate (cGMP) in vascular smooth muscle 62, 63; anti-inflamatory 
effects are also described most likely through impacts on transcriptional 
networks or signalling cascades that modulate gene expression, 
promoting anti-inflammatory mediators and NO production 11; inhibition 
of platelet aggregation was also demonstrated for the ingestion of 
(poly)phenol-containing foods such as cocoa, purple grape juice, coffee 
and tea 64-67; and (poly)phenols such as monomeric and polymeric 
catechins were shown to have an impact on lipid digestion and  
absorption 68, 69, helping in prevention of lipid accumulation in arterial 
wall and development of atherosclerosis 70.  
 
Hormone replacement therapy substitutes 
Menopause is associated with hormonal alterations which translate into 
uncomfortable symptoms and can increase the risk of developing several 
pathologies. (Poly)phenols characterized as phytoestrogens are thought to 
be a natural alternative to hormone replacement therapy used to minimize 
the physiological alterations associated with menopause 71. However, the 
Introduction 
 
22 
studies contained numerous deficiencies and results have been 
inconclusive and conflicting 72. Although isoflavones were shown to 
prevent bone loss in animal models 73, clinical trials in humans did not 
confirm it 74. Epidemiological studies also suggest a possible role of 
isoflavones in prevention of menopause associated cancers such as breast 
cancer 75, 76. However, a 6-month intervention of mixed soy isoflavones did 
not reduce breast epithelial proliferation in healthy western women, 
suggesting a lack of efficacy for breast cancer prevention 77. Nevertheless, 
there is evidence that isoflavones have potential to treat premenstrual 
symptoms. In a study where women consumed soy isoflavones in 
comparison with a placebo, it was observed that there was an 
improvement of somatic symptoms of swelling, headache, aches and 
breast tenderness 78. 
 
Prevention of neurodegenerative diseases and aging 
Almost two decades ago, James Joseph and its team observed that a diet 
supplemented with (poly)phenol-enriched extracts from strawberry and 
spinach, also characterized as rich in “antioxidants”, prevented age 
related decreases in motor and cognitive behaviour as well as brain 
function in Fisher 344 rats 79. Afterwards, they focused on the effects of 
these supplementations (where blueberry was included) in reversing age-
related deficits in brain and behavioural function in aged rats. Their 
findings revealed that supplementation improved cognitive behaviour 
and particularly blueberries also improved motor performance, carbachol-
stimulated GTPase activity and oxotremorine-enhanced dopamine  
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release 80. Since these observations, research on the neuroprotective 
abilities of (poly)phenols has expanded and many studies have been 
conducted to demonstrate neuroprotection from other plant-based foods 
or beverages. Positive results against the degenerative effects of aging 
were observed for coffee 81, concord grape juice 82, 83 and extra virgin olive 
oil 84. A substantial amount of research has also been conducted on the 
neuroprotective abilities of (poly)phenols against diseases such as 
Alzheimer, Parkinson, Huntington and multiple sclerosis 85. Evidence on 
the neuroprotective effects of (poly)phenols has been obtained from in 
vitro, in vivo and epidemiological studies. Although clinical studies are 
more reliable, these are scarce and no clear positive results have been 
reported so far. Nevertheless, epidemiological studies suggest that regular 
consumption of (poly)phenol-rich foods is associated with a lower risk of 
developing neurodegenerative disorders 86-88. In vitro and in vivo research 
has been very important in unravelling the molecular mechanisms behind 
the neuroprotective effects. (Poly)phenols were shown to interfere with 
signalling pathways such as protein kinase and lipid kinase signalling 
cascades causing direct effects on cell survival, neuronal differentiation 
and suppression of neuroinflammation 89-91. 
 
BIOAVAILABILITY OF (POLY)PHENOLS 
Absorption, metabolism and excretion of (poly)phenols is important for 
understanding their effects in human health and to find strategies to 
potentiate these effects. It is thus necessary to study their bioavailability. 
For this aim, many different models can be used, ranging from in vitro 
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enzymatic activities, cellular models, animal models or human subjects. 
Although many differences can occur between human and other animals 
digestion, animals have been essential for the knowledge that we 
currently have on (poly)phenols bioavailability and effects.  
The (poly)phenols most commonly ingested in the human diet are not 
necessarily the most active within the body either to a low intrinsic 
activity or because they are poorly absorbed, extensively metabolized and 
rapidly excreted 6. During digestion and metabolism, (poly)phenols 
undergo several structural modifications and the resulting metabolites 
found in blood and tissues may differ from the native compounds in 
terms of biological activity.  
One of the major difficulties in studying the bioavailability of 
(poly)phenols is their structural differences, resulting in different 
metabolic fates between compounds. Although common mechanisms 
exist between them, several differences in the metabolism can occur 
between classes or different compounds within the same class of 
(poly)phenols. 
Metabolism in the proximal gastrointestinal tract 
The gastrointestinal tract is covered by the mucosa, which functions as 
physical barrier, determining bioavailability of xenobiotics. This function 
is mediated by physical walls, metabolism and active transport 
mechanisms 92. For a compound to enter the body, it must traverse the 
mucosa, composed of several layers. Absorption of most food products 
occurs mainly at the duodenum and the proximal half of the jejunum 
where modifications in the mucosa such as folds (plica circularis), 
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depressions (crypts) and finger-like projections (villi) increase the 
absorption area (Fig. 3).  
 
 
Figure 3. Cross-section of human proximal small intestine. Adapted from DeSesso 
and Jacobson 93. 
 
Additionally, enterocytes, the predominant cells and the main ones 
responsible for absorption, contain in their apical cell membranes 
microvilli which increase the surface area of absorption 93. Being lipophilic 
compounds, most flavonoid aglycones permeate intestinal cells by passive 
diffusion as assessed on Caco-2 cell model 94. The same was demonstrated 
for hydroxycinnamic acids, being able to cross cells by transcellular  
route 95. Passive intestinal permeability depends on several factors, 
including lipophilicity, hydrogen bonding capacity, molecule size, etc. 
However, in plants (poly)phenols are usually present in the form of esters, 
glycosides or polymers. All these forms are usually not absorbed directly 
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and they probably resist acid hydrolysis in the stomach, being able to 
reach the duodenum 6. 
For glycosylated compounds, absorption is usually preceded by 
hydrolysis of the glycoside and release of the aglycone (Fig. 4). This is 
performed by the enzyme lactase phloridzin hydrolase (LPH) in the 
brush-border of the small intestine epithelial cells. After hydrolysis, the 
free aglycone can then enter the enterocytes by passive diffusion 96. 
Alternatively, glycosylated compounds are thought to enter enterocytes 
by the active sodium-dependent glucose transporter SGLT1 and be 
hydrolysed by the cytosolic β-glucosidase (CBG) 97.  
 
 
Figure 4. Mechanisms for hydrolysis of phenolic-glycosides and absorption of the 
resulting aglycone in enterocytes. Glycsd, glycoside; SGLT1, sodium-dependent 
glucose transporter; CBG, cytosolic β-glucosidase; LPH, lactase phloridzin 
hydrolase. Adapted from Del Rio et al.47. 
 
However, conjugation with different glycosides does not retrieve the same 
bioavailability for the aglycone, as it was observed that different 
glycosides are differentially hydrolysed in the small intestine 98. Aglycones 
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conjugated with rutinoside are poorly hydrolysed in the small intestine 
and are absorbed in the colon after hydrolysis of the glycoside by the 
colon microflora 99, 100.  
In the case of anthocyanins, research suggests that hydrolysis of the 
glycoside causes instability of the aglycone structure and induces a 
spontaneous degradation into phenolic acids and aldehydes 101-103. This 
may be an essential point for the low bioavailability of anthocyanins, 
previously reported as being near 0.1% of intake 104.  
For compounds that exist in plants in the aglycone form, such as flavanol 
monomers, their bioavailability has been reported to be higher, near 30%, 
with a fast absorption and excretion, typical of a small intestine  
absorption 47. In contrast, oligomeric and polymeric flavanols, although 
having a high level of stability under gastric and duodenal digestion 
conditions, are thought to exhibit a very low extent of absorption 105. An in 
vitro study with Caco-2 cells revealed their capacity to cross the cells is 
very low, decreasing with an increase in the molecular weight.  
Additionally, they are P-glycoprotein (P-gp) substrates, leading to their 
excretion by efflux pumps to the apical side 106. The same results are 
observed in vivo with most proanthocyanidins being very poorly  
absorbed 105. A slight exception was proanthocyanidin B2, which was 
partially absorbed intact after oral administration 107, 108. 
 
Metabolism in the colon 
Compounds not absorbed in the proximal gastrointestinal tract travel to 
the large intestine where absorption can also occur. Studies conducted 
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with subjects with an ileostomy, having had their colons removed 
surgically, have been very important for answering several questions. 
Information on the site of absorption of compounds is provided by their 
presence in urine in comparison with healthy subjects. Compounds absent 
in the urine of ileostomized patients should have originated from and be 
absorbed in the colon. Information about the metabolism in the lumen of 
small intestine is also provided in these studies, and collection of ileal 
fluid allows estimation of the amount of compounds that can pass from 
the small to the large intestine 109. In this way, reports using ileostomized 
subjects revealed that substantial amounts of the initial (poly)phenols 
passed from the small to the large intestine, with the conjugated group 
(for example different glycosides) and the structure of the aglycone being 
key determinants 110, 111. On studies with caffeoylquinic acids, it was 
observed that variation in the food matrixes and the composition of 
(poly)phenols and their amount on food also influences the intestinal 
absorption and the percentage of compounds reaching the colon 112, 113. 
Analysis of subjects’ ileal fluid after green tea ingestion revealed the 
presence of 70% of the ingested flavan-3-ols, 33% being in the form of 
parent compounds 114. 
However, after reaching the colon, (poly)phenols can suffer the action of 
colonic microbiota which are able to degrade them into low molecular 
weight phenolics and aromatic acids 109.  
Although bacteria are present in the entire human body, bacterial density 
increases in the distal small intestine, and particularly in the large 
intestine where it is estimated that there are 1011–1012 bacteria per gram of 
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colonic content, with a large number of different species, ranging from 300 
to 500 115. Of these, only a minority has been identified, with Bacteroides 
being the most common and constituting about 30% of all species. They 
are followed by Clostridium, Prevotella, Eubacterium, Ruminococcus, 
Fusobacterium, Peptococcus,and Bifidobacterium. Escherichia and Lactobacillus 
are also present, although to a lesser extent 116. The colonic microbiota are 
able to induce several transformations in the (poly)phenol structure 
including O- and C- deglycosylation, hydrolysis of esters and amides, and 
deglucuronidation. The aromatic ring of the aglycones can be ruptured 
and they can undergo dehydroxylation, demethoxylation, demethylation 
and hydrogenation. Generally, colonic activity has the ability of 
converting complex (poly)phenols into simpler phenols and aromatic 
acids, but a great portion is also converted into oxaloacetate and 
ultimately CO2 117.  
In vitro studies using faecal suspensions incubated with polyphenolic 
samples revealed the diversity of compounds generated by the colonic 
microbiota enzymatic activity. Due to the action of faecal microbiota, 
anthocyanins were deglycosylated, reconjugated with other groups and 
underwent breakdown of the anthocyanidin heterocyclic ring resulting in 
phenolic acids and other metabolites 102, 118. Miocrobiota-induced break 
down of caffeoylquinic acids into caffeic and quinic acids and conversion 
into other phenolic acids was also demonstrated 119. 
Cerdá and co-workers reported that after ingestion of several ellagitannins 
and ellagic acid containing foods, neither ellagitannins nor ellagic acid 
were detected in the urine of the subjects. However, the metabolite 
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urolithin B was suggested to have originated from the microbial 
degradation of the parent compounds in colon. Its variable amounts 
between subjects were suggested to be caused by differences in the colonic 
microbiota amongst the subjects 120. Other urolithins and their metabolites 
were subsequently identified and their origin from colonic microbiota was 
confirmed in vitro 118, 121-123. 
Catabolism of flavanols monomers but also proanthocyanidins oligomers 
and polymers by the colonic microbiota also resulted in formation of 
several simple phenols, phenolic acids and the characteristic 
valerolactones 124, 125 
Although a great portion of the colonic metabolites are excreted in faeces, 
they can still be absorbed and enter the blood flow. Their importance 
resides on a possible physiological effect or their use as biomarkers of 
polyphenol intake 6. And because all individuals have their own unique 
signature of intestinal microbiota, the metabolites resulting from its 
metabolism will vary and have a different impact on the health of the 
host. 
 
Biotransformation reactions of (poly)phenols 
As commonly occurs with xenobiotics, which enter human or other 
animals body, (poly)phenols can undergo enzymatic reactions known as 
‘biotransformations’.  The resulting compounds are usually less lipophilic 
so they can be more easily excreted by the body. These reactions include 
phase I and phase II reactions 32.  
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Phase I reactions, considered functionalization reactions due to the 
introduction or uncovering of a functional group in the xenobiotics 
molecule, allowing it to become more easily conjugated with endogenous 
substrates. These include oxidative and reductive reactions, where 
cytochrome c P450 (CYP450) and NADPH cytochrome c reductase have 
important roles; and hydrolytic reactions conducted by esterases and 
aminases 32. The liver is considered the primary site  for the catalytic 
activity of CYP450 enzymes but significant enzyme levels can be found in 
all cells lining the gastro-intestinal tract 33. Although several studies 
characterized the ability of (poly)phenols to inhibit or activate phase I 
enzymes, or even to influence their gene expression, very little 
information is available about the occurrence of phase I reactions towards 
(poly)phenols 126-129. 
Phase II reactions are conjugation reactions characterized by the 
introduction of an endogenous group, such as glucuronic acid, sulfate, 
methyl, acyl, glycine or reduced glutathione, onto the xenobiotic structure. 
The conjugates, being more water soluble, are usually rapidly excreted 
through bile or urine 32. In the metabolism of (poly)phenols in human 
body, glucuronidation, sulfation and methylation are the most frequent 
phase II reactions. For example, the aglycone caffeic acid can be subjected 
to conjugation reactions, resulting in caffeic acid-O-sulfate, caffeic acid-O-
glucuronide or its methylated form, ferulic acid (Fig. 5).   
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Caffeic acid-4-O-sulfateCaffeic acid-4-O-glucuronide Ferulic acid
 
 
 
Glucuronidation of (poly)phenols is carried out by UDP-
glucuronosyltransferases (UGTs) which catalyze the transfer of glucuronic 
acid from the cofactor  UDP-glucuronic  acid  (UDPGA) to a suitable 
nucleophilic functional group such as hydroxyl, amine or carboxylic  
acid 130. UGTs are predominantly transmembrane proteins located in the 
smooth endoplasmic reticulum and nuclear compartment of cells 130, 131. 
Although the liver is the primary site of glucuronidation in the body, the 
kidney and the gastrointestinal tract are considered the most important 
sites of extra-hepatic metabolism 131. The  versatility  of  UGTs  resides on  
the  fact  that  this  enzyme exists  as  an  enzyme  ‘super  family’,  with  
individual  enzyme  forms that  exhibit  distinct,  but  overlapping,  
substrate  and  inhibitor selectivities 131. Although  glucuronidation  occurs  
to  some  extent  in  all  mammalian  species, significant  variation  in  
enzyme  substrate  selectivity  and  rates  of  glucuronidation  between  
Figure 5 – Structures of caffeic acid in sulfated, glucuronidated and 
methylated form. 
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species  is  common  and  well  documented. For this reason, 
glucuronidation studies carried on laboratory animals not always 
correlate with humans 131. 
Sulfation is conducted by sulfotransferases (SULTs), which are a group of 
enzymes localized in the soluble fraction of cells, capable of  catalyzing the 
transfer of a sulfonate group from 3’-phosphoadenosine 5’-phosphosulfate  
(PAPS),  to  a  hydroxyl  or amino  group  of  substrate  compounds. 
Sulfation is not only important for the biotransformation of xenobiotics, 
but also of endogenous catecholamines, steroid/thyroid  hormones,  
cholesterol,  and  bile acids 132. The ability of human SULTs to sulfate a 
broad range of substrates arises from the presence of multiple isoforms. 
Therefore, SULTs have been divided into several gene families and 
subfamilies based on their amino acid sequence identity and catalytic 
properties 133. The SULT1 family is responsible for catalyzing the sulfation 
of many endogenous and exogenous phenols. Within this family, SULT1A 
has been demonstrated to have greater catalytic activity towards the 
sulfation of small planar phenolic compounds and flavonoids, whereas 
SULT1E1 was more active towards estrogen conjugation 134. 
Methylation is mediated by the catechol O-methyltransferase (COMT). 
The catalytic activity of this enzyme has been described toward  
compounds containing a catechol group or a vicinal dihydroxyphenyl 
structure, by the transfer  of  a  methyl  group  from  S-adenosyl-L-
methionine  (AdoMet)  to one  of  the  two  vicinal  hydroxyl  groups 132, 135. 
Two forms of COMT have been described in humans, the cytoplasmic 
form (S-COMT) and the membrane-bound form (MB-COMT) located in 
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the rough endoplasmic reticulum 136. Although COMT has an important 
function in the O-methylation of endogenous catecholamines 
(epinephrine, norepinephrine and dopamine) and catechol estrogens, it 
also catalyzes the O-methylation of catechol-containing xenobiotics 137. 
Kuhnle demonstrated that O-methylation of the flavanols catechin and 
epicatechin occurs in intestinal epithelial cells and can precede other 
conjugation reactions 138. When quercetin was intraperitoneally 
administered to rats, a great percentage was detected in urine in 
methylated form, a process that was proposed to inactivate the compound 
139. Other compounds have been described as substrates of COMT, either 
being simple phenols, phenolic acids or more complex  
(poly)phenols 135, 137.  
Most (poly)phenols circulate in plasma in conjugated form. While for 
some compounds such as quercetin there is no free form in plasma, others 
such as epigallocatechin gallate are present in plasma mainly in 
unconjugated form 140. Flavonols such as kaempferol and quercetin are 
mainly present as glucuronides after oral administration, however, 
sulfated (poly)phenols can also be very abundant 133.  
Conjugation of (poly)phenols is therefore a very important phenomenon 
in the human body after absorption, occurring in many different locations, 
although the liver is described as the primary site. 
Phase III – elimination of (poly)phenols 
The final step in the elimination  and/or  detoxification  of xenobiotics  or  
exogenous  compounds  introduced  into  the body  are the phase  III  
transporters. These are mainly constituted by the ABC protein family, 
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including P-gp and multidrug resistance-associated protein (MRP2, 
ABCC2) and by solute carry family (SLC) transporters 92, 141. In polarized 
cells that maintain barrier properties in tissues between lumen and the 
blood (i.e. intestinal mucosa cells, hepatocytes, kidney tubule cells, brain 
endothelial cells, etc), drug transporters have the task of eliminating the 
undesired compounds which are sent into the faeces, urine and bile 142. 
The majority of conjugated-(poly)phenols are excreted in urine. However, 
a possible excretion back into the intestinal lumen by intestinal cells or to 
bile by liver parenchymal cells should also be regarded (Fig. 6). 
 
Figure 6. Enterohepatic recirculation. After absorption in the small intestine, 
xenobiotics are transported into the liver where they are biotransformed. The 
metabolites are transported into the bile and secreted back to the duodenum. 
Degradation of the metabolites in the intestine generates catabolites available for 
reabsorption. Adapted from DeSesso et al. 93. 
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 In studies performed with rats, the extent of biliary and intestinal 
excretion between genistein, hesperetin and ferulic acid were shown to 
vary between the compounds causing considerable differences in their 
bioavailability 143. Also, in vitro studies using Caco-2 cells have 
demonstrated the importance of intestinal apical efflux transporters in the 
bioavailability of (poly)phenols by excreting conjugated –phenolics 144-146. 
Compounds excreted into bile are eventually emptied in the duodenum. 
Generally these conjugated substances are not absorbed in the small 
intestine, reaching the colon. In the colon these substances can either be 
excreted into the faeces or be degradaded by the colon microbiota and be 
reabsorbed 93. 
Bioavailability of (poly)phenols is thus a multi-stage process comprising 
de-conjugation and possible catabolism, absorption, conjugation and 
excretion (Fig. 7). However, sequestration of compounds in body tissues 
has been usually undetermined and may contribute to underestimation of 
the bioavailability of (poly)phenols. 
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Figure 7. General diagram of absorption, biotransformation and excretion of 
(poly)phenols in the human body. Adapted from Monagas et al. 125 
 
AIMS AND SCOPE OF THE THESIS 
This PhD thesis aims to identify the main bioavailable metabolites in 
humans derived from the ingestion of (poly)phenols present in berries 
fruits, particularly focusing on novel metabolites. For this five critical 
steps were undertaken: 
i) Selection and characterization of fruits – The selection of the fruits 
to be used was based on their content in (poly)phenols. Of the 
chosen fruits, two are wild and native of the Portuguese 
territory (strawberry tree fruits and Portuguese crowberry), 
while the other three are agriculturally selected fruits 
(raspberry, blueberry and blackberry), having several varieties 
available and allowing selection of the most enriched in 
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(poly)phenols. Characterization of these fruits and 
identification and quantification of (poly)phenols was mainly 
performed by HPLC.  
ii) Execution of an intervention study with human volunteers and 
collection of samples – ethical approval was obtained by the 
Faculdade de Farmácia da Universidade de Lisboa and healthy 
volunteers were recruited. Urine and plasma samples were 
collected from the volunteers after ingestion of an acute dose of 
the berries puree for breakfast. A two stage study was also 
conducted to exclude metabolites from the endogenous 
metabolism, revealed by the ingestion of a standards breakfast 
without (poly)phenols.   
iii) Identification of the main bioavailable metabolites – identification 
of the most abundant bioavailable metabolites was performed 
in urine samples from the volunteers by recurring to an LC-
Orbitrap MS which detects compounds by their exact mass. For 
this, an extensive library of possible bioavailable metabolites 
was constructed based on the metabolism previously described 
for (poly)phenols and the exact mass of compounds was 
calculated. 
iv) Synthesis of compounds to be used as standards – standard 
compounds allow unequivocal identification of metabolites 
and also allow a much finer quantification. Since many of the 
compounds identified in this work did not have any 
commercially available standards, these had to be synthesized. 
Either with use of conjugative enzymes naturally present in 
animals (liver) or by laboratorial chemical synthesis, standard 
compounds were obtained. 
v) Confirmation and quantification of metabolites in biological 
samples – metabolites were confirmed in urine and plasma 
samples by LC-MS/MS and quantified.  
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Identification and synthesis of novel metabolites represent a new 
opportunity for unravelling the mechanisms of action for the reported 
health effects associated with the consume of (poly)phenols-rich foods. 
Therefore, we aim to disclosing the protective effect of some of the 
identified and synthesized compounds against an oxidative stimulus 
on brain endothelial cells (HBMEC), which constitute the brain 
protective barrier. Integrity of this barrier is of great importance for 
prevention of neurodegenerative disorders. Additionally, we further 
tested the capacity of the compounds to cross the brain endothelial 
cells (HBMEC), simulating the entrance in the brain via blood-brain-
barrier.  
 
Introduction 
 
40 
REFERENCES 
1. Cheynier, V.; Comte, G.; Davies, K. M.; Lattanzio, V.; Martens, S. Plant 
phenolics: Recent advances on their biosynthesis, genetics, and ecophysiology. 
Plant Physiol Bioch 2013, 72, 1-20. 
2. Robards, K.; Antolovich, M. Analytical chemistry of fruit bioflavonoids - 
A review. Analyst 1997, 122, R11-R34. 
3. Quideau, S.; Deffieux, D.; Douat-Casassus, C.; Pouysegu, L. Plant 
polyphenols: chemical properties, biological activities, and synthesis 
Angew Chem Int Ed 2011, 50, 586-621. 
4. Pandey, K. B.; Rizvi, S. I. Plant polyphenols as dietary antioxidants in 
human health and disease. Oxid Med Cell Longev 2009, 2, 270-278. 
5. Vermerris, W.; Nicholson, R., Phenolic Compound Biochemistry. Springer: 
Dordrecht, Netherlands, 2006. 
6. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. 
Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79, 727-747. 
7. Serrano, J.; Puupponen-Pimia, R.; Dauer, A.; Aura, A. M.; Saura-Calixto, 
F. Tannins: current knowledge of food sources, intake, bioavailability and 
biological effects. Mol Nutr Food Res 2009, 53 Suppl 2, S310-29. 
8. Venugopala, K. N.; Rashmi, V.; Odhav, B. Review on natural coumarin 
lead compounds for their pharmacological activity. Biomed Res Int 2013, doi: 
10.1155/2013/963248. 
9. Kumar, S.; Pandey, A. K. Chemistry and biological activities of 
flavonoids: an overview. ScientificWorldJournal 2013, DOI: 10.1155/2013/162750. 
10. El Gharras, H. Polyphenols: food sources, properties and applications - a 
review. Int J Food Sci Tech 2009, 44, 2512-2518. 
11. Tangney, C. C.; Rasmussen, H. E. Polyphenols, inflammation, and 
cardiovascular disease. Curr Atheroscler Rep 2013, 15, 324. doi:  10.1007/s11883-013-
0324-x. 
12. Rimbach, G.; Boesch-Saadatmandi, C.; Frank, J.; Fuchs, D.; Wenzel, U.; 
Daniel, H.; Hall, W. L.; Weinberg, P. D. Dietary isoflavones in the prevention of 
cardiovascular disease - A molecular perspective. Food Chem Toxicol 2008, 46, 
1308-1319. 
13. Hollman, P. C. H.; Arts, I. C. W. Flavonols, flavones and flavanols - 
nature, occurrence and dietary burden. J Sci Food Agric 2000, 80, 1081-1093. 
14. Santos-Buelga, C.; Scalbert, A. Proanthocyanidins and tannin-like 
compounds - nature, occurrence, dietary intake and effects on nutrition and 
health. J Sci Food Agric 2000, 80, 1094-1117. 
15. Castaneda-Ovando, A.; de Lourdes Pacheco-Hernandez, M.; Elena Paez-
Hernandez, M.; Rodriguez, J. A.; Andres Galan-Vidal, C. Chemical studies of 
anthocyanins: A review. Food Chem 2009, 113, 859-871. 
Chapter 1 
 
41 
16. Cassidy, A.; Hanley, B.; Lamuela-Raventos, R. M. Isoflavones, lignans 
and stilbenes - origins, metabolism and potential importance to human health. J 
Sci Food Agric 2000, 80, 1044-1062. 
17. Singleton, V. L.; Rossi Jr., J. A. Colorimetry of total phenolics with 
phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965, 16, 144-
158. 
18. Perez-Jimenez, J.; Neveu, V.; Vos, F.; Scalbert, A. Identification of the 100 
richest dietary sources of polyphenols: an application of the Phenol-Explorer 
database. Eur J Clin Nutr 2010, 64, S112-S120. 
19. Spencer, J. P. E.; El Mohsen, M. M. A.; Minihane, A.-M.; Mathers, J. C. 
Biomarkers of the intake of dietary polyphenols: strengths, limitations and 
application in nutrition research. Brit J Nutr 2008, 99, 12-22. 
20. Gulcin, I. Antioxidant activity of food constituents: an overview. Arch 
Toxicol 2012, 86, 345-391. 
21. Hollman, P. C.; Cassidy, A.; Comte, B.; Heinonen, M.; Richelle, M.; 
Richling, E.; Serafini, M.; Scalbert, A.; Sies, H.; Vidry, S. The biological relevance 
of direct antioxidant effects of polyphenols for cardiovascular health in humans is 
not established. J Nutr 2011, 141, 989S-1009S. 
22. Pinto, P.; Cardoso, S.; Pimpao, R. C.; Tavares, L.; Ferreira, R. B.; Santos, C. 
N. Daily polyphenol intake from fresh fruits in Portugal: contribution from berry 
fruits. Int J Food Sci Nutr 2013, 64, 1022-1029. 
23. Parr, A. J.; Bolwell, G. P. Phenols in the plant and in man. The potential 
for possible nutritional enhancement of the diet by modifying the phenols content 
or profile. J Sci Food Agric 2000, 80, 985-1012. 
24. Daayf, F.; Lattanzio, V., Recent Advances in Polyphenol Research. Blackwell 
Publishing Ltd: 2008; Vol. I. 
25. Jaakola, L.; Maatta-Riihinen, K.; Karenlampi, S.; Hohtola, A. Activation of 
flavonoid biosynthesis by solar radiation in bilberry (Vaccinium myrtillus L.) 
leaves. Planta 2004, 218, 721-728. 
26. Ahmad, P.; Sarwat, M.; Sharma, S. Reactive oxygen species, antioxidants 
and signaling in plants. Journal of Plant Biology 2008, 51, 167-173. 
27. Agati, G.; Azzarello, E.; Pollastri, S.; Tattini, M. Flavonoids as 
antioxidants in plants: Location and functional significance. Plant Science 2012, 
196, 67-76. 
28. Weston, L. A.; Mathesius, U. Flavonoids: their structure, biosynthesis and 
role in the rhizosphere, including allelopathy. J Chem Ecol 2013, 39, 283-297. 
29. Li, Z.-H.; Wang, Q.; Ruan, X.; Pan, C.-D.; Jiang, D.-A. Phenolics and plant 
allelopathy. Molecules 2010, 15, 8933-8952. 
30. War, A. R.; Paulraj, M. G.; Ahmad, T.; Buhroo, A. A.; Hussain, B.; 
Ignacimuthu, S.; Sharma, H. C. Mechanisms of plant defense against insect 
herbivores. Plant Signal Behav 2012, 7, 1306-20. 
Introduction 
 
42 
31. Cimmino, A.; Andolfi, A.; Abouzeid, M.; Evidente, A. Polyphenols as 
fungal phytotoxins, seed germination stimulants and phytoalexins. Phytochem Rev 
2013, 12, 653-672. 
32. Nebbia, C. Biotransformation enzymes as determinants of xenobiotic 
toxicity in domestic animals. Vet J 2001, 161, 238-252. 
33. Fink-Gremmels, J. Defense mechanisms against toxic phytochemicals in 
the diet of domestic animals. Mol Nutr Food Res 2010, 54, 249-258. 
34. Cho, M. J.; Howard, L. R.; Prior, R. L.; Clark, J. R. Flavonoid glycosides 
and antioxidant capacity of varous blackberry, blueberry and red grape 
genotypes determined by high-performance liquid chromatography/mass 
spectrometry. J Sci Food Agric 2004, 84, 1771-1782. 
35. Barbehenn, R.; Dukatz, C.; Holt, C.; Reese, A.; Martiskainen, O.; 
Salminen, J. P.; Yip, L.; Tran, L.; Constabel, C. P. Feeding on poplar leaves by 
caterpillars potentiates foliar peroxidase action in their guts and increases plant 
resistance. Oecologia 2010, 164, 993-1004. 
36. Simmonds, M. S. J. Flavonoid-insect interactions: recent advances in our 
knowledge. Phytochemistry 2003, 64, 21-30. 
37. Drewnowski, A.; Gomez-Carneros, C. Bitter taste, phytonutrients, and the 
consumer: a review. Am J Clin Nutr 2000, 72, 1424-1435. 
38. Soares, S.; Kohl, S.; Thalmann, S.; Mateus, N.; Meyerhof, W.; De Freitas, 
V. Different phenolic compounds activate distinct human bitter taste receptors. J 
Agric Food Chem 2013, 61, 1525-1533. 
39. Horowitz, R. M.; Gentili, B. Taste and structure in phenolic glycosides. J 
Agric Food Chem 1969, 17, 696-700. 
40. Vitale, D. C.; Piazza, C.; Melilli, B.; Drago, F.; Salomone, S. Isoflavones: 
estrogenic activity, biological effect and bioavailability. Eur J Drug Metab 
Pharmacokinet 2013, 38, 15-25. 
41. Adams, N. R. Detection of the effects of phytoestrogens on sheep and 
cattle. J Anim Sci 1995, 73, 1509-1515. 
42. Barbehenn, R. V.; Peter Constabel, C. Tannins in plant-herbivore 
interactions. Phytochemistry 2011, 72, 1551-65. 
43. Goel, G.; Puniya, A. K.; Aguilar, C. N.; Singh, K. Interaction of gut 
microflora with tannins in feeds. Naturwissenschaften 2005, 92, 497-503. 
44. Lesschaeve, I.; Noble, A. C. Polyphenols: factors influencing their sensory 
properties and their effects on food and beverage preferences. Am J Clin Nutr 
2005, 81, 330S-335S. 
45. Arts, I. C.; Hollman, P. C. Polyphenols and disease risk in epidemiologic 
studies. Am J Clin Nutr 2005, 81, 317S-325S. 
46. Peterson, J. J.; Dwyer, J. T.; Jacques, P. F.; McCullough, M. L. Associations 
between flavonoids and cardiovascular disease incidence or mortality in 
European and US populations. Nutr Rev 2012, 70, 491-508. 
Chapter 1 
 
43 
47. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J. P. E.; Tognolini, M.; Borges, 
G.; Crozier, A. Dietary (poly)phenolics in human health: structures, 
bioavailability, and evidence of protective efects against chronic diseases. Antiox 
Redox Sign 2013, 18, 1818-1892. 
48. Vauzour, D.; Rodriguez-Mateos, A.; Corona, G.; Oruna-Concha, M. J.; 
Spencer, J. P. Polyphenols and human health: prevention of disease and 
mechanisms of action. Nutrients 2010, 2, 1106-1131. 
49. Bahadoran, Z.; Mirmiran, P.; Azizi, F. Dietary polyphenols as potential 
nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 2013, 
12, 43-43. 
50. Hanhineva, K.; Torronen, R.; Bondia-Pons, I.; Pekkinen, J.; Kolehmainen, 
M.; Mykkanan, H.; Poutanen, K. Impact of dietary polyphenols on carbohydrate 
metabolism. Int J Mol Sci 2010, 11, 1365-1402. 
51. Song, Y. Q.; Manson, J. E.; Buring, J. E.; Sesso, H. D.; Liu, S. M. 
Associations of dietary flavonoids with risk of type 2 diabetes, and markers of 
insulin resistance and systemic inflammation in women: A prospective study and 
cross-sectional analysis. J Am Coll Nutr 2005, 24, 376-384. 
52. Tadera, K.; Minami, Y.; Takamatsu, K.; Matsuoka, T. Inhibition of alpha-
glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol 2006, 52, 149-
153. 
53. Williamson, G. Possible effects of dietary polyphenols on sugar 
absorption and digestion. Mol Nutr Food Res 2013, 57, 48-57. 
54. Alzaid, F.; Cheung, H.-M.; Preedy, V. R.; Sharp, P. A. Regulation of 
Glucose Transporter Expression in Human Intestinal Caco-2 Cells following 
Exposure to an Anthocyanin-Rich Berry Extract. Plos One 2013, 8. 
55. Choi, M. S.; Jung, U. J.; Yeo, J.; Kim, M. J.; Lee, M. K. Genistein and 
daidzein prevent diabetes onset by elevating insulin level and altering hepatic 
gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. 
Diabetes Metab Res Rev 2008, 24, 74-81. 
56. Kim, D.-J.; Jeong, Y.-J.; Kwon, J.-H.; Moon, K.-D.; Kim, H.-J.; Jeon, S.-M.; 
Lee, M.-K.; Park, Y. B.; Choi, M.-S. Beneficial effect of chungkukjang on regulating 
blood glucose and pancreatic beta-cell functions in C75BL/KsJ-db/db mice. J Med 
Food 2008, 11, 215-223. 
57. Cassidy, A.; O'Reilly, E. J.; Kay, C.; Sampson, L.; Franz, M.; Forman, J. P.; 
Curhan, G.; Rimm, E. B. Habitual intake of flavonoid subclasses and incident 
hypertension in adults. Am J Clin Nutr 2011, 93, 338-347. 
58. Mink, P. J.; Scrafford, C. G.; Barraj, L. M.; Harnack, L.; Hong, C. P.; 
Nettleton, J. A.; Jacobs, D. R. Flavonoid intake and cardiovascular disease 
mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007, 
85, 895-909. 
Introduction 
 
44 
59. Cassidy, A.; Mukamal, K. J.; Liu, L.; Franz, M.; Eliassen, A. H.; Rimm, E. 
B. High anthocyanin intake is associated with a reduced risk of myocardial 
infarction in young and middle-aged women. Circulation 2013, 127, 188-196. 
60. Hollman, P. C. H.; Geelen, A.; Kromhout, D. Dietary flavonol intake may 
lower stroke risk in men and women. J Nutr 2010, 140, 600-604. 
61. Hooper, L.; Kroon, P. A.; Rimm, E. B.; Cohn, J. S.; Harvey, I.; Le Cornu, K. 
A.; Ryder, J. J.; Hall, W. L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and 
cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin 
Nutr 2008, 88, 38-50. 
62. Li, H. F.; Chen, S. A.; Wu, S. N. Evidence for the stimulatory effect of 
resveratrol on Ca2+-activated K+ current in vascular endothelial cells. Cardiovasc 
Res 2000, 45, 1035-1045. 
63. Botden, I. P. G.; Langendonk, J. G.; Meima, M. E.; Boomsma, F.; 
Seynhaeve, A. L. B.; ten Hagen, T. L. M.; Danser, A. H. J.; Sijbrands, E. J. G. Daily 
red wine consumption improves vascular function by a soluble guanylyl cyclase-
dependent pathway. Am J Hypertens 2006, 24, 162-168. 
64. Rein, D.; Paglieroni, T. G.; Wun, T.; Pearson, D. A.; Schmitz, H. H.; 
Gosselin, R.; Keen, C. L. Cocoa inhibits platelet activation and function. Am J Clin 
Nutr 2000, 72, 30-35. 
65. Freedman, J. E.; Parker, C.; Li, L. Q.; Perlman, J. A.; Frei, B.; Ivanov, V.; 
Deak, L. R.; Iafrati, M. D.; Folts, J. D. Select flavonoids and whole juice from 
purple grapes inhibit platelet function and enhance nitric oxide release. 
Circulation 2001, 103, 2792-2798. 
66. Natella, F.; Nardini, M.; Belelli, F.; Pignatelli, P.; Di Santo, S.; Ghiselli, A.; 
Violi, F.; Scaccini, C. Effect of coffee drinking on platelets: inhibition of 
aggregation and phenols incorporation. Brit J Nutr 2008, 100, 1276-1282. 
67. Steptoe, A.; Gibson, E. L.; Vuononvirta, R.; Hamer, M.; Wardle, J.; Rycroft, 
J. A.; Martin, J. F.; Erusalimsky, J. D. The effects of chronic tea intake on platelet 
activation and inflammation: A double-blind placebo controlled trial. 
Atherosclerosis 2007, 193, 277-282. 
68. Sugiyama, H.; Akazome, Y.; Shoji, T.; Yamaguchi, A.; Yasue, M.; Kanda, 
T.; Ohtake, Y. Oligomeric procyanidins in apple polyphenol are main active 
components for inhibition of pancreatic lipase and tri-glyceride absorption (vol 
55, pg 4604, 2007). J Agric Food Chem 2007, 55, 5906-5906. 
69. Vidal, R.; Hernandez-Vallejo, S.; Pauquai, T.; Texier, O.; Rousset, M.; 
Chambaz, J.; Demignot, S.; Lacorte, J. M. Apple procyanidins decrease cholesterol 
esterification and lipoprotein secretion in Caco-2/TC7 enterocytes. J Lipid Res 
2005, 46, 258-268. 
70. Quinones, M.; Miguel, M.; Aleixandre, A. Beneficial effects of 
polyphenols on cardiovascular disease. Pharmacol Res 2013, 68, 125-131. 
Chapter 1 
 
45 
71. Moreira, A. C.; Silva, A. M.; Santos, M. S.; Sardão, V. A. Phytoestrogens as 
alternative hormone replacement therapy in menopause: What is real, what is 
unknown. J Steroid Biochem Mol Biol 2014, 143, 61-71. 
72. Eden, J. A. Phytoestrogens for menopausal symptoms: A review. 
Maturitas 2012, 72, 157-159. 
73. Picherit, C.; Coxam, V.; Bennetau-Pelissero, C.; Kati-Coulibaly, S.; 
Davicco, M. J.; Lebecque, P.; Barlet, J. P. Daidzein is more efficient than genistein 
in preventing ovariectomy-induced bone loss in rats. J Nutr 2000, 130, 1675-1681. 
74. Levis, S.; Strickman-Stein, N.; Ganjei-Azar, P.; Xu, P.; Doerge, D. R.; 
Krischer, J. Soy isoflavones in the prevention of menopausal bone loss and 
menopausal symptoms: a randomized, double-blind trial. Arch Intern Med 2011, 
171, 1363-1369. 
75. Guha, N.; Kwan, M. L.; Quesenberry, C. P.; Weltzien, E. K.; Castillo, A. L.; 
Caan, B. J. Soy isoflavones and risk of cancer recurrence in a cohort of breast 
cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res. 
Treat. 2009, 118, 395-405. 
76. Wu, A. H.; Ziegler, R. G.; Nomura, A. M. Y.; West, D. W.; Kolonel, L. N.; 
Horn-Ross, P. L.; Hoover, R. N.; Pike, M. C. Soy intake and risk of breast cancer in 
Asians and Asian Americans. Am J Clin Nutr 1998, 68, 1437S-1443S. 
77. Khan, S. A.; Chatterton, R. T.; Michel, N.; Bryk, M.; Lee, O.; Ivancic, D.; 
Heinz, R.; Zalles, C. M.; Helenowski, I. B.; Jovanovic, B. D.; Franke, A. A.; 
Bosland, M. C.; Wang, J.; Hansen, N. M.; Bethke, K. P.; Dew, A.; Coomes, M.; 
Bergan, R. C. Soy isoflavone supplementation for breast cancer risk reduction: a 
randomized phase II trial. Cancer Prev Res 2012, 5, 309-319. 
78. Bryant, M.; Cassidy, A.; Hill, C.; Powell, J.; Talbot, D.; Dye, L. Effect of 
consumption of soy isoflavones on behavioural, somatic and affective symptoms 
in women with premenstrual syndrome. Brit J Nutr 2005, 93, 731-739. 
79. Joseph, J. A.; Shukitt-Hale, B.; Denisova, N. A.; Prior, R. L.; Cao, G.; 
Martin, A.; Taglialatela, G.; Bickford, P. C. Long-term dietary strawberry, spinach, 
or vitamin E supplementation retards the onset of age-related neuronal signal-
transduction and cognitive behavioral deficits. J Neurosci 1998, 18, 8047-8055. 
80. Joseph, J. A.; Shukitt-Hale, B.; Denisova, N. A.; Bielinski, D.; Martin, A.; 
McEwen, J. J.; Bickford, P. C. Reversals of age-related declines in neuronal signal 
transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or 
strawberry dietary supplementation. J Neurosci 1999, 19, 8114-8121. 
81. Barbara Shukitt-Hale; Marshall G. Miller; Yi-Fang Chu; Barbara J. Lyle; 
Joseph, J. A. Coffee, but not caffeine, has positive effects on cognition and 
psychomotor behavior in aging. AGE 2013, 35, 2183-2192. 
82. Krikorian, R.; Nash, T. A.; Shidler, M. D.; Shukitt-Hale, B.; Joseph, J. A. 
Concord grape juice supplementation improves memory function in older adults 
with mild cognitive impairment. Brit J Nutr 2010, 103, 730-734. 
Introduction 
 
46 
83. Krikorian, R.; Boespflug, E. L.; Fleck, D. E.; Stein, A. L.; Wightman, J. D.; 
Shidler, M. D.; Sadat-Hossieny, S. Concord grape juice supplementation and 
neurocognitive function in human aging. J Agric Food Chem 2012, 60, 5736-5742. 
84. Farr, S. A.; Price, T. O.; Dominguez, L. J.; Motisi, A.; Saiano, F.; Niehoff, 
M. L.; Morley, J. E.; Banks, W. A.; Ercal, N.; Barbagallo, M. Extra virgin olive oil 
improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012, 28, 81-92. 
85. Bhullar, K. S.; Rupasinghe, H. P. V. Polyphenols: multipotent therapeutic 
agents in neurodegenerative diseases. Oxid Med Cell Longev 2013, 2013, 891748-
891748. 
86. Scarmeas, N.; Luchsinger, J. A.; Mayeux, R.; Stern, Y. Mediterranean diet 
and Alzheimer disease mortality. Neurology 2007, 69, 1084-1093. 
87. Beking, K.; Vieira, A. Flavonoid intake and disability-adjusted life years 
due to Alzheimer's and related dementias: a population-based study involving 
twenty-three developed countries. Public Health Nutr 2010, 13, 1403-1409. 
88. Gao, X.; Cassidy, A.; Schwarzschild, M. A.; Rimm, E. B.; Ascherio, A. 
Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology 
2012, 78, 1138-1145. 
89. Spencer, J. P. E. The interactions of flavonoids within neuronal signalling 
pathways. Genes Nutr 2007, 2, 257-273. 
90. Williams, R. J.; Spencer, J. P.; Rice-Evans, C. Flavonoids: antioxidants or 
signalling molecules? Free Radic Biol Med 2004, 36, 838-849. 
91. Spencer, J. P. Beyond antioxidants: the cellular and molecular interactions 
of flavonoids and how these underpin their actions on the brain. Proc Nutr Soc 
2010, 69, 244-60. 
92. Yoshida, K.; Maeda, K.; Sugiyama, Y. Hepatic and intestinal drug 
transporters: prediction of pharmacokinetic effects caused by drug-drug 
interactions and genetic polymorphisms. Annu Rev Pharmacol Toxicol 2013, 53, 
581-612. 
93. DeSesso, J. M.; Jacobson, C. F. Anatomical and physiological parameters 
affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 2001, 
39, 209-228. 
94. Tian, X. J.; Yang, X. W.; Yang, X. D.; Wang, K. Studies of intestinal 
permeability of 36 flavonoids using Caco-2 cell monolayer model. Int J Pharm 
2009, 367, 58-64. 
95. Farrell, T. L.; Poquet, L.; Dew, T. P.; Barber, S.; Williamson, G. Predicting 
phenolic acid absorption in Caco-2 cells: a theoretical permeability model and 
mechanistic study. Drug Metab Dispos 2012, 40, 397-406. 
96. Day, A. J.; Canada, F. J.; Diaz, J. C.; Kroon, P. A.; McLauchlan, R.; Faulds, 
C. B.; Plumb, G. W.; Morgan, M. R. A.; Williamson, G. Dietary flavonoid and 
isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin 
hydrolase. FEBS Letters 2000, 468, 166-170. 
Chapter 1 
 
47 
97. Gee, J. M.; DuPont, M. S.; Day, A. J.; Plumb, G. W.; Williamson, G.; 
Johnson, I. T. Intestinal transport of quercetin glycosides in rats involves both 
deglycosylation and interaction with the hexose transport pathway. J Nutr 2000, 
130, 2765-2771. 
98. Makino, T.; Shimizu, R.; Kanemaru, M.; Suzuki, Y.; Moriwaki, M.; 
Mizukami, H. Enzymatically modified isoquercitrin, alpha-oligoglucosyl 
quercetin 3-O-glucoside, is absorbed more easily than other quercetin glycosides 
or aglycone after oral administration in rats. Biol Pharm Bull 2009, 32, 2034-2040. 
99. Bredsdorff, L.; Nielsen, I. L.; Rasmussen, S. E.; Cornett, C.; Barron, D.; 
Bouisset, F.; Offord, E.; Williamson, G. Absorption, conjugation and excretion of 
the flavanones, naringenin and hesperetin from alpha-rhamnosidase-treated 
orange juice in human subjects. Br J Nutr 2010, 103, 1602-1609. 
100. Graefe, E. U.; Wittig, J.; Mueller, S.; Riethling, A. K.; Uehleke, B.; 
Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics 
and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 2001, 41, 
492-499. 
101. Kay, C. D.; Kroon, P. A.; Cassidy, A. The bioactivity of dietary 
anthocyanins is likely to be mediated by their degradation products. Mol Nutr 
Food Res 2009, 53, S92-S101. 
102. Aura, A. M.; Martin-Lopez, P.; O'Leary, K. A.; Williamson, G.; Oksman-
Caldentey, K. M.; Poutanen, K.; Santos-Buelga, C. In vitro metabolism of 
anthocyanins by human gut microflora. Eur J Nutr 2005, 44, 133-142. 
103. Sadilova, E.; Stintzing, F. C.; Carle, R. Thermal degradation of acylated 
and nonacylated anthocyanins. J Food Sci 2006, 71, C504-C512. 
104. Kay, C. D.; Mazza, G.; Holub, B. J. Anthocyanins exist in the circulation 
primarily as metabolites in adult men. J Nutr 2005, 135, 2582-2588. 
105. Serra, A.; Macia, A.; Romero, M.-P.; Valls, J.; Blade, C.; Arola, L.; Motilva, 
M.-J. Bioavailability of procyanidin dimers and trimers and matrix food effects in 
in vitro and in vivo models. Brit J Nutr 2010, 103, 944-952. 
106. Zumdick, S.; Deters, A.; Hensel, A. In vitro intestinal transport of 
oligomeric procyanidins (DP 2 to 4) across monolayers of Caco-2 cells. Fitoterapia 
2012, 83, 1210-1217. 
107. Holt, R. R.; Lazarus, S. A.; Sullards, M. C.; Zhu, Q. Y.; Schramm, D. D.; 
Hammerstone, J. F.; Fraga, C. G.; Schmitz, H. H.; Keen, C. L. Procyanidin dimer 
B2 [epicatechin-(4 beta-8)-epicatechin] in human plasma after the consumption of 
a flavanol-rich cocoa. Am J Clin Nutr 2002, 76, 798-804. 
108. Shrestha, S. P.; Thompson, J. A.; Wempe, M. F.; Gu, M.; Agarwal, R.; 
Agarwal, C. Glucuronidation and methylation of procyanidin dimers b2 and 3,3″-
di-o-galloyl-b2 and corresponding monomers epicatechin and 3-o-galloyl-
epicatechin in mouse liver. Pharm Res 2012, 29, 856-865. 
Introduction 
 
48 
109. Borges, G.; Lean, M. E. J.; Roberts, S. A.; Crozier, A. Bioavailability of 
dietary (poly)phenols: a study with ileostomists to discriminate between 
absorption in small and large intestine. Food Funct 2013, 4, 754-762. 
110. Knaup, B.; Kahle, K.; Erk, T.; Valotis, A.; Scheppach, W.; Schreier, P.; 
Richling, E. Human intestinal hydrolysis of phenol glycosides - a study with 
quercetin and p-nitrophenol glycosides using ileostomy fluid. Mol Nutr Food Res 
2007, 51, 1423-1429. 
111. Marks, S. C.; Mullen, W.; Borges, G.; Crozier, A. Absorption, metabolism, 
and excretion of cider dihydrochalcones in healthy humans and subjects with an 
ileostomy. J Agric Food Chem 2009, 57, 2009-2015. 
112. Erk, T.; Williamson, G.; Renouf, M.; Marmet, C.; Steiling, H.; Dionisi, F.; 
Barron, D.; Melcher, R.; Richling, E. Dose-dependent absorption of chlorogenic 
acids in the small intestine assessed by coffee consumption in ileostomists. Mol 
Nutr Food Res 2012, 56, 1488-1500. 
113. Erk, T.; Renouf, M.; Williamson, G.; Melcher, R.; Steiling, H.; Richling, E. 
Absorption and isomerization of caffeoylquinic acids from different foods using 
ileostomist volunteers. Eur J Nutr 2014, 53, 159-166. 
114. Stalmach, A.; Mullen, W.; Steiling, H.; Williamson, G.; Lean, M. E. J.; 
Crozier, A. Absorption, metabolism, and excretion of green tea flavan-3-ols in 
humans with an ileostomy. Mol Nutr Food Res 2010, 54, 323-334. 
115. O'Hara, A. M.; Shanahan, F. The gut flora as a forgotten organ. Embo 
Reports 2006, 7, 688-693. 
116. Etxeberria, U.; Fernandez-Quintela, A.; Milagro, F. I.; Aguirre, L.; Alfredo 
Martinez, J.; Portillo, M. P. Impact of polyphenols and polyphenol-rich dietary 
sources on gut microbiota composition. J Agric Food Chem 2013, 61, 9517-9533. 
117. Williamson, G.; Clifford, M. N. Colonic metabolites of berry polyphenols: 
the missing link to biological activity? Brit J Nutr 2010, 104, 48-66. 
118. Gonzalez-Barrio, R.; Edwards, C. A.; Crozier, A. Colonic catabolism of 
ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro 
studies. Drug Metab Dispos 2011, 39, 1680-1688. 
119. Ludwig, I. A.; Paz de Pena, M.; Cid, C.; Crozier, A. Catabolism of coffee 
chlorogenic acids by human colonic microbiota. Biofactors 2013, 39, 623-632. 
120. Cerda, B.; Tomas-Barberan, F. A.; Espin, J. C. Metabolism of antioxidant 
and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and 
oak-aged wine in humans: Identification of biomarkers and individual variability. 
J Agric Food Chem 2005, 53, 227-235. 
121. Cerda, B.; Periago, P.; Espin, J. C.; Tomas-Barberan, F. A. Identification of 
urolithin A as a metabolite produced by human colon microflora from ellagic acid 
and related compounds. J Agric Food Chem 2005, 53, 5571-5576. 
Chapter 1 
 
49 
122. Seeram, N. P.; Henning, S. M.; Zhang, Y.; Suchard, M.; Li, Z.; Heber, D. 
Pomegranate juice ellagitannin metabolites are present in human plasma and 
some persist in urine for up to 48 hours. J Nutr 2006, 136, 2481-2485. 
123. Gonzalez-Sarrias, A.; Gimenez-Bastida, J. A.; Garcia-Conesa, M. T.; 
Gomez-Sanchez, M. B.; Garcia-Talavera, N. V.; Gil-Izquierdo, A.; Sanchez-
Alvarez, C.; Fontana-Compiano, L. O.; Morga-Egea, J. P.; Pastor-Quirante, F. A.; 
Martinez-Diaz, F.; Tomas-Barberan, F. A.; Carlos Espin, J. Occurrence of 
urolithins, gut microbiota ellagic acid metabolites and proliferation markers 
expression response in the human prostate gland upon consumption of walnuts 
and pomegranate juice. Mol Nutr Food Res 2010, 54, 311-322. 
124. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, M. E. J.; Edwards, C. A.; 
Crozier, A. Green tea flavan-3-ols: colonic degradation and urinary excretion of 
catabolites by humans. J Agric Food Chem 2010, 58, 1296-1304. 
125. Monagas, M.; Urpi-Sarda, M.; Sanchez-Patan, F.; Llorach, R.; Garrido, I.; 
Gomez-Cordoves, C.; Andres-Lacueva, C.; Bartolome, B. Insights into the 
metabolism and microbial biotransformation of dietary flavan-3-ols and the 
bioactivity of their metabolites. Food Funct 2010, 1, 233-253. 
126. Anger, D. L.; Petre, M. A.; Crankshaw, D. J. Heteroactivation of 
cytochrome P450 1A1 by teas and tea polyphenols. Br J Pharmacol 2005, 145, 926-
933. 
127. Kimura, Y.; Ito, H.; Ohnishi, R.; Hatano, T. Inhibitory effects of 
polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol 
2010, 48, 429-435. 
128. Pohl, C.; Will, F.; Dietrich, H.; Schrenk, D. Cytochrome p450 1A1 
expression and activity in Caco-2 cells: Modulation by apple juice extract and 
certain apple polyphenols. J Agric Food Chem 2006, 54, 10262-10268. 
129. Schwarz, D.; Kisselev, P.; Schunck, W.-H.; Roots, I. Inhibition of 17 beta-
estradiol activation by CYP1A1: Genotype- and regioselective inhibition by St. 
John's Wort and several natural polyphenols. Biochim Biophys Acta 2011, 1814, 168-
174. 
130. Shangari, N.; Chan, T. S.; O'Brien, P. J., Sulfation and glucuronidation of 
phenols: Implications in coenyzme Q metabolism. In Phase II Conjugation Enzymes 
and Transport Systems, Sies, H.; Packer, L., Eds. 2005; Vol. 400, pp 342-359. 
131. Rowland, A.; Miners, J. O.; Mackenzie, P. I. The UDP-
glucuronosyltransferases: Their role in drug metabolism and detoxification. Int J 
Biochem Cell Biol 2013, 45, 1121-1132. 
132. Kurogi, K.; Alazizi, A.; Liu, M. Y.; Sakakibara, Y.; Suiko, M.; Sugahara, T.; 
Liu, M. C. Concerted actions of the catechol O-methyltransferase and the cytosolic 
sulfotransferase SULT1A3 in the metabolism of catecholic drugs. Biochem 
Pharmacol 2012, 84, 1186-1195. 
Introduction 
 
50 
133. Meng, S.; Wu, B.; Singh, R.; Yin, T.; Morrow, J. K.; Zhang, S.; Hu, M. 
SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can 
be explained by the relevant molecular docking studies. Mol Pharm 2012, 9, 862-
873. 
134. Ung, D.; Nagar, S. Variable sulfation of dietary polyphenols by 
recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1. 
Drug Metab Dispos 2007, 35, 740-746. 
135. Lautala, P.; Ulmanen, I.; Taskinen, J. Molecular mechanisms controlling 
the rate and specificity of catechol O-methylation by human soluble catechol O-
methyltransferase. Mol Pharmacol 2001, 59, 393-402. 
136. Bai, H.-W.; Shim, J.-Y.; Yu, J.; Zhu, B. T. Biochemical and molecular 
modeling studies of the O-methylation of various endogenous and exogenous 
catechol substrates catalyzed by recombinant human soluble and membrane-
bound catechol-O-methyltransferases. Chem Res Toxicol 2007, 20, 1409-1425. 
137. Zhu, B. T.; Patel, U. K.; Cai, M. X. X.; Conney, A. H. O-methylation of tea 
polyphenols catalyzed by human placental cytosolic catechol-O-
methyltransferase. Drug Metab Dispos 2000, 28, 1024-1030. 
138. Kuhnle, G.; Spencer, J. P. E.; Schroeter, H.; Shenoy, B.; Debnam, E. S.; Srai, 
S. K. S.; Rice-Evans, C.; Hahn, U. Epicatechin and catechin are O-methylated and 
glucuronidated in the small intestine. Biochem Biophys Res Commun 2000, 277, 507-
512. 
139. Zhu, B. T.; Ezell, E. L.; Liehr, J. G. Catechol-o-methyltransferase-catalyzed 
rapid o-methylation of mutagenic flavonoids - metabolic inactivation as a 
possible reason for their lack of carcinogenicity in-vivo. J Biol Chem 1994, 269, 292-
299. 
140. Williamson, G.; Barron, D.; Shimoi, K.; Terao, J. In vitro biological 
properties of flavonoid conjugates found in vivo. Free Radical Res 2005, 39, 457-
469. 
141. Xu, C. J.; Li, C. Y. T.; Kong, A. N. T. Induction of phase I, II and III drug 
metabolism/transport by xenobiotics. Arch Pharmacal Res 2005, 28, 249-268. 
142. Döring, B.; Petzinger, E. Phase 0 and phase III transport in various 
organs: Combined concept of phases in xenobiotic transport and metabolism. 
Drug Metab Rev 2014, Doi:10.3109/03602532.2014.882353. 
143. Silberberg, M.; Morand, C.; Mathevon, T.; Besson, C.; Manach, C.; 
Scalbert, A.; Remesy, C. The bioavailability of polyphenols is highly governed by 
the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur 
J Nutr 2006, 45, 88-96. 
144. Brand, W.; van der Wel, P. A. I.; Rein, M. J.; Barron, D.; Williamson, G.; 
van Bladeren, P. J.; Rietjens, I. M. C. M. Metabolism and transport of the citrus 
flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos 2008, 36, 1794-
1802. 
Chapter 1 
 
51 
145. Barrington, R.; Williamson, G.; Bennett, R. N.; Davis, B. D.; Brodbelt, J. S.; 
Kroon, P. A. Absorption, conjugation and efflux of the flavonoids, kaempferol 
and galangin, using the intestinal CaCo-2/TC7 cell model. J Funct Foods 2009, 1, 
74-87. 
146. Williamson, G.; Aeberli, I.; Miguet, L.; Zhang, Z.; Sanchez, M. B.; Crespy, 
V.; Barron, D.; Needs, P.; Kroon, P. A.; Glavinas, H.; Krajcsi, P.; Grigorov, M. 
Interaction of positional isomers of quercetin glucuronides with the transporter 
ABCC2 (cMOAT, MRP2). Drug Metab Dispos 2007, 35, 1262-1268. 
 
 
 
52 
 
 
 
 
 
 
 
Chapter 2 
 
  
 
Analysis of (poly)phenols in berries  
 
 
 
 
 
 
This chapter is based on the following manuscript: 
Analysis of phenolic compounds in Portuguese wild and commercial 
berries after multi-enzyme hydrolysis. 
Rui C. Pimpao; Tristan Dew; Pedro B. Oliveira; Gary Williamson;, Ricardo B. 
Ferreira; Cláudia N. Santos. Journal of Agricultural and Food Chemistry 2013, 61, 
4053-4062. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter contains published data in which the author of this 
dissertation executed all the experimental work and wrote the manuscript.  
Chapter 2 
 
55 
 
Contents 
Abstract ..................................................................................................... 56 
Introduction ............................................................................................. 57 
Material and methods ............................................................................ 59 
Chemicals and standards ........................................................................................... 59 
Plant material............................................................................................................... 60 
Soluble solids content (SSc) and total titratable acidity (TAc) .............................. 60 
Extraction of phytochemicals .................................................................................... 61 
Total phenolic measurement ..................................................................................... 61 
Anthocyanin content .................................................................................................. 61 
Peroxyl Radical Scavenging Capacity Assay .......................................................... 62 
Vitamin C determination ........................................................................................... 62 
Enzymatic hydrolysis of glycosides ......................................................................... 63 
HPLC analysis of (poly)phenols ............................................................................... 64 
Statistical analysis ....................................................................................................... 65 
Results and Discussion ......................................................................... 67 
Soluble solid content and titratable acidity ............................................................. 67 
Phytochemical analysis .............................................................................................. 68 
HPLC analysis ............................................................................................................. 71 
Analysis of aglycones after enzyme hydrolysis of glycosides .............................. 73 
Acknowledgements ................................................................................ 86 
References ................................................................................................ 86 
Supplementary Material ....................................................................... 92 
 
 
Analysis of (poly)phenols in berries 
 
56 
ABSTRACT 
Berry fruits are a good source of phenolic compounds, and thus 
potentially beneficial to health. Phenolic compounds are mainly present as 
a variety of conjugated forms, either with sugars via O-glycosidic bonds 
or with other polyols as esters. This chemodiversity makes 
characterization and identification highly demanding. Selected varieties of 
commercial blueberries, raspberries and blackberries, and two wild 
berries, Portuguese crowberry and strawberry tree fruit, were 
characterized for individual phenolic content by Liquid Chromatography 
– Diode Array Detection and mass spectrometry (HPLC-DAD-MS) after 
hydrolysis by a novel combination of the fungal glycosidases, 
hesperidinase and cellulase. This approach is shown to be a simple 
alternative to other existing methods for analysis of plant phenolic 
compound aglycones. The hydrolysis of glycosides and organic acid esters 
is efficient, and less aggressive than acid and alkaline hydrolysis. This 
method is able to disclose new sources of dietary phenolic compounds 
and the potential usefulness of Portuguese crowberry and strawberry tree 
fruit is herein demonstrated. 
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INTRODUCTION 
Experimental and epidemiological evidence suggests that insufficient 
intake of fruit and vegetables may predispose the human body to a range 
of chronic health disorders. Consumption of fruit and vegetables has been 
associated with a decreased risk for certain degenerative diseases, such as 
coronary heart disease, stroke, cancer, diabetes mellitus and  
osteoporosis 1-6. These effects have been associated with the ingestion of 
(poly)phenols, a class of plant secondary metabolites, which although not 
being classically “essential”, are described as having beneficial health 
effects such as anti-inflammatory, antioxidant, neuroprotective and 
promoters of healthy ageing 7-14.  
Berry fruits are particularly rich in a diverse range of (poly)phenols 1 from 
several different classes. The most abundant classes in berries are phenolic 
acids, tannins, and flavonoids, especially anthocyanins, responsible for the 
colored pigmentation 10.  Most phenolic compounds are present in plants 
as a variety of conjugated forms, either with sugars via O-glycosidic 
bonds or with other polyols as esters 15. Numerous points of conjugation 
per aglycone can be possible (depending on class), leading to a diverse 
range of potential forms, differing in their bioavailabilities and 
bioactivities. This complexity also makes characterization and 
identification challenging. Following ingestion, whilst some (poly)phenols 
may be absorbed intact, typically absorption in the digestive tract requires 
hydrolysis of glycoside conjugates by small-intestinal lactase phlorizin 
hydrolase or cytosolic β-glucosidase 16, 17. Aglycones are then subjected to 
phase II metabolism, and can be sulfated, methylated and  
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glucuronidated 18. Compounds that escape from absorption in the small 
intestine can reach the colon and undergo biotransformation by the 
colonic microflora resulting in simpler catabolites which may also be 
absorbed and metabolized 19.  
Commercial exploitation of a wider range of edible fruits could facilitate 
increased consumer intake, and characterization of (poly)phenols within 
these novel species may yield useful hints as to their potential bioactive 
capacity. Portuguese crowberry, Corema album L., is a low trailing shrub 
endemic to the Iberian Peninsula, belonging to the Empetraceae family and 
grows mainly in coastal habitats, particularly in sand dunes.  It produces 
edible quasi-spherical drupes, approximately 1 cm in diameter, which are 
white when ripe and have a sugary and water-rich pulp 20. The berries 
take months to ripen and peak of ripening happens in August and early 
September. Portuguese crowberries are edible and although they are not 
currently commercially exploited, are a potentially important source of 
nutrients and phytochemicals. Recently, they were described as a good 
source of phenolic acids and flavonols 21. 
Strawberry tree, Arbutus unedo L., belongs to the Ericaceae family and is a 
typical shrub of the Mediterranean region. It produces edible spherical red 
berries when ripe, which are mostly processed to manufacture alcoholic 
beverages, jams and marmalades 22. They are a good source of sugars, 
minerals, vitamins, carotenoids, organic acids and phenolic compounds 
such as proanthocyanidins and flavonoids and phenolic acids, which as 
expected are mostly glycosylated or esterified with organic acids 23-26.  
In addition to these native berries, the specific climatic conditions in 
Portugal grant to producers the possibility of off-season production of 
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high quality berry fruits that are already commercially exploited, such as 
blueberries, raspberries and blackberries. Several commercial varieties of 
these berries are being tested in the Experimental Field of Fataca for 
perfecting production technologies and to enhance fruit quality and 
phytochemical value.  
The aim of this study was to perform a novel combination of enzymes for 
hydrolysis of phenolics glycosides and quantification of aglycones by 
HPLC-diode array detection (DAD) with confirmation by mass 
spectrometry. The usefulness of this method was tested in five different 
berries, Portuguese crowberry, strawberry tree fruits, blueberry, raspberry 
and blackberry. 
 
MATERIAL AND METHODS 
Chemicals and standards 
Organic solvents were purchased from Fischer Scientific and were of 
HPLC grade. Formic acid was purchased from the same company. 
Phloroglucinaldehyde, p-coumaric acid, ferulic acid, caffeic acid, 
punicalagin and avicularin were from Sigma Aldrich (St. Louis, MO, 
USA). All other reagents otherwise stated were purchased from Sigma 
Aldrich. Folin-Ciocalteau reagent and vanillic acid were from Fluka 
(Buchs, Switzerland). 5-Caffeoylquinic acid, 3-caffeoylquinic acid and 
protocatechuic acid were from Acros Organics (Geel, Belgium). 3-
Methylgallic acid was from Apin Chemicals Ltd. (Abingdon, UK) and 
syringic acid from Alfa Aesar (Haverhill, USA). Gallic acid, daidzein, 
cyanidin-3-O-glucoside, (+)-catechin, (-)-epicatechin, ellagic acid, 
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myricetin, quercetin, kaempferol, myricitrin, hyperoside, quercitrin, rutin, 
isoquercitrin, astragalin and nicotiflorine were purchased from 
Extrasynthese (Lyon, France). Cellulase (EC. 3.2.1.4) and hesperidinase 
(EC. 3.2.1.40) from Aspergillus niger were purchased from Sigma Aldrich 
(St. Louis, MO, USA). 
 
Plant material 
Blueberry (Vaccinum spp.) fruits of six cultivars (Biloxi, Sharpblue, Misty, 
Jubilee, Star, Georgia Gem), Raspberry (Rubus idaeus) fruits of three 
varieties (Glen Lyon, Polka and Himbo Top) and Blackberry (Rubus L. 
subgenus Rubus Watson) of five varieties (Arapaho, Loch Tay, Olallie, 
Oros and Karaka Black) were grown in the Fataca experimental field in 
Odemira, Portugal. Wild Portuguese crowberry fruits (Corema album L.) 
were collected in the Comporta region and wild strawberry tree fruits 
(Arbutus unedo L.) were collected from the Alentejo region of Portugal and 
grouped. Fruits were hand-harvested at a mature stage determined by 
their colour and were stored until analysis at -20 °C for no more than 2 
months. 
 
Soluble solids content (SSc) and total titratable acidity (TAc) 
Samples of the fruits were pooled to obtain a composite sample and 
analysed for SSc using a hand refractometer Milwaukee model MR32ATC, 
with a scale range of Brix degrees (°Brix) from 0% to 32.0%.  
TAc was determined by titrating a known volume of fruit juice with 0.1 N 
NaOH until the pH reached 7. The pH was measured with a Crison micro-
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pH 2002 pH meter. The volume of NaOH required was used to calculate 
TAc, which is expressed as g(tartaric acid)/L.  
 
Extraction of phytochemicals 
Fruits were blended using a domestic food processor until they were 
homogeneous, freeze-dried and were then stored at -80 °C. For total 
phenolics, anthocyanins and Oxygen Radical Absorbance Capacity 
(ORAC) analysis, phytochemicals were extracted as previously  
described 23. To each gram of lyophilized powder, 12 mL of ethanol-water 
(1:1) solvent were added and the mixture was shaken for 30 min, at room 
temperature in the dark. The mixture was then centrifuged at 12,400 g 
during 10 min at room temperature. The supernatant was filtered through 
0.20 µm cellulose acetate membrane filters. The resulting extracts were 
stored frozen at –80 °C. 
 
Total phenolic measurement 
Determination of total phenolic compounds was performed by the Folin-
Ciocalteau method 27 adapted for microplates as described elsewhere 28. 
Gallic acid was used as standard and the results were expressed in mg of 
gallic acid equivalents per g of dry weight of plant material (mg GAE/g 
dw). 
 
Anthocyanin content 
The total anthocyanin content of the fruit extracts was determined using a 
pH differential absorbance method as described elsewhere 29. Absorbance 
readings were related to anthocyanin content using the molar extinction 
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coefficient of 26900 (L mol-1 cm-1) for cyanidin-3-O-glucoside 30. Results 
were expressed as mg of cyanidin-3-O-glucoside equivalents per 100 g of 
dry weight of plant material (mg cy-3-gluc/g dw).  
 
Peroxyl Radical Scavenging Capacity Assay 
Peroxyl radical scavenging capacity was determined by the ORAC 
method 31, 32 adapted to microplate as described elsewhere 28. The final 
results were calculated using the area differences under the fluorescence 
decay curves between the blank and the sample, and were expressed as 
mM Trolox equivalents per 100 g of dry weight of plant material (mM 
TE/100 g dw). 
 
Vitamin C determination 
To quantify the total amount of vitamin C (ascorbic acid plus 
dehydroascorbic acid), 50 g of fruits were homogenised with 50 mL of 
phosphoric acid. The homogenate was then centrifuged at 13,000 g for 20 
min at 4 °C and the supernatant filtered using 0.20 µm cellulose acetate 
membrane filters. To 1 mL of the filtrate was added 0.2 mL dithiothreitol 
(20 mg/mL) to reduce dehydroascorbic acid, and allowed to stand in 
darkness for 2 h 33. The solution was then passed through a Millipore 0.45 
µm PTFE filter and injected into the HPLC system. Ascorbic acid 
quantification was conducted on a Hitachi HPLC instrument (VWR) 
equipped with EZChrom Elite software (Agilent), a model L-2130 pump 
system, a model L-2200 autosampler, a model L2300 column oven and a 
model L2455 DAD system. A sample volume of 10 µL was injected and 
separations were achieved on an Inertsil ODS-3V column (250 × 4.6 mm, 5 
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µm), operated at 30 °C. The column was held at 30°C and ascorbic acid 
was eluted isocratically using a 0.7 mL/min flow of 0.01 M H2SO4 (pH 2.5). 
Solutions of L-ascorbic acid prepared in water with concentration values 
between 5 and 500 mg/L were used for the calibration curve and detection 
was made at 262 nm. 
 
Enzymatic hydrolysis of glycosides 
To perform enzymatic hydrolysis of glycosides, phytochemicals were 
extracted by homogenizing 0.3 g of blended fruits with 2.7 mL of ethanol-
water (1:1) containing 1 mM of butylated hydroxytoluene (BHT) and 0.1 
mM of daidzein as internal standard. Samples were vortexed (10 min), 
sonicated (10 min) then vortexed again (10 min), then centrifuged at 3000 
g for 20 min at 4 °C. After collecting the supernatant, the pellet was re-
extracted by the same procedure with 0.9 mL of the extraction solution. 
Supernatants were combined, centrifuged as described and filtered 
through a 0.2 µm PTFE filter. One part of the extract was used directly for 
HPLC analysis of total anthocyanins and caffeoylquinic acids. Another 
part of the extract was dried and reconstituted in water with 1 mM 
ascorbic acid, to protect samples from oxidation. Samples for aglycone 
analysis were adjusted to pH 3.8 with acetate buffer 0.2 M and incubated 
for 16 h at 40 °C with 0.02 U/mL hesperidinase (one unit corresponds to 
333 mg of protein and is defined as the amount required to liberate 1.0 
µmol of glucose from hesperidin per minute at pH 3.8 at 40 °C). The pH 
was then increased to 5.0 with sodium acetate and cellulase was added to 
a final concentration of 20 U/mL (one unit corresponds to 0.885 mg of 
protein and is defined as the amount required to liberate 1.0 µmol of 
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glucose from cellulose in 1 h at pH 5.0 at 37 °C). Samples were incubated 
for a further 4 h at 37 °C and then extracted 3 times with ethyl acetate. The 
ethyl acetate phase (containing phenolic aglycones) was separated, 
evaporated and samples were reconstituted with 2 mL of 0.1% (w/v) 
ascorbic acid solution in ethanol-water (1:1), and filtered through a 0.2 µm 
PTFE filter prior to analysis. The procedure was performed in triplicate for 
each fruit. Hydrolysis conditions were optimized by testing the hydrolysis 
efficiency of fruit extracts by testing individual enzymes incubated for 4 
and 18 h and combined (hesperidinase for 18 h followed by cellulase for 4 
h and cellulase for 18 h followed by hesperidinase for 4 h). Efficiency of 
hydrolysis was also tested by incubating different commercial standards 
of flavonol-glycosides (isoquercitin, hyperoside, rutin, quercitrin, 
avicularin, myricitrin, astragalin and nicotiflorine), 5-caffeoylquinic acid 
and 3-caffeoylquinic acid and punicalagin. Standards were dissolved to a 
concentration of 500 µM and were incubated with enzymes as described 
previously. Efficiency of hydrolysis was evaluated by substrate 
disappearance. Recoveries of the identified aglycones were calculated for 
each compound by spiking each fruit with the identified aglycones (table 
5). Recoveries were used to correct the quantification values of aglycones 
by dividing the determined value by the percentage of the recovery. 
 
HPLC analysis of (poly)phenols 
HPLC analysis was conducted on a series 1200 HPLC instrument (Agilent 
Technologies, Manchester, UK) equipped with ChemStation software 
(B.03.01), a model G1379B degasser, a model G1312B binary gradient 
pump, a model G1367C temperature controlled autosampler, a model 
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G1316B column oven, and a model G1315C DAD. A sample volume of 5 
µL was injected and separations were achieved on a Zorbax Eclipse XDB-
C18 (4.6x50 mm; 1.8 μm), operated at 30 °C, with a 0.2 μm stainless steel 
in-line filter. The method was performed as described by Pandino and co-
workers 34 with the exception of the mobile phase consisting in 0.1% (v/v) 
formic acid in water (solvent A) and 0.1% (v/v) formic acid in acetonitrile 
(solvent B), used at a flow rate of 0.5 mL/min. The gradient started with 
5% B to reach 10% B at 5 min, 40% B at 20 min, 90% B at 25 min, 90% B at 
29 min. 
Chromatograms were recorded at 272, 280, 302, 324, 370 and 520 nm from 
diode array data collected between 200 and 600 nm. All standards were 
dissolved in ethanol or ethanol-water (1:1) and used as stock solutions. 
Calibration curves of peak area against concentration showed a good 
linear correlation with r2 > 0.99. Limits of detection and quantification as 
well as the wavelengths use to detect each compound are represented in 
Table 1. 
Statistical analysis 
The results reported in this work are the averages of at least three 
independent experiments and are represented as the mean ± SD. 
Differences among treatments were detected by analysis of variance with 
Tukey HSD (Honest Significant Difference) multiple comparison test (α = 
0.05) using SigmaStat 3.10 (Systat). 
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Table 1. Chromatography parameters of standard compounds used for peak 
identification 
Standards 
Retention 
Time 
(min) 
Wavelength 
(nm) 
LOD 
(mg/
mL) 
LOQ 
(mg/
mL) 
Calibration 
range 
(mg/mL) 
Gallic acid 2.59 272 0.25 0.5 0.5-100 
Protocatechuic acid 5.26 272 0.09 0.2 0.5-100 
3-Methylgallic acid 6.28 272 0.09 0.2 0.5-100 
3-Caffeoylquinic acid 6.03 324 0.5 0.75 0.75-100 
Cyanidin-3-O-glucoside 8.07 520 0.75 2.5 2.5-100 
5-Caffeoylquinic acid 8.40 324 0.25 0.75 0.75-100 
(+)-Catechin 8.60 280 0.55 1 2.5-100 
Vanillic acid 9.41 272 0.09 0.2 0.5-100 
Caffeic acid 9.84 324 0.04 0.1 0.5-100 
Syringic acid 10.06 272 0.05 0.2 0.25-100 
(-)-Epicatechin 10.54 280 0.3 0.55 1-100 
Phloroglucinaldehyde 12.00 280 0.05 0.1 0.1-100 
p-Coumaric 12.11 302 0.04 0.09 0.1-100 
Ellagic acid 12.97 370 0.1 0.4 0.75-100 
Ferulic acid 13.16 324 0.05 0.15 0.25-100 
Myricetin 15.50 370 0.1 0.25 0.25-100 
Daidzein 17.20 302 0.1 0.25 0.25-100 
Quercetin 18.30 370 0.1 0.25 0.25-100 
Kaempferol 20.83 370 0.1 0.25 0.25-100 
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RESULTS AND DISCUSSION 
Portugal has good climatic conditions to facilitate production of different 
types of berries, and several different varieties have already been 
introduced in experimental fields. In order to select fruits to be further 
analyzed with a diverse chemical composition, an initial screening of 
chemical parameters for available commercial varieties and two wild 
species was performed. 
 
Soluble solid content and titratable acidity 
Fruit quality parameters, such as soluble solids content (SSc) and titratable 
acidity (TAc), important as a quality indexes for the consumer, were 
determined for the berries and their varieties (Table 2). Strawberry tree 
fruit showed the highest SSc, far above the other analyzed berries, in 
contrast to Portuguese crowberry, which exhibited the lowest value. Some 
variability between the varieties of each commercial berry was observed, 
although in general blueberry varieties possessed the highest SSc and 
raspberries the highest TAc values, whilst blueberries were lowest. The 
ratio between SSc and TAc was particularly low for raspberry fruits, 
Portuguese crowberry and blackberry variety Oros, suggesting that 
acidity would be obvious to consumers. The opposite was observed for 
blueberry varieties and strawberry tree fruit where a sweet flavour would 
be more prevalent. The high sugar content of strawberry tree fruit 
translates to a proclivity towards fermentation, making its chief utilization 
as a processed product rather than a fresh fruit. On the other hand the 
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high acidity of Portuguese crowberry fruits may contribute to the lack of 
demand by Portuguese consumers. 
 
Table 2. Analysis of fruits for soluble solids content (SSc) and titratable acidity 
(TAc)  
Fruit Variety SSc (ºBrix) TAc [g(tartaric 
acid)/L] 
SSc/TAc 
Blueberry Biloxi 12.2  0.8ª 3.5       3.4 
 
Sharp Blue 12.0  1.3ª 5.6 2.1 
Misty 11.3  0.8ª 5.5 2.1 
Jubilee 12.7  2.3ª 5.4 2.3 
Star 14.2  2.1ª 2.9 4.8 
Georgia Gem 15.3  1.5ª 2.6 5.8 
Raspberry Glen Lyon 9.2  1.0
a
 14.6 0.6 
Polka 8.7  1.5ª 9.1 1.0 
Himbo Top 9.0  0
a
 13.3 0.7 
Blackberry Loch Tay 13.0  2.1
ab
 5.1 2.5 
Olallie 7.4  0.9
c
 4.5 1.7 
Arapaho 9.8  1.0
bc
 7.1 1.4 
Oros 7.1  0.9
c
 8.9 0.8 
Karaka Black 13.7  2.0
a
 6.2 2.2 
Portuguese crowberry  6.8  0 8.7 0.8 
Strawberry tree fruit 27.8  0.1 7.4 3.7 
 A, b, c represent the significance levels between varieties of the same fruit. 
 
Phytochemical analysis 
Fruit extracts were quantified for total phenols, anthocyanins and 
antioxidant capacity (Fig. 1). These methods, although having some 
limitations and interferences, were selected as preliminary assays for 
quantification of phenolic compounds, in order to choose one variety of 
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each for subsequent studies. Blackberries and blueberries were the fruits 
with higher content in total phenolic compounds and antioxidant 
capacity, which can be attributed to their high content of anthocyanins. 
The values of total phenolic compounds and antioxidant capacity of both 
wild berries were at a similar level to raspberries although their content of 
anthocyanins was very low. Whilst strawberry tree fruit have a red peel, 
their anthocyanin level is low. In terms of varietal diversity, for 
blueberries, Georgia Gem contained the highest values for total phenolic 
compounds and anthocyanins. For raspberries, Himbo Top contained the 
highest values of total phenolic compounds, anthocyanins and antioxidant 
capacity. All blackberry varieties possessed high values for anthocyanins 
and antioxidant capacity, and although Karaka Black contains slightly 
lower values for both parameters, it was the highest for total phenolic 
compounds content.  
Based on these results, the blueberry variety Georgia Gem, the raspberry 
variety Himbo Top and the blackberry variety Karaka Black were selected 
together with strawberry tree and Portuguese crowberry fruits for a more 
detailed analysis of phenolic compounds and free aglycones for the 
proposed method. 
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HPLC analysis 
Analysis of intact, non-hydrolyzed fruit extracts by HPLC-DAD revealed 
a great complexity and diversity of compounds hampering individual 
identification of compounds. Only 3-caffeoylquinic and 5-caffeoylquinic 
acids were identified and quantified based on their retention time and 
absorption spectra in comparison with standards (Table 3). Both 
caffeoylquinic acids were found to be the major compounds in Portuguese 
crowberry fruits, and 5-caffeoylquinic acid was also abundant in 
blueberry. In a recent study, 5-caffeoylquinic acid was identified as the 
most abundant compound in Portuguese crowberry fruits, at higher levels 
than observed in our study, although reported levels of 3-caffeoylquinic 
acid were lower 21. The values of 5-caffeoylquinic acid are slightly lower 
than described previously for blueberry (47 mg/100 g fw cf published 
values of 64.6 - 208 mg/100 g fw 35, 36. In the other analyzed berries, if 
present, these compounds were too low to be detected or were obscured 
by other peaks. Anthocyanins were also analyzed by HPLC with detection 
at 520 nm and expressed as cyanidin-3-O-glucoside equivalents. Blueberry 
expressed the highest values, whereas anthocyanins were not detected in 
Portuguese crowberry fruits. Despite the fact that strawberry tree fruit has 
a red exocarp (when mature), they contained only 9.7 mg/100 g fw of 
anthocyanins, but even this is higher than the value of 0.51 mg/100 g fw 
previously reported 37. The anthocyanins present in strawberry tree fruits 
are expected to be cyanidin and delphinidin both conjugated with 
galactose and glucose, and the former also conjugated with arabinose 24, 37. 
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Total vitamin C was determined for the berries (Table 3). Strawberry tree 
fruit vitamin C content was far above that of the other fruits and exceeded 
values reported previously by Pallauf and co-workers 24, but in agreement 
with Alarcão-E-Silva and co-workers, who found a similarly high 
ascorbate content compared to other common fruits 22. Values for vitamin 
C in Portuguese crowberries were similar to blackberry while blueberries 
contained the smallest amount (Table 3). 
 
Analysis of aglycones after enzyme hydrolysis of glycosides 
To overcome the complexity of (poly)phenol analysis, the extracts were 
incubated with enzymes from Aspergillus niger: hesperidinase containing 
α-L-rhamnosidase and β-D-glucosidase activities, and cellulase containing 
endo-1,4-β-D-glycosidic activity. Other enzymes from A. niger have 
previously been used to release phenolic acids from carbohydrates 38-40.  
Optimization of hydrolysis conditions and incubation time by using this 
novel combination of enzymes was performed. Fruit extracts and flavonol 
glycoside standards were used to test hydrolysis efficiency. Blueberry, 
due its phytochemical complexity, was selected for this optimization 
process, and the results extrapolated to the other fruits. First, individual 
and a combination of enzymes were incubated with fruit extracts and 
production of aglycones was compared. A combination of enzymes 
proved to be more efficient to obtain a higher degree of aglycones than 
individual enzymes. Hesperidinase hydrolysis was time-dependent 
whereas cellulase had similar efficiency in flavonol-glycoside hydrolysis 
for both 4 and 18 h incubation periods. On the basis of these results, 
incubation of fruit extracts with both enzymes, hesperidinase for 18 h and 
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cellulase for 4 h, allowed complementary hydrolysis optimized the 
reaction to obtain maximum yield of aglycones. 
 Further tests were performed to determine the hydrolytic efficiency of 
flavonol glycosides, by using standard compounds (Table 4). Incubation 
with the above enzyme combination enabled efficient hydrolysis of 
glucosides, rutinosides, and galactosides. The hydrolysis of arabinoside 
bonds was less efficient, as was hydrolysis of the rhamnoside bond in 
myricitrin and quercitrin. The enzymes also hydrolyzed the ester bond 
between caffeic and quinic acids of 3- and 5-caffeoylquinic acids, although 
hydrolysis of 3-caffeoylquinic acid was not complete (Table 4).  
 
Table 4. Hydrolysis efficiency of standard compounds incubated with 
hesperidinase for 18 h, followed by cellulase for 4 h.  
Aglycone Conjugated sugar Compound Name 
Efficiency of 
hydrolysis 
Quercetin Glucoside Isoquercitrin Complete 
 Galactoside Hyperoside Complete 
 Rutinoside Rutin Complete 
 Rhamnoside Quercitrin Incomplete (18%) 
 Arabinoside Avicularin Incomplete (56%) 
Myricetin Rhamnoside Myricitrin Incomplete (17%) 
Kaempferol Glucoside Astragalin Complete 
 Rutinoside Nicotiflorine Complete 
  
5-caffeoylquinic 
acid 
Complete 
  
3-caffeoylquinic 
acid 
Incomplete (61%) 
  Punicalagin Incomplete (73%) 
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The combination of enzymes was observed to hydrolyze punicalagin, an 
ellagitannin, although not completely, resulting in smaller compounds 
such as ellagic (Table 4). This additional hydrolysis (of non-glycosidic 
bonds) was probably due to the presence of other enzyme activities such 
as esterases in commercial enzymes which are only partially purified. 
For each fruit extract, recovery of aglycones was calculated after spiking 
with the reference standard and the values were used for correction of 
quantification (Table 5). Values for most compounds in all extracts were 
satisfactory, with the exception of gallic acid. However, the (low) 
efficiency of extraction of gallic acid was reproducible, implying that the 
limitation was in the incomplete partitioning and not due to instability. 
As expected, HPLC-DAD chromatograms of fruit extracts were far less 
complex following hydrolysis and the respective aglycones present in 
these berries were revealed (Fig. 2-6). 
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Figure 3. HPLC-DAD chromatograms of aglycones present in raspberry var. 
Himbo Top extracts after enzyme hydrolysis: (A) recorded at 270 nm; (B) 
recorded at 370 nm. 1- Gallic acid, 2 - protocatechuic acid, 6 - caffeic acid,  
8 - (-)-epicatechin, 9 - phloroglucinaldehyde, 11 - ellagic acid, 12 - ferulic acid, 
14 - daidzein (IS), 15 - quercetin. 
Figure 2. HPLC-DAD chromatograms of aglycones present in blueberry var. 
Georgia Gem extracts after enzyme hydrolysis: (A) recorded at 270 nm; (B) 
recorded at 370 nm. 1- Gallic acid, 2 - protocatechuic acid, 3 - 3-methylgallic 
acid, 5 - vanillic acid, 6 - caffeic acid, 7 - syringic acid, 8 - (-)-epicatechin, 9 - 
phloroglucinaldehyde, 10 - p-coumaric acid, 11 - ellagic acid, 12 - ferulic acid, 
13 - myricetin, 14 - daidzein (IS), 15 - quercetin, 16 - kaempferol. 
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Identification of the aglycones in the extracts was performed by use of LC-
MS data and confirmed with reference standards. LC-MS data is shown as 
supplementary information (supplementary tables 1-5). Blueberry analysis 
revealed the presence of a high diversity of aglycones (Fig. 2, Table 5 and 
6), with caffeic and gallic acids as the most abundant compounds. The 
majority of caffeic acid resulted from hydrolysis of 5-caffeoylquinic acid 
(as initially quantified) but a proportion is also likely derived from the 
hydrolysis of caffeic-4-O-glucoside, a minor compound previously 
reported in these berries 36. The flavonols myricetin, quercetin and 
kaempferol were also present in blueberries, and are present in 
glycosylated form with values comparable to those reported here 35, 41. 
Protocatechuic, gallic, p-coumaric and ferulic acids present in hydrolyzed 
extracts were previously found conjugated with glucose 36. The same 
study also reported the presence of ferulic, p-coumaric and caffeic acids 
esterified with quinic acid. Of the flavanols, only (-)-epicatechin was 
detected in blueberries. This compound was found in previous studies in 
concentrations between 0.7 and 1.1 mg/100g fresh fruit 15, 42. However, in 
another study, no (-)-epicatechin was observed in 4 varieties of blueberries 
whilst in three of these varieties, (+)-catechin and Procyanidin B2 were 
identified, neither of which were found in our study 43. This clearly reflects 
some chemical diversity of the minor compounds within blueberry 
varieties.  
In the hydrolysed extracts, 3-methylgallic acid, syringic acid, vanillic acid 
and phloroglucinaldeyde were also present, which might be derived from 
hydrolysis or catabolism of compounds initially present in berries.  
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Figure 5. HPLC-DAD chromatograms of aglycones present in Portuguese 
crowberry fruit extracts after enzyme hydrolysis: (A) recorded at 270 nm; (B) 
recorded at 370 nm. 1- Gallic acid, 2 - protocatechuic acid, 5 - vanillic acid, 6 - 
caffeic acid, 8 - (-)-epicatechin, 10 - p-coumaric acid, 12 - ferulic acid, 13 - 
myricetin, 14 - daidzein (IS), 15 - quercetin, 16 - kaempferol. 
Figure 4. HPLC-DAD chromatograms of aglycones present in blackberry var. 
Karaka Black extracts after enzyme hydrolysis: (A) recorded at 270 nm; (B) 
recorded at 370 nm. 1- Gallic acid, 2 - protocatechuic acid, 8 - (-)-epicatechin,  
9 - phloroglucinaldehyde, 11 - ellagic acid, 12 - ferulic acid, 14 - daidzein (IS), 
15 - quercetin, 16 - kaempferol. 
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For raspberries (Fig. 3, Table 5 and 6), the most abundant compound was 
ellagic acid. Whilst this compound has been previously quantified in the 
free form or attached to glycosides, it is mainly found esterified in 
ellagitanins such as sanguiin-H6 and lambertianin C 44, 45. Of the flavanols, 
only quercetin and (-)-epicatechin were detected. The presence of other 
flavanols such as (+)-catechin and procyanidin B2   is inconsistent between 
studies and appears to vary between varieties 42, 46, 47. The same appears to 
happen for kaempferol which was not detected in this work and also in 
some previous studies 46, 47 but was found in other studies 44, 45. Caffeic acid 
was detected and may be derived from the 5-caffeoylquinic acid content 
previously reported in raspberries 48. Mullen and co-workers reported a 
similar method for quantification of  phenolics in raspberry, performing 
an hydrolysis of the extracts with β-glucosidase 45, but of the phenolic 
acids, only the presence of p-coumaric, caffeic and ellagic acids were 
reported. In this work, we also found gallic, protocatechuic and ferulic 
acids, and phloroglucinaldeyde in the hydrolyzed extracts (Fig. 3, Table 
6).  
In blackberries (Fig. 4, Table 5 and 6), the most abundant compounds were 
protocatechuic acid, phloroglucinaldeyde and ellagic acid. Ellagic acid 
was previously found in the free form in blackberries but also esterified as 
ellagitannins 49, 50 whilst protocatechuic acid was previously found in low 
amounts conjugated with glucose 36. As in blueberry and raspberry, of 
flavanols, only (-)-epicatechin was detected in blackberries following 
hydrolysis. However, in previous studies, (+)-catechin was also found in 
low concentrations (6.6 mg/kg) 42, 51 as well as other flavanols (0.06 and 
0.83 mg/100g) 51. Therefore, the presence of some flavanols might be 
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variety dependent, sometimes under the limit of detection.  Quercetin was 
the most abundant flavonol in blackberries, with kaempferol in lower 
amounts in contrast with its absence in previous studies 41, 52. Gallic and 
ferulic acids were also found in hydrolysed blackberry extracts, both 
found previously conjugated with glucose, and ferulic acid with quinic 
acid 36, 49. To be noted is the absence of caffeic acid, which was previously 
described by Schuster in blackberries as conjugated with glucose and 
quinic acid 36. Differences in the presence or absence of some compounds 
in comparison with previous studies might be the result of differences in 
cultivar between fruits and growing conditions.  
Portuguese crowberry extracts also contained a great diversity of phenolic 
aglycones after enzyme hydrolysis (Fig. 5, Table 5 and 6). The most 
abundant compound was caffeic acid, derived mainly from the hydrolysis 
of 3-caffeoylquinic and 5-caffeoylquinic acids, which were abundant in the 
non-hydrolyzed extracts (Table 3). Other hydroxycinnamates such as 
ferulic and p-coumaric acids were found at lower levels. The flavonols 
quercetin, kaempferol and myricetin were present in the hydrolyzed 
extracts. The same compounds were also detected conjugated with 
glycosides in a previous study by HPLC-DAD-MS/MS 21. (-)-Epicatechin, 
however, was not found in the same study.  Gallic, protocatechuic and 
vanillic acids were also found in Portuguese crowberry fruits (Table 6).  
These compounds had been found previously by GC-MS but not by HPLC 
21, demonstrating the utility of the proposed hydrolysis method.    
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In strawberry tree fruit extracts (Fig. 6, Table 5 and 6), gallic acid appears 
as the most abundant compound, at a much higher level than the other 
berries. The abundance of gallic acid is supported by previous studies 
where gallic acid is in the free form or conjugated either with quinic acid, 
shikimic acid or glucose 23, 37, 53. The second most abundant compound was 
(+)-catechin, a compound previously reported in this fruit 24. However, the 
(+)-catechin content of strawberry tree fruits reported here is similar to the 
total content in flavanols reported previously 24. It is possible that this 
higher content in catechin comes from the breakdown of 
proanthocyanidins during enzyme incubation. Ellagic acid was the third 
most abundant compound, and had been previously found conjugated in 
this fruit with glycosides 23, 24. Myricetin, quercetin, and ellagic acid were 
also detected in hydrolyzed extracts (Table 6) and were previously found 
in these berries conjugated with glycosides 24. Protocatechuic acid and 
phloroglucinaldehyde were also detected, and are believed to come 
mainly from hydrolysis and thermal degradation of anthocyanins, even at 
Figure 6. HPLC-DAD chromatograms of aglycones present in strawberry tree 
fruit extracts after enzyme hydrolysis: (A) recorded at 270 nm; (B) recorded at 
370 nm. 1- Gallic acid, 2 - protocatechuic acid, 4 - (+)-catechin,  
9 - phloroglucinaldehyde, 11 - ellagic acid, 13 - myricetin, 14 - daidzein (IS), 15 
- quercetin. 
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acidic pH 54. Anthocyanin degradation is the probable source of 3-
methylgallic acid observed in hydrolyzed blueberry extracts 19. Kay and 
co-workers have detected absorption and phase II metabolites of 
protocatechuic acid and phloroglucinaldehyde in a Caco-2 cell model after 
spontaneous degradation of anthocyanins, and suggest that these 
catabolites may be at least partially responsible for the biological activity 
of anthocyanins in vivo 55.  
The use of this method in five different fruit matrices reveals its 
versatility. Moreover the method is very efficient for hydrolysis of 
glucosides, galactosides and rutinosides, although rhamnosides are less 
efficiently hydrolyzed. Overall, it is a simple and rapid method for 
identification and quantification of phenolic aglycones. Identification and 
quantification of phenolics in plant tissues can be sometimes difficult due 
to a high number and diversity of compounds. Therefore, hydrolysis of 
glycosides and analysis of the resulting aglycones is a usual methodology 
to overcome this problem. Traditional methods based on acid hydrolysis 
of glycoside-bonds require relatively high concentrations (1–2 M) of 
mineral acids at temperatures close to 100 oC 56, 57. However, this 
methodology can be too harsh for some compounds which may undergo 
partial degradation, as observed for catechins and flavonols such as 
myricetin, kaempferol and quercetin 58. It was observed that it is hard to 
reach a compromise as an increase in incubation time can increase 
degradation, but a reduced time can result in underestimation of the 
phenolic content 56, 58. Alkaline hydrolysis can also lead to significant 
losses in hydroxycinnamic acid derivatives as reported by Krygier and co-
workers 59. 
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Methods employing commercial enzymes to release and identify phenolic 
aglycones have also been previously used and have been reported to be 
adequate for phenolic acid quantification in cereals 60-62. Hesperidinase has 
been used for hydrolysis of flavonol-glycosides and analysis of aglycones 
63. Fungal glycosidases can be very useful either for analytical or for other 
purposes.  Previously, rhamnosidases were used to produce functional 
beverages by converting flavonoid-rhamnosides to glucosides, and thus 
increasing bioavailability 64, 65. 
Here, we report for the first time, combined use of hesperidinase and 
cellulase as an efficient method for releasing flavonols and phenolic acids 
aglycones from glycosidic bonds for analytical purposes. Other methods 
have been used for this purpose, but each has advantages and limitations, 
and so should be chosen according to the aim of the determination. This 
method is a simple alternative to analyse complex samples, and its 
usefulness has been demonstrated by application to two non-commercial 
fruits. Blueberry, raspberry and blackberry fruits were also analysed by 
this method and results, with minor exceptions, are generally in 
agreement with published data.  
The results highlight wild berries, Portuguese crowberry and strawberry 
tree, as good source of phenolic compounds. Strawberry tree fruit is 
mostly characterized by the presence of gallic acid derivatives, while 
Portuguese crowberry fruit contains high amounts of caffeic acid 
derivatives. Therefore, they constitute a good alternative to the other berry 
fruits traditionally consumed to increase and diversify of the ingestion of 
phenolic compounds in our diet. 
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SUPPLEMENTARY MATERIAL 
Table 1. LC-MS of blueberry fruit extracts after enzyme hydrolysis 
Peak nr. 
Retention 
Time (min) 
Wavelength 
(nm) 
m/z 
[M-H] 
Compounds 
1 2.59 272 169 Gallic acid 
2 5.26 272 153, 109 Protocatechuic acid 
3 6.28 272 183, 124 3-Methylgallic acid 
5 9.41 272 165 Vanillic acid 
6 9.84 324 179, 135 Caffeic acid 
7 10.06 272 197.1 Syringic acid 
8 10.54 280 289 (-)-Epicatechin 
9 12.00 280 153 Phloroglucinaldehyde 
10 12.11 302 163 p-Coumaric 
11 12.97 370 363, 333 Ellagic acid 
12 13.16 324 193, 355 Ferulic acid 
13 15.50 370 317 Myricetin 
15 18.30 370 301, 331 Quercetin 
16 20.83 370 345 Kaempferol 
Figures in bold are the main m/z. Peaks identification was performed with LC-MS data and confirmed 
with reference standards. 
Total ion scan of fruit extracts was performed as described 34. 
 
 
Table 2. LC-MS of raspberry fruit extracts after enzyme hydrolysis 
Peak nr. 
Retention 
Time (min) 
Wavelength 
(nm) 
m/z 
[M-H] 
Compounds 
1 2.59 272 169 Gallic acid 
2 5.26 272 153, 109 Protocatechuic acid 
6 9.84 324 577, 179 Caffeic acid 
8 10.54 280 289 (-)-Epicatechin 
9 12.00 280 153 Phloroglucinaldehyde 
11 12.97 370 301 Ellagic acid 
12 13.16 324 301, 193 Ferulic acid 
15 18.30 370 
361,  207, 
178, 301 
Quercetin 
Figures in bold are the main m/z. Peaks identification was performed with LC-MS data and confirmed 
with reference standards. 
Total ion scan of fruit extracts was performed as described 34. 
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Table 3. LC-MS of blackberry fruit extracts after enzyme hydrolysis 
Peak nr. 
Retention 
Time (min) 
Wavelength 
(nm) 
m/z 
[M-H] 
Compounds 
1 2.59 272 169, 125 Gallic acid 
2 5.26 272 153, 109 Protocatechuic acid 
8 10.54 280 289, 319 (-)-Epicatechin 
9 12.00 280 153 Phloroglucinaldehyde 
11 12.97 370 301 Ellagic acid 
12 13.16 324 300.9, 223 Ferulic acid 
15 18.30 370 301 Quercetin 
Figures in bold are the main m/z. Peaks identification was performed with LC-MS data and confirmed 
with reference standards. 
Total ion scan of fruit extracts was performed as described 34. 
 
 
 
Table 4. LC-MS of Portuguese crowberry fruit extracts after enzyme hydrolysis 
Peak nr. 
Retention Time 
(min) 
Wavelength 
(nm) 
m/z 
[M-H] 
Compounds 
1 2.59 272 169 Gallic acid 
2 5.26 272 153, 109 Protocatechuic acid 
6 9.84 324 179, 135 Caffeic acid 
8 10.54 280 289, 381 (-)-Epicatechin 
10 12.11 302 163, 119.1 p-Coumaric 
12 13.16 324 193, 301 Ferulic acid 
13 15.50 370 317 Myricetin 
15 18.30 370 331 Quercetin 
16 20.83 370 
206.8, 
178.9, 
284.9 
Kaempferol 
Figures in bold are the main m/z. Peaks identification was performed with LC-MS data and confirmed 
with reference standards. 
Total ion scan of fruit extracts was performed as described 34. 
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Table 5. LC-MS of strawberry tree fruit extracts after enzyme hydrolysis 
Peak nr. 
Retention Time 
(min) 
Wavelength 
(nm) 
m/z 
[M-H] 
Compounds 
1 2.59 272 169, 125 Gallic acid 
2 5.26 272 153, 109 Protocatechuic acid 
4 8.60 280 289 (+)-Catechin 
9 12.00 280 
197, 163, 
206.9, 
152.9 
Phloroglucinaldehyde 
11 12.97 370 223.1, 301 Ellagic acid 
13 15.50 370 317 Myricetin 
15 18.30 370 206.9, 301 Quercetin 
Figures in bold are the main m/z. Peaks identification was performed with LC-MS data and confirmed 
with reference standards. 
Total ion scan of fruit extracts was performed as described 34. 
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Bioavailable (poly)phenol-metabolites in urine of 
human volunteers after ingestion of a mixed berry 
fruit puree  
 
This chapter is based on the following manuscript: 
Urinary metabolite profiling identifies novel colonic metabolites and 
conjugates of phenolics in healthy volunteers. 
Rui C. Pimpao; Tristan Dew; Maria E. Figueira; Gordon J. McDougall; Derek 
Stewart; Ricardo B. Ferreira;, Cláudia N. Santos; Gary Williamson. Molecular 
Nutrition & Food Research 2014, published online, DOI: 10.1002/mnfr.201300822. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter contains published data in which the author of this 
dissertation had a major contribution in the planning of the experimental 
work, performed all the experiments and wrote the manuscript.  
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ABSTRACT 
The colonic metabolism of dietary (poly)phenols is complex and many 
metabolites and conjugates have not yet been unambiguously identified in 
humans.  
Urine samples from nine healthy human volunteers obtained after the 
ingestion of a puree of five (poly)phenol-rich berry fruits were analysed 
using LC-Orbitrap mass spectrometry to provide a preliminary indication 
of possible metabolites based on exact mass. In most cases, the identity of 
compounds was confirmed using standards produced either chemically or 
enzymically followed by analysis using LC-triple quadrupole mass 
spectrometry. Sulfated, glucuronidated and methylated forms of catechol, 
pyrogallol and protocatechuic acid mostly appeared in urine after 8 hours, 
suggesting colonic metabolism. Gallic acid and (-)-epicatechin conjugates 
appeared mainly before 4 hours, indicative of absorption from the small 
intestine.  Conjugates of ferulic, caffeic, and vanillic acid appeared at 
intermediate times.  
We have positively identified metabolites and conjugates, some novel, in 
the urine of healthy volunteers after intake of multiple phenolics from a 
mixed puree from berry fruits, with each being excreted at specific and 
signature times. Some of these compounds could potentially be used as 
biomarkers of fruit intake. The possible biological activities of these 
colonic metabolites require further assessment. 
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INTRODUCTION 
The association between consumption of fruits and vegetables and the 
decrease in risk of suffering from degenerative diseases has been well 
established. Several studies have provided evidence for the effects of 
dietary fruit in reducing the risk of cardiovascular/inflammatory diseases 
1, 2 as well as of Alzheimer’s disease and other neuropathies 3. These effects 
have been at least partially attributed to the presence of (poly)phenols, 
present in plant foods. Berry fruits are particularly rich in some classes of 
these compounds, such as phenolic acids, tannins, and flavonoids 4. 
However, when trying to correlate the beneficial health effects described 
for (poly)phenols present in fruits and their bioavailability in humans, it is 
often observed that some of these compounds are poorly absorbed and 
may undergo several metabolic modification steps. Additionally, 
metabolism by the colonic microbiota may result in several catabolites 
which can be absorbed and contribute to an increased bioavailability 5, 6. 
Thus, it is unlikely that the compounds initially present in fruits, or even 
their aglycones, are responsible solely for the biological effects in vivo. 
Nonetheless, current literature on bioavailability of (poly)phenol 
metabolites and their degradation pathways is still limited and therefore 
more studies are necessary to fill this gap. Recently, blueberries, 
raspberries, blackberries, Portuguese crowberry and strawberry tree fruits 
were characterized for phenolics 7, and these fruits provide a diverse 
range of (poly)phenols in the diet, ideal for an intervention study 
examining the metabolism of a broad mixture of (poly)phenols. In this 
work, healthy subjects ingested a standardised puree of these fruits and 
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the urinary excretion of phenolic compounds was assessed. The main 
urinary metabolites in healthy volunteers were initially assessed by using 
exact mass scanning with a LC-Orbitrap MS,  and subsequently confirmed 
by comparison with chemically and enzymically synthesized standards 
and then analysed using LC-triple quadrupole MS.   
 
MATERIALS AND METHODS 
Preparation of fruit puree 
The consumed fruit puree consisted of 100 g of each of five fruits: 
blueberries (Vaccinum spp. variety Georgia Gem), blackberries (Rubus L. 
subgenus Rubus Watson variety Karaka Black) and raspberries (Rubus 
idaeus L. variety Himbo Top) were harvested at the Fataca experimental 
field in Odemira, Portugal; strawberry tree fruits (Arbutus unedo L.) were 
harvested in the Alentejo region, Portugal; and Portuguese crowberries 
(Corema album L.) were harvested in the Comporta region, Portugal. Fruits 
were blended together using a domestic food processor, for 1 min at room 
temperature. The puree was prepared on the day of the study and was 
passed through a sieve to remove seeds before being given to the 
volunteers. A sample of the puree was also freeze-dried and stored at -80 
°C until analysis. 
 
Subjects and study design 
This study was conducted according to the guidelines laid down in the 
Declaration of Helsinki, and all procedures involving human subjects 
were approved by the ethical committee of the Faculty of Pharmacy, 
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University of Lisbon, Portugal (02/CEECFFUL/2012). The protocol was 
explained to each volunteer and written informed consent was given 
before the study. Nine individuals (six females and three males) aged 
between 23 and 54 years with a body mass index of 23.2 ± 3.5 were 
recruited. Individuals were all considered healthy by a medical 
questionnaire and standard blood tests where the levels of glucose, urea, 
creatinine, total cholesterol, high-density lipoprotein cholesterol, 
triglycerides, C-reactive protein, and the activity of aspartate 
aminotransferase, alanine aminotransferase, gamma glutamyl transferase, 
were assessed. Volunteers did not have any history of cardiovascular 
diseases or any other medical illnesses, were non-smoking, and were not 
receiving medication or taking vitamins that could interfere with the 
study. 
Volunteers followed a (poly)phenol-free diet for 2 days before the study 
and throughout the day of the study, and the compliance with this 
restriction was confirmed through a questionnaire. After an overnight 
fast, volunteers ingested 500 mL of the above fruit puree with a standard 
breakfast containing no additional (poly)phenols, consisting of bread, 
with ham or cheese, yogurt and biscuits. 
Urine samples were collected into a container (containing 0.5 g of ascorbic 
acid) before the ingestion of the puree, and in the periods of 0-2 h, 2-4 h, 4-
8 h and 8-24 h, and the volumes recorded. Sodium azide (0.1% w/v) was 
added to urine samples which were kept at -20 °C until analysis. 
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Determination of phenolic compounds in the prepared fruit puree 
For determination of (poly)phenols, the dried puree was extracted with 
ethanol-water (1:1), containing 1 mM butylated hydroxytoluene (BHT) 
and 0.1 mM daidzein as internal standard. One part of the extract was 
used directly for HPLC-DAD analysis of total anthocyanins and 
caffeoylquinic acids. Another part of the extract was incubated with 
cellulase (EC. 3.2.1.4, Sigma Aldrich, St. Louis, MO, USA) and 
hesperidinase (EC. 3.2.1.40, Sigma Aldrich, St. Louis, MO, USA) from 
Aspergillus niger and analysed by HPLC-DAD, as described previously 7. 
 
Extraction of phenolics from urine 
A 2 mL aliquot of urine was spiked with 10 µL of 1 mg/mL rutin as 
internal standard and was added to 10 mL of acetonitrile. Samples were 
centrifuged at 3000 g for 15 min. The supernatant was collected, dried 
under vacuum and reconstituted in 500 µL of 50% (v/v) ethanol with 0.1% 
(w/v) ascorbic acid and 20 µg/mL of taxifolin as second internal standard 
for further analysis. 
 
Prediction of metabolites in human samples 
A list of metabolites and conjugates potentially present in human urine 
after ingestion of the fruits was drawn up based on prediction of 
metabolic pathways. The structures of 205 compounds were drawn and 
their exact mass calculated by using MarvinSketch software 5.7.0 from 
Chemaxon. 
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Urine analysis using LC-Orbitrap MS 
A small proportion of each aliquot of urine from each time point from all 
volunteers were pooled together just for the LC-Orbitrap MS analysis. 
Phenolics were extracted as described above. Samples were separated on a 
HPLC Accela 600 HPLC system (Thermo Scientific) using a C18 Synergi 
Hydro RP18 column (Phenomenex, Macclesfield, UK) 4 µm particle size 
and dimensions 2 mm ID x 150 mm. The column was fitted with a 
Security GuardTM guard system containing an Aqua 10 µm C18 Guard 
Cartridge (2 mm ID x 4 mm)  (Phenomenex, Macclesfield, UK) and eluted 
over a gradient of 100%  solvent A (95% H2O, 5% ACN with 0.1% (v/v) 
formic acid) to reach 15% B (95% ACN, 5% H2O with 0.1% (v/v) formic 
acid) at 10 min, 25% B at 30 min, 60% B at 60 min, 100% B at 63 min, 100% 
B at 68 min at a flow rate of 0.26 mL/min. Analysis was done on a LTQ 
Orbitrap™ XL hybrid mass spectrometer (Thermo Scientific, Bremen, 
Germany). 
MS analysis was performed using data dependent Nth order double play 
analysis comprising full scan mass range 80-2000 amu , 30000 resolution, 
Data type Centroid and data dependent MS/MS (60 seconds of exclusion 
duration) on the top 3 most intense ions detected above threshold 
automatically in the independent scan event. Electrospray ionization 
settings were as follows: source voltage, 3.4 kV; the capillary temperature 
was 300 °C with a sheath gas at 40 psi and auxiliary gas at 5 psi.  
MS data handling software (Xcalibur QualBrowser software, Thermo 
Electron Corp.) was used to search for predicted metabolites by their 
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appropriate m/z value. All peaks were checked for m/z value and 
fragmentation products. 
 
Preparation of liver cytosolic fractions 
For preparation of liver cytosolic fractions, ox and pig liver were rinsed 
with 250 mM sucrose solution and a sample of 13 g was weighed. Samples 
were minced and homogenized with 50 mL Tris-HCl buffer 50 mM pH 7.5 
using a polytron for 2 min on ice. Samples were centrifuged for 10 min at 
17400 g at 6 °C. The supernatant was recovered and centrifuged for 90 min 
at 3500 g and 6 °C. The supernatant was recovered and stored at -80 °C 
until use. 
 
Preparation of liver microsomes 
For preparation of microsomes, pig liver was rinsed with 250 mM sucrose 
solution and a sample of 13 g was weighed. Samples were minced and 
homogenized with 50 mL of the sucrose solution using a polytron for 2 
min on ice. Samples were centrifuged for 10 min at 17400 g at 6 °C, 
supernatant was recovered and 0.2 mL of 88 mM CaCl2 was added to 20 
mL of supernatant. The solute was left to stand on ice for 5 min with 
occasional swirling. The mixture was centrifuged at 27000 g for 15 min at 6 
°C, and after discarding the supernatant the pellet was resuspended in 2.5 
mL of 50 mM Tris-HCl buffer, pH 7.5, containing 10 mM EDTA and 20% 
(v/v) glycerol. Microsomal fractions were stored at -80 °C until use. 
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Sulfation of phenolic substrates 
Individual phenolic compounds used as substrates were incubated at a 
concentration of 300 µM with 35 µM adenosine 3′-phosphate  
5′-phosphosulfate (PAPS) and 5.1 mM p-nitrophenyl sulfate (pNPS) as co-
factors, 1 mM dithiothreitol, 10 mM sodium sulfite and 100 µM ascorbic 
acid in 100 mM potassium phosphate buffer, pH 7.4. To this solution,  
25 µL of liver cytosolic fraction was added and the reaction was incubated 
at 37 °C for 4 h. The reaction was stopped with addition of 200 µL of ice 
cold, ACN containing 500 mM HCl. Samples were centrifuged twice for 15 
min at 17000 g and the supernatant was stored at -20 °C until analysis. 
 
Glucuronidation of phenolic substrates 
The protocol is based on the modification of the method followed by 
Dueñas et al. 8.  Individual compounds used as substrates were incubated 
at a concentration of 800 µM with 25 mM HEPES buffer, pH 7.2, 
containing 1 mg.mL-1 alamethicin, 2 mM uridine 5′-diphosphoglucuronic 
acid trisodium salt (UDPGA), and 1 mM saccharolactone in a final volume 
of 110 µL. The reaction was started with the addition of 5 µL of pig liver 
microsomes and incubation was performed at 37 °C for 4 h. Reaction was 
stopped by the addition of 200 µL of methanol containing 1.6 mM ascorbic 
acid. Samples were centrifuged twice for 15 min at 17000 g, and the 
supernatant was stored at -20 °C until analysis. 
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Chemical synthesis of hydroxycinnamate metabolites 
The hydroxycinnamate and dihydroxycinnamate-sulfates and 
glucuronides used as standards were chemically synthesized and 
characterized as described previously 9 and were kindly provided by Prof. 
Denis Barron, NIHS, Lausanne, Switzerland. 
 
LC-MS/MS analysis 
Individual urine samples were analysed by LC-MS/MS. The HPLC system 
comprised an Agilent 1200 series micro degasser, SL binary pump, SL 
autosampler with chilled sample compartment (8 °C), column oven (30 
°C), and diode array detector (Agilent Technologies, Cheadle, UK). The 
system was controlled and data processed by Agilent MassHunter 
software (version B.01.03). An Atlantis T3 Column, 100 Å, 3 µm, 2.1 mm 
ID x 100 mm HPLC column (Waters, Hertfordshire, UK) was used for 
chromatographic separations at a flow rate of 0.26 mL/min over a gradient 
of 100% solvent A (95% H2O, 5% ACN with 0.5% (v/v) formic acid) for 10 
min, reaching 15% B (95% ACN, 5% H2O with 0.5% (v/v) formic acid) 
from 10 to 20 min. Solvent B increased to 25% at 40 min and to 100% B at 
43 min where it was maintained for 5 min returning to 0% in 2 min. MS 
analysis was performed with an Agilent 6410a triple-quadrupole LC-MS-
MS with electrospray source at 350 °C, a source voltage of 4 kV , and N2 
drying gas flow rate of 11 L/min at a pressure of 30 psi (Peak Scientific, 
NM30LA, Inchinnan, UK). The analysis was performed in negative MRM 
mode and optimisation for ion transmission was achieved by repeated 
injections of individual standards. 
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Relative amounts of compounds were estimated after normalizing to 
internal standard (rutin) and corrected by urinary volume. 
 
Statistical analysis 
Pharmacokinetic excretion profile of urine metabolites was constructed 
using GraphPad Prism 5. This package was also used for statistical 
analysis. Box-and-Whiskers plots for minimum and maximum values 
were produced. Comparisons in relation to the baseline were performed 
with two tailed Wilcoxon matched pairs test with a confidence level of 
95%.  
 
RESULTS 
Identification and quantification of phenolic compounds in fruit puree 
The puree containing blueberries, raspberries, blackberries, Portuguese 
crowberry and strawberry tree fruits was characterized by HPLC-DAD for 
the major compounds (Caffeoylquinic acids and anthocyanins, Table 1) 
and the aglycones were also quantified after multi-enzyme hydrolysis of 
the glycosides (Table 2). The most abundant compounds were 
anthocyanins, chlorogenic acids and gallic acid. Caffeic acid was abundant 
after hydrolysis and possibly resulted from esterase activity on 
caffeoylquinic acids plus glycosidase activity towards glycosides of caffeic 
acid.  
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Table 1. Quantification of total anthocyanins, 5-O-caffeoylquinic acid, and 3-O-
caffeoylquinic acid [mg/500 mL] in fruit puree ingested by volunteers determined 
by HPLC-DAD (details see materials and methods section) 
Compounds Concentration 
(mg/500 mL fruit 
puree) 
Total anthocyanins
1
 636 ±19 
5-Caffeoylquinic acid 130 ± 2 
3-Caffeoylquinic acid 5.9 ± 0.1 
1 Anthocyanin peaks were summed and quantified as cyanidin-3-O-glucoside equivalents 
  
 
Table 2. Quantification of phenolic compounds in fruit juice, consumed by 
volunteers,  after hydrolysis using hesperidinase and cellulase using HPLC-DAD 
relative to authentic standards.  
Compound Concentration 
(mg/500 mL 
fruit puree) 
Gallic acid 425.9 ± 14.0 
Protocatechuic acid 16.7 ± 0.2 
3-Methylgallic acid 12.9 ± 0.1 
(+)-Catechin 17.6 ± 3.9 
Vanillic acid 2.9 ± 0.5 
Caffeic acid 140.4 ± 2.2 
Phloroglucinaldehyde 28.8 ± 0.3 
Syringic acid 13.2 ± 0.6 
(-)-Epicatechin 12.2 ± 1.6 
Ellagic acid 24.8 ± 1.3 
Ferulic acid 6.9 ± 0.1 
Myricetin 15.6 ± 0.2 
Quercetin 15.5 ± 0.4 
Kaempferol 2.4 ± 0.0 
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Initial determination of metabolites in urine using exact mass data 
Compounds were identified in pooled urine samples for each time point 
by comparing their exact mass and fragmentation patterns (when 
available) obtained using an LC- Orbitrap MS with predicted metabolites. 
By comparing chromatograms of urine samples before ingestion and after 
ingestion of the fruit puree, it was observed that several metabolites 
appeared after ingestion. Only metabolites which increased in abundance 
after ingestion of the fruit puree were selected for confirmation to exclude 
compounds that could result from endogenous metabolism 
(supplementary Tables 1 to 5). Anthocyanins, which were very abundant 
in the fruit puree, were not evident by LC-Orbitrap MS analysis. After this 
initial analysis, the most abundant compounds were selected for 
confirmation by comparison with enzymically or chemically synthesised 
standards in individual samples using the LC-triple quadrupole MS.   
 
Enzymatic synthesis of phenolic compounds 
For production of conjugated compounds, (poly)phenol aglycones were 
incubated in vitro with pig liver microsomes and UDP-GA to generate 
glucuronide conjugates, and with an ox liver cytosolic fraction in the 
presence of the co-factors PAPS and p-NPS to generate the formation of 
mono-sulfated compounds. Ox liver cytosolic fraction was used instead of 
pig liver as it was observed to be more efficient in generating sulfated 
conjugates. The resulting conjugates were identified by their mass and 
fragmentation pattern (multiple reaction monitoring - MRM transitions), 
and are shown in Table 3.  
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Table 3. Summary of HPLC- triple quadrupole MS/MS detection properties for 
commercial or synthesized standards and indication of their presence in urine. A 
= aglycone, M = metabolite, RT = retention time.  
Metabolite 
code 
RT [M-H]- (m/z) Metabolite identity Presence in 
urine 
Standards Origin 
Precursor Fragment 
A1 8.1 109.1  Catechol Χ C 
M1 7.12 189.1 109.1 Catechol-O-sulfate   S 
M2 11.7 285.1 109.1 Catechol-O-glcrnd   S 
A2 19.3 123.1  4-Methylcatechol Χ C 
M3 18.7 203.1 123.1 4-Methylcatechol-O-sulfate *   S 
M4 20.9 299.1 123.1 4-Methylcatechol-O-glcrnd *   S 
A3 3.1 125.1  Pyrogallol   C 
M5 3.5 205.1 125.1 Pyrogallol-O-sulfate *   S 
M6 6.2 205.1 125.1 Pyrogallol-O-sulfate *   S 
M7 3.7 301.1 125.1 Pyrogallol-O-glcrnd *   S 
M8 9. 7 301.1 125.1 Pyrogallol-O-glcrnd *   S 
A4 13.1 139.1  1-O-Methylpyrogallol Χ C 
M9 10.5 219.1 139.1 1-O-Methylpyrogallol-O-sulfate *   S 
M10 11.2 219.1 139.1 1-O-Methylpyrogallol-O-sulfate * Χ            S 
A5 9.0 139.1  2-O-Methylpyrogallol Χ C 
M11 6.0 219.1 139.1 2-O-Methylpyrogallol-1-O-sulfate   S 
A6 6.5 153.1 108.1 Protocatechuic acid   C 
M12 5.9 233.1 153.1 Protocatechuic acid-O-sulfate *   S 
A7 16.6 167.1 151.8 Vanillic acid   C 
M13 7.8 247.1 167.1 Vanillic acid-4-O-sulfate   S 
A8 18.5 167.1 151.8 Isovanillic acid Χ C 
M14 10.5 247.1 167.1 Isovanillic acid-3-O-sulfate Χ S 
M15 5.0 301.1 167.1 Vanillic acid-O- glcrnd *   S 
M16 8.9 301.1 167.1 Vanillic acid-O- glcrnd *   S 
A9 2.9 169.1 124.9 Gallic acid   C 
M17 1.3 345.1 169.1 Gallic-acid-O- glcrnd * Χ S 
M18 2.4 345.1 169.1 Gallic-acid-O- glcrnd * Χ S 
M19 4.6 345.1 169.1 Gallic-acid-O- glcrnd *   S 
A10 10.0 183.1 167.8 4-O-Methylgallic acid   C 
M20 7.6 263.1 183.1 4-O-Methylgallic acid-3-O-sulfate   S 
A11 24.1 193 134, 178 Ferulic acid Χ C 
A12 25.1 193 134, 178 Isoferulic acid Χ C 
A13 18.2 174 135 Caffeic acid   C 
A14 15.0 181 137 Dihydrocaffeic acid   C 
A15 22.7 195 136 Dihydroferulic acid   C 
M21 18.5 369 193, 113 Ferulic acid-4-O-glcrnd   P 
M22 22.3 369 193, 113 Isoferulic acid-3-O-glcrnd   P 
M23 17.4 357 181, 137 DHC acid-4-O-glcrnd Χ P 
M24 18.3 357 181, 137 DHC acid-3-O-glcrnd   P 
M25 20.3 371 195, 113 DHF acid-4-O- glcrnd   P 
M26 21.5 273 193, 178 Ferulic acid-4-O-sulfate   P 
M27 22.7 273 193, 178 Isoferulic acid-3-O-sulfate   P 
M28 19.2 259 179, 135 Caffeic acid-4-O-sulfate   P 
M29 20.1 259 179, 135 Caffeic acid-3-O-sulfate             P 
M30 17.4 261 181, 137 DHC acid-4-O-sulfate   P 
M31 17.6 261 181, 137 DHC acid-3-O-sulfate   P 
M32 20.3 275 195, 136 DHF acid-4-O-sulfate   P 
A16 21.0 289.1 244.9 (-)-Epicatechin Χ C 
M33 17.2 465.1 289 Epicatechin-O-glcrnd *   S 
M34 17.8 465.1 289 Epicatechin-O-glcrnd * Χ S 
M35 18.3 465.1 289 Epicatechin-O-glcrnd * Χ S 
M36 18.9 465.1 289 Epicatechin-O-glcrnd * Χ S 
M37 20.8 465.1 289 Epicatechin-O-glcrnd *   S 
M38 17.6 369.1 289 Epicatechin-O-sulfate *   S 
M39 20.1 369.1 289 Epicatechin-O-sulfate * Χ S 
M40 21.9 369.1 289 Epicatechin-O-sulfate *   S 
* - Conjugated compounds which were not possible to distinguish between isomers due to more than 
one available position for conjugation. 
Legend:  – present in urine, X – absent in urine, Glcrnd – Glucuronide, C – Commercially available 
(HPLC grade), S – Enzymically synthesized, P – Provided by Prof. Denis Barron 
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When multiple conjugates resulted from the reaction owing to the 
presence of multiple available hydroxyl groups, it was not possible to 
distinguish the exact position of the conjugation, with exception for the 
compounds synthesized chemically.  
Gallic acid (GA), although theoretically having only two different hydroxyl 
groups for conjugation, yielded three glucuronidated metabolites (Fig. 1 
A). Also, vanillic acid (VA), possessing a single hydroxyl group available 
for conjugation, originated one sulfate as expected, but apparently two 
glucuronides Fig. 1 B). The one sulfated metabolite of 4-O-methylgallic 
acid (4-MeGA) was produced as expected; however, protocatechuic acid 
(PA) yielded only one peak (Fig. 1 C), even though two hydroxyl groups 
are available for conjugation. These events suggest a positional specificity 
of sulfotransferases for these compounds if only one metabolite is being 
produced, or alternatively overlapping of two metabolites in one peak.  
(-)-Epicatechin yielded three sulfates, although five hydroxyl groups are 
theoretically available for sulfation or glucuronidation. However, 
glucuronidation of epicatechin yielded five peaks (Fig. 1 D) but with large 
differences in efficiency of conjugation for the different positions. 
Conjugates of catechol (Cat), 4-methylcatechol (4-MeCat), pyrogallol (Pyr) 
and its O-methylated forms, 1-O-methylpyrogallol (1-MePyr) and 2-O-
methylpyrogallol (2-MePyr), are summarized in Table 3 and occurred as 
expected. The only exception was 4-MeCat which, although having two 
available hydroxyl groups, yielded only one glucuronide and one sulfate. 
Therefore, enzymic synthesis of sulfated compounds is not strictly regio-
selective for most compounds, but reveals a preference for certain 
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positions, as revealed by differences in peak areas for synthesized isomers 
of the same parent compound. 
 
 
Figure 1. LC-MS chromatograms of enzymically produced compounds in vitro. 
The [M-H]- ion chromatograms were selected for: (A) m/z 345.1, GA-O-
glucuronides; (B) m/z 301.1, VA-O-glucuronides; (C) m/z 233.1, PA-O-sulfate; (D) 
m/z 465.1, epicatechin-O-glucuronides. 
 
Confirmation and kinetics of metabolites in human urine 
Individual urine samples from each volunteer and each time point were 
analysed using the triple quadrupole LC-MS in MRM mode, using 
conditions optimized for the standard compounds, to confirm if 
compounds initially identified by exact mass scanning matched the 
synthesized standards. The presence of aglycones and conjugates in urine 
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is indicated in Table 3. The aglycones PA and dihydrocaffeic (DHC) acids, 
and GA-O-glucuronide, were not detected by the LC Orbitrap-MS due to 
low levels of the compounds combined with the lower sensitivity of this 
method, but were, however, detected with LC-triple quadrupole MS. On 
the other hand, some aglycones (such as Cat, 4-MeCat, ferulic and 
isoferulic acids) were tentatively identified using the Orbitrap-MS but 
were not found by the MRM method. This might result from technical 
limitations such as misleading identification of the peak due to other 
compounds with the same exact mass, or due to non-intentional in-source 
fragmentation of the conjugated compounds resulting in the detection of a 
“ghost” aglycone.  
Therefore, the presence of sulfated and glucuronidated conjugates was 
confirmed in individual urine samples (Table 3). The levels of compounds 
which increased in urine after consumption of the fruit puree are shown 
in Figs. 2 to 8.  
GA, found in the free form, appeared in urine at early time points, 
reaching a maximum between 0 and 4 h post ingestion (Fig. 2A). Phase II 
metabolites of GA (glucuronide, methyl and methyl-sulphate) reached a 
maximum excretion in urine between 2 to 4 h, slightly later than GA 
(Table 3, Fig. 2 B, C and D). O-Glucuronidated metabolites of GA were not 
observed with the initial screening using the LC-Orbitrap MS, but were 
found using the triple quadrupole LC-MS. One O-sulfated conjugate of 
PA was also found in urine samples (Table 3) and matched the single 
conjugate synthesized in vitro.  
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Figure 2. Box plot of relative quantification based on peak area of conjugated 
metabolites of GA found in urine at different collection times in human 
volunteers. (A) GA (A9), (B) GA-O-glucuronide (M19), (C) 4-MeGA (A10), (D) 4-
MeGA-3-O-sulfate (M20). No star, not significant; *, p < 0.05; **, p < 0.01 relative to 
time zero. 
 
PA-O-sulfate and phase II metabolites of VA had an intermediate time of 
excretion, peaking between 4 and 8 h (Fig. 3).  
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Figure 3. Box plot of relative quantification of conjugated metabolites of 
protocatechuic acid and vanillic acid found in urine at different collection times in 
human volunteers. (PA-O-sulfate (M12), (B) VA-4-O-sulfate (M13), (C) VA-O-
glucuronide (M15), (D) VA-O-glucuronide (M16). No star, not significant; *, p < 
0.05; **, p < 0.01 relative to time zero. 
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 The excretion profiles of phase II metabolites of hydroxycinnamic acids 
(Table 3) are shown in Figs. 4 and 5. 
 Figure 4. Box plot of relative quantification of conjugated metabolites of caffeic 
acid, ferulic acid and isoferulic acid found in urine at different collection times in 
human volunteers. (A) Caffeic acid-4-O-sulfate (M28), (B) caffeic acid-3-O-sulfate 
(M29), (C) ferulic acid-4-O-glucuronide (M21), (D) ferulic acid-4-O-sulfate(M26), 
(E) isoferulic acid-3-O-glucuronide (M22), (F) isoferulic acid-3-O-sulfate (M27). 
No star, not significant; *, p < 0.05; **, p < 0.01 relative to time zero. 
 
Figure 5. Box plot of relative quantification of conjugated metabolites of DHC 
acid and DHF acid found in urine at different collection times in human 
volunteers. (A) DHC acid-4-O-sulfate (M30), (B) DHC acid-3-O-sulfate (M31), (C) 
DHC acid-3-O-glucuronide (M24), (D) DHF acid-4-O-sulfate (M32), (E) DHF acid-
4-O-glucuronide (M25). No star, not significant; *, p < 0.05; **, p < 0.01 relative to 
time zero. 
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Several (-)-epicatechin conjugates were enzymically produced in vitro, but 
only two O-sulfated and two O-glucuronidated metabolites were found in 
urine (Table 3), thus suggesting a more selective mechanism of 
conjugation in vivo by phase II enzymes. The time course in urine of (-)-
epicatechin conjugates is consistent with a rapid excretion (Fig. 6). 
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Figure 6. Box plot of relative quantification of conjugated metabolites of (-)-
epicatechin found in urine at different collection times in human volunteers. (A) 
(-)-Epicatechin-O-glucuronide (M33), (B) (-)-epicatechin-O-glucuronide (M37), (C) 
(-)-epicatechin-O-sulfate (M38), (D) (-)-epicatechin-O-sulfate (M40). No star, not 
significant; *, p < 0.05; **, p < 0.01 relative to time zero. 
 
Both O-glucuronides and O-sulfates of Cat and 4-MeCat were detected 
and had very similar profiles of appearance in urine (Fig. 7), starting from 
low levels at initial time points, and increasing especially after 4 h. The 
same excretion profile was observed for phase II metabolites of Pyr (Fig. 
8). Only one sulfated metabolite of 1-MePyr was identified, although two 
metabolites were obtained in vitro.  
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Figure 7. Box plot of relative quantification of conjugated metabolites from 
catechol and 4-methylcatechol found in urine at different collection times in 
human volunteers.  (A) Catechol-O-sulfate (M1), (B) catechol-O-glucuronide (M2), 
(C) 4-methylcatechol-O-sulfate (M3), (D) 4-methylcatechol-O-glucuronide (M4). 
No star, not significant; *, p < 0.05; **, p < 0.01 relative to time zero. 
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Figure 8. Box plot of relative quantification of conjugated metabolites of 
pyrogallol, 1-O-methylpyrogallol and 2-O-methylpyrogallol found in urine at 
different collection times in human volunteers. (A) pyrogallol-O-sulfate (M5), (B) 
pyrogallol-O-sulfate (M6), (C) pyrogallol-O-glucuronide (M7), (D) pyrogallol-O-
glucuronide (M8), (E) 1-O-methylpyrogallol-O-sulfate (M9), (F) 2-O-
methylpyrogallol-1-O-sulfate (M11). No star, not significant; *, p < 0.05; **, p < 0.01 
relative to time zero. 
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DISCUSSION 
Berries contribute significantly to the dietary intake of (poly)phenols 10 but 
many of the metabolites and conjugates produced after consumption are 
not known. This study focused on the identification of urinary metabolites 
and their conjugates after ingestion of a berry-rich fruit puree containing a 
high level of different (poly)phenols. Multi-enzyme hydrolysis was used 
for identification and quantification of aglycone equivalents in the fruit 
puree, as previously described for each individual fruit 7. This hydrolysis 
also mimics to a certain extent the deglycosylation known to occur in vivo, 
either in small intestine or in colon, prior to absorption 6, 11.  
Our results show that, as expected, excretion generally follows phase II 
conjugation. GA appears to be an exception, as it was detected in the urine 
of all volunteers in relatively high amounts in its unconjugated form, 
although it was also the most abundant aglycone in the fruit puree. This 
compound was also found in urine after phase II metabolism, i.e. in 
glucuronidated, methylated and sulfated forms. GA and 4-MeGA have 
been reported in humans after tea intake 12 and, in addition to these 
compounds, 4-MeGA-3-O-sulfate was reported in rats after ingestion of 
GA 13. In humans, this metabolite was only tentatively identified after 
ingestion of (poly)phenol-rich juice 14 and red wine 15. An O-
glucuronidated conjugate of GA, although not detected with LC-Orbitrap 
MS, was detected in the urine of volunteers with LC-triple quadrupole 
MS, due to its very low levels. This compound was confirmed using the 
standard that we prepared, and, to our knowledge, this is the first report 
of this metabolite in mammals. Absorption of GA appears to be fast and 
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elimination of this compound and its phase II metabolites in urine peaked 
2 to 4 h after ingestion (Fig. 1), even though conjugates are still found in 
urine between 8 and 24 h. This suggests that GA is still being produced 
and absorbed several hours after ingestion of the fruit puree, possibly due 
to degradation by the colonic microbiota of compounds such as esters of 
GA, although they may also arise as breakdown products of anthocyanins 
such as malvidin or delphinidin 16-18.  
Anthocyanins were very abundant in the puree, mainly glycosides of 
cyanidin from raspberries and blackberries 19-21, but also glycosides of 
malvidin, delphinidin, petunidin, cyanidin and peonidin from blueberry 
20, 21. However, their presence in urine was not demonstrated in LC-
Orbitrap MS, due to their very low levels.  Recent evidence suggests that 
anthocyanins are found in plasma and urine in very low amounts; 
nevertheless, the products of their degradation, colonic catabolism and 
metabolism are much more abundant 16, 22-24. In a recent study, Czank and 
co-workers 25 administered isotopically labelled cyanidin-3-O-glucoside to 
human subjects, and revealed that apparent bioavailability of 
anthocyanin-derived products was far higher than expected; metabolites 
present in urine and plasma included degradation products of cyanidin 
such as PA and phloroglucinaldehyde. These reactions are consistent with 
in vitro data 24, 26. Additionally phenylacetic acids, phenylpropenoic acids, 
hippuric acid and phase II conjugates of PA as metabolites derived from 
labelled cyanidin-3-O-glucoside were also detected in humans 25.  
In our study, phloroglucinaldehyde was not evident in the urine of 
volunteers by LC-Orbitrap MS analysis. However, PA, at least partly 
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resulting from the degradation of cyanidin, was found in urine essentially 
as one O-sulfated conjugate. Although two hydroxyl groups are available 
for sulfation in the PA molecule, only one peak was generated both in 
vitro and in vivo. However, two isomers have been described in humans 
for PA-O-sulfate 25. VA, possibly resulting from O-methylation of PA, was 
also found in urine, although its isomer isovanillic acid was not.  In fact, 
VA was found conjugated with sulfate and glucuronic acid, and VA-O-
sulfate has been previously identified in humans 25, 27. Phase II metabolites 
of PA appeared in urine, particularly between 4 and 8 h (Fig. 2), 
suggesting a colonic origin. The appearance of one more O-
glucuronidated metabolites than the number of available hydroxyl groups 
in the VA molecule might be due to peak dissociation caused by the 
chromatography conditions, or possibly glucuronidation of the carboxylic 
group which has been observed before 27. The same situation might occur 
with GA as we detected three glucuronidated metabolites after in vitro 
enzymic synthesis.  
Caffeic acid (CA), also found in high amounts in the fruit puree mostly 
conjugated with quinic acid, was found in urine in sulfated forms. 
However, other conjugated metabolites were also found, possibly 
resulting from metabolism of CA in the digestive tract since CA generates 
ferulic  and isoferulic acids (FA and IA, respectively) by methylation, 
DHC acid by reduction and dihydroferulic (DHF) acid by both events 9. 
Although FA was also initially present in the fruit puree, it is possible that 
it also results from methylation of CA, as phase II metabolites of IA were 
found in urine and IA was not present in the fruit puree.  
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CA-O-sulfates were observed in two temporal phases (Fig. 3 A, B). The 
first phase (peaking between 2 and 4 h) is consistent with the hydrolysis of 
5-O-caffeoylquinic acid by esterases in the small intestine 28 but CA might 
also be derived from glycosidase action in the small intestine on CA 
glycosides. The second phase (peaking between 8 and 24 h) might result 
from the action of esterases from colonic microbiota on caffeoylquinic 
acids. Additionally, the late urinary peaks of DHC and DHF acids  
conjugates (Fig. 4 A to E) could also be explained by the action of the 
colonic microbiota on CA, as suggested previously 28. In fact, studies made 
with ileostomist patients reveal that a proportion of the ingested 
caffeoylquinic acids can be recovered in the ileal fluid of humans, and 
thus reach the colon (between 26 and 78%, depending on the food matrix) 
29, 30. 
Although not very abundant in fruit puree, the presence of phase II 
metabolites of (-)-epicatechin in urine of volunteers was observed. Two O-
sulfates and two O-glucuronides of epicatechin were found in urine, 
although the position of the conjugation was not confirmed. These 
metabolites reached a maximum in urine between 2 and 4 h (Fig. 5), 
indicating early absorption and excretion. Previous work has also 
indicated that epicatechin metabolites reached a maximum amount in 
plasma generally before 4 h after ingestion 14, 31. Previously, three O-
glucuronidated conjugates of epicatechin were found in plasma and urine 
of human subjects, identified as epicatechin-3'-O-β-D-glucuronide, 
picatechin-4'-O-β-D-glucuronide and epicatechin-7-O-β-D-glucuronide 31. 
The same study reported the presence of two O-sulfated conjugates of 
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epicatechin characterized as epicatechin-3'-O-sulfate and (-)-epicatechin-
4'-O-sulfate.  
Although not found in fruit puree, phase II metabolites of Pyr and Cat 
were relatively abundant in urine samples. Pyr and Cat in their free forms 
had been previously found as products of metabolism when Concord 
grape juice was incubated in vitro with faecal slurries 17. They were also 
found in the urine of volunteers after ingestion of Concord grape juice 
especially at later time points, but neither of these compounds were 
observed in the urine of ileostomist patients 32, which strongly suggests a 
colonic origin based on degradation of other (poly)phenols. Pyr has also 
been suggested to be generated from colonic degradation of malvidin-3-O-
glucoside 16. In our study, Pyr in the free form was detected in low 
amounts but Cat was not detected. However, methylated, sulfated and 
glucuronidated metabolites of these compounds increased significantly at 
later time points in urine (Fig. 6 and 7). Cat-O-sulfate and Cat-O-
glucuronide were previously found in urine of rats in which Cat had been 
injected into the renal portal circulation 33 or after administration of a 
Glechoma longituba extract 34. However, to our knowledge, the presence of 
Cat-O-glucuronide in the urine of humans has never been described, and 
Cat-O-sulfate, although previously detected in human urine, was not 
related to the consumption of (poly)phenols 35. Moreover, this is also the 
first report of O-sulfated and O-glucuronidated metabolites of 4-MeCat in 
human urine. Regarding Pyr-O-glucuronide, it was previously identified 
in rat urine after ingestion of gallic acid 13. In the same study, 2-MePyr was 
found as the aglycone and also in a glucuronidated form 13. Pyr-O-
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glucuronide and Pyr-O-sulfate were also previously identified in 
volunteers after green and black tea consumption 27, 36, 37. Isomers of 
MePyr-O-sulfate were also found after green and black tea consumption 
27. Phase II metabolites of both Pyr and Cat, therefore, appear to be 
generated from further catabolism of (poly)phenol metabolites by colonic 
microbiota. 
In conclusion, this study focused particularly on detection and 
identification of phase II metabolites of phenolic acids after ingestion of a 
(poly)phenol-rich fruit puree. Either directly absorbed or produced via 
degradation of more complex (poly)phenols, these metabolites showed a 
significant and substantial increase in urine of volunteers after ingestion 
of the puree, and represent possible biomarkers for (poly)phenol intake. 
Several metabolites were for the first time reported and confirmed in 
human urine after ingestion of (poly)phenols, including 4-O-methylgallic 
acid-3-O-sulfate, gallic acid-O-glucuronide, catechol-O-sulfate and -O-
glucuronide, and 4-methylcatechol-O-sulfate and -O-glucuronide. 
Additionally, when considering the effect of certain dietary (poly)phenols 
on human health, these metabolites and conjugates should be considered 
for their possible biological activities.  
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SUPPLEMENTARY MATERIAL 
Table 1. Structure of metabolites of protocatechuic, vanillic and gallic acids, and 
presence in human urine using the Orbitrap LC-MS. 
 
 
Metabolite R1 R2 R3 R4 Exact 
mass 
Detected 
in urine 
Protocatechuic acid OH OH OH OH 154.0266    Χ 
Protocatechuic acid-3-
O-sulfate 
OSO3 OH H OH 
233.9834   
Protocatechuic acid-4-
O-sulfate 
OH OSO3 H OH 
Vanillic acid 
Isovanillic acid 
OCH3 
OH 
OH 
OCH3 
H 
H 
OH 
OH 168.0423   
Vanillic acid-4-O-
sulfate 
OCH3 OSO3 H OH 
247.9991   
Isovanillic acid-3-O-
sulfate 
OSO3 OCH3 H OH 
Vanillic acid-4-O-
glcrnd 
OCH3 OGlcrnd H OH 
344.0743 
 
  
Isovanillic acid-3-O-
glcrnd 
OGlcrnd OCH3 H OH 
Gallic acid OH OH OH OH 170.0215   
Gallic acid-1-O-glcrnd OGlcrnd OH OH OH 
346.0536    Χ 
Gallic acid-2-O-glcrnd OH OGlcrnd OH OH 
4-O-Methylgallic acid OH OCH3 OH OH 184.0372   
4-O-Methylgallic acid-
3-O-sulfate 
OSO3 OCH3 OH OH 
263.9940   
Legend: Glcrnd - Glucuronide 
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Table 2. Structure of metabolites of caffeic and ferulic acids, and presence in 
human urine using the Orbitrap LC-MS. 
 
 
Legend: Glcrnd - Glucuronide 
 
Metabolites R1 R2 Exact 
mass 
Detected 
in urine 
Caffeic acid OH OH 180.0423   
Caffeic acid-3-O-
sulfate 
OSO3 OH 
259.9991   
Caffeic acid-4-O-
sulfate 
OH OSO3 
Caffeic acid-3-O-
glcrnd 
OGlcrnd OH 
356.0743   
Caffeic acid-4-O-
glcrnd 
OH OGlcrnd 
Ferulic acid OCH3 OH 194.0579   
Ferulic acid-4-O-
sulfate 
OCH3 OSO3 
274.0147   
Ferulic acid-4-O-
glcrnd 
OCH3 OGlcrnd 
370.0900   
Isoferulic acid OH OCH3 194.0579   
Isoferulic acid-3-O-
sulfate 
OSO3 OCH3 
274.0147   
Isoferulic acid-3-O-
glcrnd 
OGlcrnd OCH3 
370.0900   
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Table 3. Structure of metabolites of dihydrocaffeic acid and dihydroferulic acid, 
and presence in human urine using the Orbitrap LC-MS. 
 
 
Metabolites R1 R2 Exact 
mass 
Detected 
in urine 
DHC acid OH OH 182.0579 Χ 
DHC acid-3-O-
sulfate 
OSO3 OH 
262.0147   
DHC acid-4-O-
sulfate 
OH OSO3 
DHC acid-3-O-
glcrnd 
OGlcrnd OH 
358.0900    Χ 
DHC acid-4-O-
glcrnd 
OH OGlcrnd 
DHF acid OCH3 OH 196.0736    Χ 
DHF acid-4-O-
sulfate 
OCH3 OSO3 
276.0304   
DHF acid-4-O-
glcrnd 
OCH3 OGlcrnd 
372.1056   
Legend: Glcrnd - Glucuronide 
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Table 4. Structure of metabolites of (-)-epicatechin and presence in human urine 
using the Orbitrap LC-MS.  
 
 
Metabolites R1 R2 R3 R4 R5 Exact 
mass 
Detected in 
urine 
(-)-Epicatechin OH OH OH OH OH 290.0790   
(-)-Epicatechin-3-O-
sulfate 
OSO3 OH OH OH OH 
370.0359   
(-)-Epicatechin-5-O-
sulfate 
OH OSO3 OH OH OH 
(-)-Epicat 
´Lechin-7-O-sulfate 
OH OH OSO3 OH OH 
(-)-Epicatechin-3'-O-
sulfate 
OH OH OH OSO3 OH 
(-)-Epicatechin-4'-O-
sulfate 
OH OH OH OH OSO3 
(-)-Epicatechin-3-O-
glcrnd 
Oglcrnd OH OH OH OH 
466.1111   
(-)-Epicatechin-5-O-
glcrnd 
OH Oglcrnd OH OH OH 
(-)-Epicatechin-7-O-
glcrnd 
OH OH Oglcrnd OH OH 
(-)-Epicatechin-3'-O-
glcrnd 
OH OH OH Oglcrnd OH 
(-)-Epicatechin-4'-O-
glcrnd 
OH OH OH OH Oglcrnd 
Legend: Glcrnd - Glucuronide 
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Table 6. Structure of metabolites of catechol and pyrogallol, and presence 
in human urine using the Orbitrap LC-MS. 
 
Metabolite R1 R2 R3 R4 Exact 
mass 
Detected 
in urine 
Catechol OH OH H H 110.0368   
Catechol-1-O-sulfate OSO3 OH H H 189.9936   
Catechol-1-O-glcrnd OGlcrnd OH H CH3 286.0689   
4-Methylcatechol OH OH H CH3 124.0524   
4-Methylcatechol-1-O-sulfate OSO3 OH H CH3 
204.0092   
4-Methylcatechol-2-O-sulfate OH OSO3 H CH3 
4-Methylcatechol-1-O-glucrnd OGlcrnd OH H CH3 
300.0845   
4-Methylcatechol-2-O-glucrnd OH OGlcrnd H CH3 
Pyrogallol OH OH OH H 126.0317   
 Pyrogallol-1-O-sulfate OSO3 OH OH H 
205.9885   
Pyrogallol-2-O-sulfate OH OSO3 OH H 
Pyrogallol-1-O-Glcrnd OGlcrnd OH OH H 
302.0638 
  
Pyrogallol-2-O-Glcrnd OH OGlcrnd OH H   
1-O-Methylpyrogallol OCH3 OH OH H 
140.0473    Χ 
2-O-Methylpyrogallol OH OCH3 OH H 
1-O-Methylpyrogallol-3-O-sulfate 
1-O-Methylpyrogallol-2-O-sulfate 
OCH3 
OCH3 
OH 
OSO3 
OSO3 
OH 
H 
H 220.0042   
2-O-Methylpyrogallol-1-O-sulfate OSO3 OCH3 OH H 
1-O-Methylpyrogallol-3-O-glcrnd 
1-O-Methylpyrogallol-2-O-glcrnd 
OCH3 
OCH3 
OH 
OGlcrnd 
OGlcrnd 
OH 
H 
H 330.0587    Χ 
2-O-Methylpyrogallol-1-O-glcrnd OGlcrnd OCH3 OH H 
Legend: Glcrnd - Glucuronide 
 
 
 
 
 
 
 
Chapter 4 
 
  
 
Confirmation and quantification of phenolic-
metabolites in plasma of human volunteers after 
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ABSTRACT 
Bioavailability studies are vital to assess the potential impact of bioactive 
compounds on human health. Although conjugated phenolics from 
colonic metabolism have been identified in urine, the quantification and 
appearance of these compounds in plasma is less well studied, but 
important when assessing potential activity in vivo. To address this gap, a 
crossover intervention with ingestion of fruit puree and a standard 
(poly)phenol-free meal by thirteen volunteers was conducted, and plasma 
metabolites identified by HPLC-MS/MS. Sulfated-standards were 
chemically synthesized to facilitate quantification. There was a fast 
absorption of gallic and caffeic acid-conjugates, reaching a maximum 
concentration between 1 and 2 h. Sulfated-metabolites resulting from 
colonic degradation of more complex (poly)phenols started to increase in 
plasma from 4 h, and reached 5-20 µM at 6 h for pyrogallol-sulfate and 
catechol-sulfate. In conclusion, phenolic-sulfates were quantified in 
plasma and reached much higher concentrations than their parent 
compounds. They have potential use as biomarkers of (poly)phenol intake 
and their biological activities need to be considered. 
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INTRODUCTION 
Berry fruits assume great importance for daily consumption of 
(poly)phenols, due to the high contents of compounds such as phenolic 
acids and flavonoids, particularly anthocyanins (1, 2). Even in populations 
where there is only a small consumption of  berries, the contribution of 
these fruits to the overall ingestion of (poly)phenols can be high, in 
comparison to other food sources (3). Epidemiological and experimental 
studies suggest that (poly)phenols reduce the risk of developing several 
pathological conditions (4-6). In vitro studies are important to elucidate the 
mechanism of action of (poly)phenols in this regard. However, for the 
credibility of these studies, it is essential to use compounds that can 
actually be found in the human body and use them in physiologically-
relevant concentrations. The role of intervention studies in calculating 
bioavailability and understanding the metabolic fate of the ingested 
compounds is very important (7, 8).  
Recently,  the idea has emerged that quantification of (poly)phenols in 
biological samples collected from humans and animals might be 
underestimated, since many metabolites formed from catabolism of 
(poly)phenols by colon microbiota can still be absorbed into the blood, 
and are usually not accounted for (9, 10). Many of these compounds can 
undergo further metabolism and be conjugated by phase II enzymes, to 
form sulfated, glucuronidated and methylated compounds (11). We 
previously identified several phenolics in conjugated form in the urine of 
healthy human volunteers, after ingestion of a puree composed of five 
different berry fruits (12). Some of these compounds were indentified in 
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humans and associated with the consumption of (poly)phenols for the 
first time.  It is now important to calculate the plasma appearance of these 
metabolites and assess the physiological concentration they can reach, in 
order to account for total and combined (poly)phenol bioavailability.  
In this study, the sulfated compounds previously identified were 
chemically synthesized and used as standards for quantification in plasma 
of human subjects, after ingestion of the berry puree. A crossover study in 
which participants ingested either the fruit puree or a standard 
(poly)phenol-free meal was also conducted to assess any endogenous or 
non-(poly)phenol dietary origin of the studied metabolites. 
 
MATERIAL AND METHODS 
Reagents and reference materials 
All chemicals used in this investigation were purchased from Sigma-
Aldrich, unless stated otherwise and purchased reference standards were 
all HPLC grade (>95%). ACN (LS-MS grade) was purchased from Fisher 
Scientific Ltd. (Leicestershire, UK). LC-MS grade water was produced by 
an Elix/MilliQ purification system (Millipore, Waterford, UK). 4-
Methylgallic acid and 2-methylpyrogallol were obtained from Apin 
chemicals (Oxon, UK). Taxifolin was obtained from Extrasynthese. 
Hydroxycinnamic acid-conjugates were chemically synthesized and 
characterized as described previously (13) and were kindly provided by 
Prof. Denis Barron, NIHS, Lausanne, Switzerland; protocatechuic acid-3-
O-sulfate and protocatechuic acid-4-O-sulfate were kindly provided by 
Dr. Paul Needs, IFR, Norwich, UK. 
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Fruit puree 
The fruit puree was prepared on the day of the study and its composition 
has been described previously (12). Briefly, 100 g of each of five fruits were 
used: blueberries (Vaccinum spp. variety Georgia Gem), blackberries 
(Rubus L. subgenus Rubus Watson variety Karaka Black) and raspberries 
(Rubus idaeus L. variety Himbo Top) were harvested at the Fataca 
experimental field in Odemira, Portugal; strawberry tree fruits (Arbutus 
unedo L.) were harvested in the Alentejo region, Portugal; and Portuguese 
crowberries (Corema album L.) were harvested in the Comporta region, 
Portugal. Fruits were blended on a domestic food processor, for 1 min at 
room temperature.  
 
Subjects and study design 
Twenty two volunteers (4 of them male), aged between 22 and 54, with an 
average BMI of 22.6 kg/m2 were recruited for this study. Individuals were 
all considered healthy by a medical questionnaire and standard blood 
tests. Volunteers did not have any history of cardiovascular diseases or 
any other medical illnesses, were non-smoking, and were not receiving 
medication or taking vitamins that could interfere with the study. 
The study was divided in two groups. In the first group, nine volunteers 
followed a (poly)phenol-free diet for 2 days before the study and 
throughout the day of the study. After an overnight fast, volunteers 
ingested 500 mL of the above fruit puree with a standard breakfast 
containing no additional (poly)phenols, consisting of bread, with ham or 
cheese, yogurt and biscuits. Blood samples were collected into EDTA 
containing tubes before ingestion of the puree and after at 0.5, 1, 2, 4 and 6 
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h. The second group, containing thirteen volunteers, participated in a 
cross-over controlled trial. The procedure was similar as the first group, 
however the two stages, which occurred two weeks apart, varied with 
ingestion of the puree or a standard breakfast (poly)phenols free, where 
the puree was substituted by plain yogurt. Blood samples were collected 
into EDTA containing tubes before ingestion of the fruit puree and at 2 
and 4 h after ingestion.  
The compliance with the food restriction was confirmed through a 
questionnaire.  
The study protocol was in accordance with the Declaration of Helsinki of 
1975, as revised in 1983, and all procedures involving human subjects 
were approved by the ethical committee of the Faculty of Pharmacy, 
University of Lisbon, Portugal (02/CEECFFUL/2012). The protocol was 
explained to each volunteer and written informed consent was given 
before the study. 
 
Sample treatment 
After collection, blood samples were immediately centrifuged at 2200 g for 
15 min, and 1 mL plasma samples were stored in cryotubes with addition 
of 30 µL of formic acid (50% v/v). Samples were kept at -80 °C prior to 
analysis.  
Protein precipitation was based on a modification of a previously 
described method (14). Briefly, to 380 µL of plasma were added 20 uL 
ascorbic acid 4 mg/mL (final concentration of 1 mM) and taxifolin as 
internal standard to a final concentration of 250 nM. Sample was 
combined with 1 mL hexane, homogenized and centrifuged for 10 min at 
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17 000 g.  The aqueous phase was recovered and added dropwise to 1200 
µL of ACN. The mixture was vortexed for 2 min and centrifuged for 10 
min at 17 000 g. Supernatant was recovered and pellet was reconstituted 
with 400 µL ACN and after centrifugation, ACN supernatants were 
combined and dried on a centrifugal evaporator. Samples were 
reconstituted in 100 µL of water containing 1 µM of sinapic acid as second 
internal standard. Samples were centrifuged at 17 000 g for 10 min and the 
supernatants were filtered prior to HPLC-MS/MS analysis. 
 
HPLC-MS/MS analysis 
Plasma sample analysis was conducted on an Agilent HPLC 1200 series 
comprising a micro degasser, SL binary pump, SL autosampler with 
chilled sample compartment (8 °C), column oven (30 °C), and diode array 
detector (Agilent Technologies, Cheadle, UK) connected with a 6410a 
triple-quadrupole LC-MS-MS. Separation was achieved on an Atlantis T3 
Column, 100 Å, 3 µm, 2.1 mm ID x 100 mm HPLC column (Waters, 
Hertfordshire, UK) at a flow rate of 0.26 mL/min over a gradient of 100% 
solvent A (95% H2O, 5% ACN with 0.5% (v/v) formic acid) for 10 min, 
reaching 15% B (95% ACN, 5% H2O with 0.5% (v/v) formic acid) from 10 
to 20 min. Solvent B increased to 25% at 40 min and to 100% B at 43 min 
where it was maintained for 5 min returning to 0% in 2 min. 
MS interface was set at 350 °C, a source voltage of 4kV, and N2 drying gas 
flow rate of 11 L/min at a pressure of 30 psi (Peak Scientific, NM30LA, 
Inchinnan, UK). The analysis was performed in negative Multiple 
Reaction Monitoring (MRM) mode optimized using the reference 
standards (see Table 1). The system was controlled and data processed by 
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Agilent MassHunter software (version B.01.03). The m/z transitions 
optimized for each standard were previously optimized (12). Quantification 
of metabolites in plasma was obtained using calibration curves of the 
available standards. At least 8 concentrations, ranging from 0.05 to 20 µM, 
were constructed from analytical standards and each point was injected in 
triplicate. Standard curves were all linear within the concentration range 
and linearity was ensured as R2=0.997-1.000 (Table 1). 
 
Statistical analysis 
Pharmacokinetic profile of plasma metabolites was constructed using 
GraphPad Prism 5. This package was also used for statistical analysis. 
Box-and-Whiskers plots for minimum and maximum values were 
produced. Comparisons in relation to the baseline were performed with 
two tailed Wilcoxon matched pairs test with a confidence level of 99%.  
For the cross-over study comparisons were made between consumption of 
fruit puree and the control breakfast for each time point and the same test 
was used. 
 
Synthesis of sulfated compounds 
The products were synthesized by a treatment of the initial aglycones (500 
mg) with sulfor trioxide pyridine [pyridine:SO3]. The aglycones (500 mg) 
and pyridine:SO3 (1 equivalent for all compounds with exception of 
vanillic acid where 2 equivalents were used) were dissolved in 10 mL of 
anhydrous pyridine and kept at 65 °C with constant stirring for 24 h. 
Reaction was stopped by addition of water. Solvents were dried in vacuo 
and the residue was dissolved in water. The unreacted aglycones were 
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separated with ethyl acetate and the product in the water phase was 
purified with a Dowex 50W-X8 ion-exchange column loaded with Na+.  
Purified compounds were then dried in vacuo and characterized by 1H and 
13C NMR. NMR chemical shifts are reported using the residual solvent 
peak as reference. Peak assignments were based on COSY and HMQC 
experiments. 
 
Catechol-O-sulfate [(2-hydroxyphenyl)-oxidanesulfonic acid] : 674 mg,  
66% yield; 1H NMR (400 MHz, DMSO-d6): δ 8.85 (s, 1H, OH), 7.12 (dd, 1H, 
J 1.6, 7.96 Hz), 6.96 (ddd, 1H, J1.64, 7.96, 9.26 Hz), 6.83 (dd, 1H, J 1.6, 8 Hz), 
6.75 (ddd, 1H, J 1.68, 7.92, 9.24 Hz); 13C NMR (100 MHz, DMSO-d6): δ 
149.21, 140.92, 124.88, 123.13, 119.25, 117.24. 
 
Pyrogallol-O-sulfate: 677 mg, 75% yield; mixture of two compounds in 
approximate similar proportion; pyrogallol-2-O-sulfate [(2,6-
dihydroxyphenyl)-oxidanesulfonic acid]:1H NMR (400MHz, D2O): δ 6.97 
(t, 1H, J 8.24 Hz, H-4), 6.51 (d, 2H, J 8.28 Hz, H-3 + H-5) and  pyrogallol-O-
sulfate [(2,3-dihydroxyphenyl)oxidanesulfonic acid]: 1H NMR (400MHz, 
D2O): δ 6.90 – 6.86 (m, 1H, H-5), 6.79 – 6.74 (m, 2H, H-4 + H-6); 13C NMR 
(100 MHz, D2O): δ 149.84, 145.42, 139.76, 127.19, 120.34, 114.31, 113,80, 
108.93.  
 
2-Methylpyrogallol-O-sulfate [(3-hydroxy-2-methoxyphenyl)-
oxidanesulfonic acid]:  450 mg, 44% yield, having 11% contamination with 
the disulfated byproduct. 1H NMR (400MHz, DMSO-d6): δ 8.97 (s, 1H, 
OH), 6.97 (dd, J 1.52, 8.32 Hz, H-6), 6.74 (t, 1H, J 8.2 Hz, H-5), 6.51 (dd, 1H, 
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J 1.52, 8.08 Hz, H-4), 3.34 (s, 3H, CH3); 13C NMR (100 MHz, DMSO-d6): δ 
150.57, 147.20, 139.10, 122.33, 112.30, 110.89, 60.09. 
 
1-Methylpyrogallol-O-sulfate: 500 mg, 58% yield; (2-hydroxy-6-
methoxyphenyl)-oxidanesulfonic acid and (2-hydroxy-3-methoxyphenyl)-
oxidanesulfonic acid, mixture of both compounds in approximate equal 
amounts (56%:44%). 1H NMR (400MHz, DMSO-d6): δ 9.20 (s, 1H, OH), 
8.52 (s, 1H, OH), 6.92 (t, 1H, J 8.60 Hz), 6.77-6.68 (m, 3H), 6,52-6.44 (dd, 
2H); 13C NMR (100 MHz, DMSO-d6): δ 153.39, 150.93, 149.17, 141.35, 
139.07, 124.86, 118.07, 115.65, 110.08, 108.64, 104.11, 55.87, 55.72 
 
4-Methylcatechol-O-sulfate: 604 mg, 66% yield. Mixture of the two 
compounds, (2‐hydroxy‐4‐methylphenyl)-oxidanesulfonic acid and 
2‐hydroxy‐5‐methylphenyl)-oxidanesulfonic acid, not being possible to 
distinguish them, One is present at 64%, 1H NMR (400MHz, DMSO-d6): δ 
8.76 (s, 1H, OH), 6.96 (d, 1H, J 8.08 Hz), 6.64 (d, 1H, J 1.76 Hz), 6.55 (dd, 
1H, J 2.04, 8.6 Hz), 2.20 (s, 3H, CH3). The other being 36% of the sample, 1H 
NMR (400MHz, DMSO-d6): δ 8.62 (s, 1H, OH), 6.93 (d, 1H, J 1.84 Hz), 6.77 
(dd, 1H, J 1.56, 8.04 Hz), 6.71 (d, 1H, J 8.12 Hz), 2.19 (s, 3H, CH3); 13C NMR 
(100 MHz, DMSO-d6): δ 148.87, 146.80, 140.70, 138.80, 134.20, 128.14, 
125.27, 123.58, 122.94, 119.87, 117.77, 116.96, 20.06, 20.47. 
 
4-Methylgallic-3-O-sulfate [3‐hydroxy‐4‐methoxy‐5‐(sulfooxy)benzoic 
acid]:  485 mg, 57% yield, having a contamination of 13% of the disulfate 
and 6% of the starting material;1H NMR (400MHz, D2O): δ 7.46 (d, 1H, J 
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2.04 Hz, H-2), 7.32 (d, 1H, J 2 Hz, H-6), 3.88 (s, 3H, CH3) ; 13C NMR (100 
MHz, D2O):δ 172.07, 149.19, 143.99, 142.85, 129.61, 115.42, 114.84, 61.29. 
 
Vanillic acid-4-O-sulfate [3‐methoxy‐4‐(sulfooxy)benzoic acid]: 924 mg, 
quantitative yield. 1H NMR (400MHz, DMSO-d6): δ 7.57 (d, 1H, J 8.16 Hz, 
H-2), 7.50-7.47 (m, 2H, H-5+H-6), 3.79 (s, 3H, CH3); 13C NMR (100 MHz, 
DMSO-d6): δ 167.39, 149.51, 148.4, 146.41, 121.96, 119.33, 112.71, 55.48. 
 
RESULTS 
Composition of fruit puree  
Detailed identification and quantification of (poly)phenols in the fruit 
puree have been described previously (12). The fruit puree (500 mL) 
contained anthocyanins (636 ±19 mg) and caffeoylquinic acids (5-
caffeoylquinic and 3-caffeoylquinic acids, 135.9 ± 2.1 mg). Aglycones were 
quantified after hydrolysis by the use of gycosidases from Aspergillus niger 
as previously published (15). Gallic acid (GA) was the most abundant 
aglycone (425.9 ± 14.0 mg/500 mL fruit puree). Caffeic acid (CA) was also 
abundant (140.4 ± 2.2 mg/500 mL fruit puree), resulting from hydrolysis of 
the caffeoylquinic acids and conjugated glycosides. After hydrolysis, 
several other phenolic acids were detected and quantified including the 
flavanols (-)-epicatechin and (+)-catechin, and the flavonols quercetin, 
myricetin and kaempferol. The presence of vanillic (VA), ferulic (FA) and 
protocatechuic (PA) acids were also observed in the hydrolyzed extract. 
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Chemical synthesis of sulfated phenolics 
(Poly)phenol metabolites were identified previously in urine samples 
from human volunteers after ingestion of the fruit puree (12). In this work, 
we focused on quantification of sulfated-metabolites in plasma. Some 
were chemically synthesized for this purpose (Table 1). Synthesized 
compounds were mostly pure as determined by NMR, except for 2-
methylpyrogallol-O-sulfate (89% pure due to a double-sulfate subsituted 
compound) and 4-methylgallic acid-3-O-sulfate (81% pure due to the 
presence of some aglycone and a double-sulfate substituted derivative). 
The LC-MS/MS chromatographic profile of the synthesized standards is 
shown in Table 1, with most compounds resulting in single peaks. 
However, for the compounds 4-methylcatechol (4-MeCat) and 1-
methylpyrogallol (1-MePyr), two different sulfated metabolites were 
obtained after synthesis as can be observed by NMR, although they co-
eluted as only one chromatographic peak. Protocatechuic acid-3-O-sulfate 
(PA-3-sulf) and protocatechuic acid-4-O-sulfate (PA-4-sulf) also co-eluted 
when run together on HPLC-MS/MS.  
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Table 1- HPLC-MS/MS parameter for the quantification of phenolic metabolites in 
human plasma after ingestion of 500 mL of fruit puree 
Compound name Compound 
abbreviation 
MRM 
parent 
ion 
MRM 
daughter 
ion 
Calibration 
curve range 
(µM) 
R
2
 
Gallic acid GA 169.1 124.9 0.4-20 0.998 
4-Methylgallic acid 4-MeGA 183.1 167.8 0.1-8 0.997 
4-methylgallic acid-3-O-
sulfate 
4-MeGA-sulf 163.1 183.1 0.29-14.7 0.998 
Protocatecuic acid-O-
sulfate 
PA-sulf 233.1 153.1 0.2-16 0.999 
Vanillic acid-4-O-sulfate VA-sulf 147.1 167.1 0.18-18.5 1.000 
Caffeic acid-O-sulfate CA-sulf 259 179 0.1-16 1.000 
Ferulic acid-4-O-sulfate FA-sulf 273 193 0.05-8 1.000 
Isoferulic acid-3-O-
sulfate 
IFA-sulf 273 193 0.05-8 1.000 
Dihydrocaffeic acid-O-
sulfate 
DHCA-sulf 261 181 0.1-8 0.999 
Dihydroferulic acid-4-O-
sulfate 
DHFA-sulf 275 195 0.1-8 0.999 
Catechol-O-sulfate Cat-sulf 189.1 109.1 0.2-20 0.999 
4-Methylcatechol-O-
sulfate 
4-MeCat-sulf 203.1 123.1 0.1-20 0.999 
Pyrogallol-O-sulfate Pyr-sulf 205.1 125.1 0.2-20 0.998 
1-Methylpyrogallol-O-
sulfate 
1-MePyr-sulf 219.1 139.1 0.34-17 1.000 
2-Methylpyrogallol-1-O-
sulfate 
2-MePyr-sulf 219.1 139.1 0.2-20 0.999 
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Plasma appearance of phenolics 
Previously, several metabolites were identified in the urine of volunteers 
after ingestion of fruit puree, and although only a relative quantification 
was performed, sulfated-phenolics were more abundant than 
glucuronidated-phenolics (12). In this work, plasma of human volunteers 
was analysed after ingestion of the fruit puree for confirmation of the 
presence of those sulfated-metabolites by LC-MS/MS (Fig 1). Gallic acid 
was identified, as well as its conjugated metabolites 4-O-methylgallic acid 
(4-MeGA) and 4-O-methylgallic acid-3-O-sulfate (4-MeGA-Sulf). Sulfated-
metabolites of VA, FA, dihydroferulic (DHFA) and dihydrocaffeic 
(DHCA) acids were also confirmed in plasma. PA-O-sulf was also present, 
but it was not possible to distinguish between the isomers PA-3-O-sulf 
and PA-4-O-sulf, since they co-eluted. 
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Gallic acid 4-MeGA-3-sulfate PA-3-sulfate
VA-4-sulfate CA-3-sulfate CA-4-sulfate FA-4-sulfate
IFA-3-sulfate DHCA-3-sulfate DHCA-4-sulfate DHFA-4-sulfate
Cat-sulfate Pyr-1-O-sulfate
Pyr-2-sulfate 1-MePyr-2-sulfate 1-MePyr-3-sulfate 2-MePyr-1-sulfate
PA-4-sulfate
4-MeCat-2-sulfate 4-MeCat-1-sulfate
4-MeGA
 
Figure 1. Structure of phenolic metabolites searched for in the plasma from 
human volunteers: 4-MeGA, 4-methylgallic acid; PA, protocatechuic acid; VA, 
vanillic acid; CA, Caffeic acid; FA, ferulic acid; IFA, isoferulic acid; DHCA, 
dihydrocaffeic acid; DHFA, dihydroferulic acid; Cat, catechol; 4-MeCat, 4-
methylcatechol; Pyr, Pyrogallol; MePyr, Methylpyrogallol. 
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Although one peak of sulphated DHCA was found in plasma at low 
levels, it is possible that this could be two sulfated metabolites, since they 
co-eluted (Table 2).  The presence of sulfated metabolites of catechol (Cat), 
4-MeCat, 1-MePyr and 2-O-methylpyrogallol (2-MePyr) was also 
confirmed. Two sulfated-metabolites of pyrogallol (Pyr) were found, 
corresponding to the synthesized standards.  
 
Table 2 –Concentration in plasma of phenolic conjugated-metabolites and 
presence in volunteers after ingestion of 500 mL of fruit puree 
Metabolite Cmax (nM)
†
 Tmax (hours)* Number of 
volunteers 
present 
4-MeGA 
300 ± 138 2 7 
4-MeGA-sulf 
2028 ± 1095 2 9 
VA-sulf 
1345 ± 1310 4 6 
PA-sulf 
1055 ± 972 4 6 
CA-3-sulf 
181 ± 127 1 8 
FA-sulf 
188 ± 107 1 9 
Cat-sulf 
12194  ± 5860 6 9 
4-MeCat-sulf 
636 ± 469 6 7 
Pyr-sulf (1) 
652 ± 328 6 7 
Pyr-sulf (2) 
11430 ± 6678 6 8 
1-mePyr-sulf 
2879 ± 1807 6 9 
2-MePyr-sulf 
1969 ± 982 6 8 
 
 
†Cmax, peak plasma concentration calculated from the average concentration in volunteers where it was 
present. 
*Tmax, time to reach Cmax of the metabolites for the times of collection. It is no to exclude higher 
concentration of some metabolites after 6h.  
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Plasma quantification of phenolic metabolites 
The synthesized standards or pure aglycones were used for the 
quantification of phenolic metabolites (Table 1).  For the co-eluting 
compounds in plasma (sulfates of PA, 1-MePyr and 4-MeCat) 
quantification was done as corresponding to a single compound. 
Measurement of plasma metabolites was performed between 0 and 6 h 
following the ingestion of 500 mL of fruit puree. The pharmacokinetic 
profile of each metabolite is shown in Fig. 2 and an average maximum 
concentration of the metabolites when present in six or more volunteers is 
presented in Table 2. GA, despite being present in all volunteers, was 
mostly found under the limit of quantification, only being quantifiable in 
three out of nine volunteers, reaching a maximum concentration of 
840±340 nM at 1 h after ingestion of the fruit puree. However, its 
conjugated metabolites 4-O-methylgallic (4-MeGA) and 4-O-methylgallic-
3-O-sulfate clearly peaked at 2 h. DHFA-O-sulf was detected in the 
plasma of volunteers, however it was under the limit of quantification. 
DHCA-O-sulfate was only quantifiable in four volunteers at 6h where it 
reached 151±18 nM.  
The metabolites Cat-sulf, 4-MeCat-sulf, Pyr-O-sulfates and MePyr-O-
sulfates were found at baseline in several volunteers (Fig. 2). All these 
metabolites, with exception of 4-MeCat-sulf, had a statistically significant 
increase over the collection period time in comparison to the baseline. 
Interestingly, the compounds Cat-sulf and Pyr-sulf even reached 
concentrations up to 20 µM in some volunteers. However, variability 
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between plasmatic concentrations between the volunteers was high for all 
the quantified metabolites.  
 
 
Figure 2. Plasma quantification of phenolic metabolites at baseline, and at 0.5, 1, 2, 
4 and 6 h after ingestion of 500 mL of fruit puree. A – 4-MeGA, B – 4MeGA-sulf,  
C – PA -sulf, D – VA-sulf, E – CA-sulf, F – FA-sulf, G – Cat-sulf, H – 4-MeCat-sulf, 
I – Pyr-sulf (1),  J – Pyr-sulf (2), K – 2-MePyr-sulf, L – 1-MePyr-sulf.  Statistical 
comparison is in relation to baseline. No star, not significant; *, p < 0.05; **, p < 
0.01 relative to time zero. 
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Comparison between ingestion of fruit puree and (poly)phenol-free 
meal 
Confirmation of the provenance of the analysed metabolites was assessed 
by the ingestion of a (poly)phenol-free meal (control) as opposed to the 
ingestion of fruit puree by the same volunteers. Comparative analysis was 
done in plasma samples collected at baseline, at 2 h and at 4 h and is 
summarized in Fig 3. At baseline, no differences were observed between 
ingestion of the fruit puree or the (poly)phenol-free meal. However, for 
most metabolites, a statistically significant increase was observed after 
ingestion of the fruit puree at a certain time point. The only exceptions 
were observed for PA-sulf where an increase was observed both after 
ingestion of the fruit puree and the control meal and for VA-sulf which at 
4 h had a higher increase in plasma after ingestion of the control meal than 
for the fruit puree. 
For Pyr-sulf, although a small increase was observed in plasma of 
volunteers 2 h after the ingestion of the control meal, at 4 h there was a 
marked increase in the plasma of volunteers ingesting the fruit puree. 
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Figure 3. Plasma quantification of phenolic metabolites at baseline, and at 2 and 
4h after ingestion of the fruit puree (■) or standard breakfast (□). A – 4-MeGA,  
B – 4-MeGA-sulft, C – PA-sulf, D – VA-sulf, E – CA-sulf, F – FA-sulf, G – Cat-sulf, 
H – 4-MeCat-sulf, I – Pyr-sulf (2),  J – 2-MePyr-sulf, K – 1-MePyr-sulf. Statistics 
compare plasma concentrations of each volunteer after ingestion of the fruit 
puree or standard breakfast. No star, not significant; *, p < 0.05; **, p < 0.01,  
p < 0.005 relative to time zero. 
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DISCUSSION 
Conjugation reactions, particularly sulfation, glucuronidation and 
methylation, are known to be involved in the metabolism of phenolics in 
the human body, generally resulting in stabilisation and increased water-
solubility, and therefore modifying their distribution and excretion (16, 17). 
Sulfate conjugation is one of the major metabolic pathways for 
endogenous and exogenous phenolic compounds (18). Previously, we 
demonstrated that sulfated phenols were found in urine after ingestion of 
a fruit puree containing 5 berry fruits (12). In the present study, some of 
those compounds were chemically synthesized and used for 
quantification purposes in plasma collected from volunteers. 
Confirmation of their provenance was also achieved by comparing the 
amounts in plasma of volunteers consuming the puree or a (poly)phenol-
free standard meal.  
GA, a compound present as aglycone in high amounts in the fruit puree, 
was previously quantified in human plasma as well as its methylated 
metabolite 4-MeGA after ingestion of GA tablets and black tea(19). Its 
kinetics were similar to the present study, reaching a maximum 
concentration near 1.5 h. Identified for the first time in rats urine by 
Yasuda and co-workers (20), 4-MeGA-3-sulf was quantified in human 
plasma for the first time in the present study and was undoubtedly 
derived from compounds within the fruit puree (Fig. 3). Its kinetic profile 
was similar to GA and 4-MeGA reaching a maximum concentration at 2 h 
(Figure 2, Table 1), suggesting that absorption and metabolism of GA was 
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fast, with the 4-hydroxyl group being regioselectively preferred for 
methylation and the 3-hydroxyl group for sufation.  
Previous studies suggested PA as one of the major metabolites from 
degradation of cyanidin (21, 22). Of the compounds studied here, PA-sulf, 
VA-sulf and FA-sulf were previously identified in plasma as metabolites 
resulting from the degradation of 13C-labeled cyanidin-3-glucoside in the 
digestive tract (9). However, in the present study, only at 6 h was there a 
significant increase of PA-sulf and VA-sulf compared to the baseline, and 
an increase of these metabolites was registered also in the control meal. It 
is unlikely that (poly)phenols are present in the control meal, and so 
phenolics present after ingestion of the control meal are likely to be 
derived from endogenous metabolism. A comparable example is 
dopamine metabolism, where homovanillic acid is a known metabolite, 
which would probably exist as homovanillic acid-O-sulfate (23).  
Hydroxycinnamic acid metabolism has been widely studied in relation to 
coffee consumption and our results are consistent with these data. 
Sulfation is dominant over glucuronidation for most hydroxycinnamic 
acids (24), but methylation also appears to have a important role, resulting 
in FA and isoferulic acid (25). CA-3-O-sulfate and FA-4-O-sulfate clearly 
resulted from ingestion of the puree (Fig. 3) and were quantified in 
plasma, having similar values and absorption kinetics. These results were 
in accordance with previous studies proposing rapid absorption kinetics 
for CA and FA metabolites in plasma (25, 26). DHCA and DHFA-conjugates 
were not quantifiable in plasma, being mostly under the limit of 
quantification. However, these are derived from the action of colonic 
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bacterial reductases (25), and so would only start to appear at 5 hours and 
have a Tmax between 7 and 11 hours (27).  
Previously we identified conjugated-phenolic metabolites possibly 
resulting from catabolism of other (poly)phenols (12). Their colonic origin is 
suggested since some unconjugated phenolics have been identified in 
faeces after ingestion of (poly)phenols (10, 28). However, our data suggest 
that absorption in the colon might also occur and these compounds can 
subsequently be found conjugated in plasma. The origin of these phenolic-
conjugates such as catechol, pyrogallol, 2-methylpyrogallol and 1-
methylpyrogallol -O-sulfated metabolites was a consequence of 
consuming the fruit puree, and to our knowledge this is the first time that 
these compounds have been quantified in human plasma and associated 
with (poly)phenol metabolism. Clearly, this class of metabolites has been 
neglected in bioavailability studies and, since they reached considerable 
amounts in the plasma, further studies are needed to access their 
biological significance. Recently, the importance of colonic catabolism of 
(poly)phenols and several metabolites has been appreciated. Due to the 
ability of the colonic microbiota to catalyse reactions such as O- and C-
deglycosylation, ester and amide hydrolysis and deglucuronidation, 
flavonoids, once considered to show poor bioavailability, might result in 
smaller phenolics with a much higher absorption than the parent 
compounds (29). Additionally, new classes of metabolites have been 
specifically assigned to colonic metabolites of flavonoids, such as 
valerolactones from catabolism of catechins and urolithins from 
catabolism of ellagic acid and ellagitannins (28, 30). These metabolites of 
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colonic origin might be of great importance for the health effects 
commonly associated to the ingestion of polyphenols. 
Glucuronidation has been described as being a major route for 
conjugation of phenolics such as acetaminophen (31), quercetin (32), PA and 
VA (33) and other substances with a 1,2-dihydroxybenzene group (34). 
However, sulfation is the primary conjugation route of the 
hydroxycinnamic acids CA, FA and DHCA (24) and many other sulfated 
phenolics have been reported, including sulfates of protocatechuic and 
vanillic acids (35). Sulfation of phenolics is carried out by cytosolic 
sulfotransferases (SULTs) which catalyze the transfer of a sulfonate group 
from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to a substrate 
containing a hydroxyl group. The isoforms SULT1A1, SULT1A3/4, 
SULT1B1, SULT1E1 and SULT2A1 were considered the most relevant in 
(poly)phenol metabolism in human adults (18). Besides sulfation, 
methylation, carried out by catechol O-methyltransferase (COMT), also 
has great importance in metabolism of phenolic compounds (17). This 
activity may be responsible for the conversion of pyrogallol to 1- and 2-
methylpyrogallol, GA to 4-MeGA, CA to FA, DHCA to DHFA and PA to 
VA. Additionally, all of these compounds could be sulfated, and this dual 
conjugation of compounds will affect re-activation of conjugated 
compounds via deconjugation reactions (17).  
In summary, our results confirm the provenance of several phenolic-
conjugates resulting from the ingestion of a (poly)phenol-rich berry fruit 
puree by humans, since they increase in plasma in comparison to either 
the baseline or after ingestion of a (poly)phenol-free control meal. 
Metabolism of fruit (poly)phenols results in methylated, sulfated and 
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some dual conjugated compounds. We highlight the importance of 
catabolism in the colon, generating simple phenols that can then be 
absorbed from the colon and circulate in conjugated form in the blood. 
Therefore, they contribute indirectly to the bioavailability of food 
(poly)phenols, and can potentially also be used as markers for 
(poly)phenol intake. 
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ABSTRACT 
A great amount of research has focused on the possible protective effects 
of dietary (poly)phenols against human neurodegenerative disorders. 
However, the knowledge of the metabolites able to cross the blood-brain 
barrier and affect the brain is still scarce, as well as their mechanisms of 
action. With the discovering of novel bioavailable metabolites resulting 
from the ingestion of (poly)phenols, new opportunities arise for 
unraveling this process. 
In this study, phenolic conjugates found in plasma of humans following 
the ingestion of (poly)phenols were chemically synthesized and tested on 
an in vitro model of the blood-brain barrier formed by confluent 
monolayers of brain microvascular endothelial cells (HBMEC). The 
toxicity of the phenolic-conjugates at physiological concentrations was 
tested in the HBMEC and their ability to cross the endothelial monolayer 
was evaluated by HPLC-MS. Additionally, the protective effect of 
compounds against injury induced by H2O2 was evaluated, as well as their 
effect on the expression and activity of the efflux transporter P-
glycoprotein (P-gp).  
All the phenolic-conjugates were not toxic and they were able, although 
only in a very small percentage, to cross the HBMEC. They were also able 
to protect the cells from H2O2 injury. Additionally, the compounds had no 
effect on P-gp activity and expression. Overall, our results suggest that 
biovailable phenolic-conjugates may protect the brain function at 
physiological concentrations at the level of the blood-brain barrier and 
have the potential to enter the brain.  
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INTRODUCTION 
Epidemiological studies have suggested that a diet rich in fruits and 
vegetables can reduce the development of neurodegenerative disorders 1. 
(Poly)phenols, considered some of the active compounds, were also 
shown to improve the cognitive performance in aged rats upon dietary 
supplementation with blueberries and partially reverse some of the 
degenerative effects of ageing 2. The potential of (poly)phenols to exert 
protective actions in neuronal cells was, in other experiments, related with 
ability of compounds to interact with signaling pathways and alter gene 
expression 3, although the mechanisms of action at the molecular level 
remain poorly understood.  
The effective uptake of (poly)phenols into the brain is still open to debate. 
Assays with exsanguinated and perfused animals revealed that 
(poly)phenols can enter the brain at measurable levels 4-6. The knowledge 
of (poly)phenol compartmentalization within the central nervous system, 
whatsoever, is rather scarce. There is now good evidence from cell culture 
experiments that (poly)phenols are able to enter at least in some cell  
types 7, 8 and exert pharmacological effects. To have an activity in the 
brain, (poly)phenols have to be able to permeate the blood-brain barrier 
(BBB), an ability that is related with their bioavailability. 
However, for most experiments, bioavailability has not been much 
considered since many of the compounds tested were pure aglycones or 
plant extracts, used at concentrations much above the physiological range 
and do not necessarily reflect what occurs in vivo. 
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It is expected that for (poly)phenols to exert protective activities in the 
brain they necessarily have to be bioavailable and reach the target tissues. 
However, during digestion only a portion of food polyphenols are 
absorbed in the small intestine and most of them reach the colon. In the 
colon (poly)phenols are catabolized by colonic microbiota and degraded 
into simpler units such as simple phenols, phenolic acids and non-
aromatic metabolites, which can still be absorbed 9. After absorption, 
metabolites generally go through phase II conjugation, becoming less 
lipophilic and easier to excrete 10. However, conjugated-phenolics are able 
to circulate in the blood and potentially reach the tissues. Moreover, 
although phase II conjugation usually inactivates compounds, the 
opposite has been observed, with some compounds being in fact  
activated 11, and therefore a pharmacological action is not excluded.  
Previously, we identified and chemically synthesized bioavailable 
metabolites of colonic origin resulting from the ingestion of a puree 
composed of five different berry fruits 12, 13. Here, we test the effect of these 
bioavailable (poly)phenol-conjugated compounds in preventing H2O2 
damage in human brain microvascular endothelial cells (HBMEC) and 
their ability to permeate across cells in a confluent monolayer, and further 
accessed if they interfere with expression and activity of the efflux 
transporter P-glycoprotein (P-gp). For this, we used a cell line of HBMEC 
as a simplified in vitro model of the human BBB 14, considering that brain 
microvascular endothelial cells are the principal component of such 
important interface, forming the intimal surface of blood vessels that 
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selectively limits the passage of most molecules into the brain and 
regulates the brain extracellular fluid composition 15. 
  
MATERIAL AND METHODS 
Reagents 
All the used chemicals were purchased from Sigma-Aldrich, unless stated 
otherwise. Basal medium Roswell Park Memorial Institute (RPMI) 1640 
and antibiotic-antimycotic solution were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Non-essential amino acids (NEAA), sodium 
pyruvate, L-glutamine, fetal bovine serum (FBS) and minimum essential 
medium (MEM) vitamins were purchased from Biochrom AG (Berlin, 
Germany). Nuserum IV and rat-tail collagen I were acquired from BD 
Biosciences (Erembodegem, Belgium). The primary antibodies for the P-
gp were from Calbiochem and for caveolin-1were from Cell Signalling. 
The secondary antibodies Alexa 594 anti-rabbit IgG and Alexa 488 anti-
mouse IgG were from Invitrogen. Triton X-100 was obtained from Merck. 
ACN (LC-MS grade) was purchased from Fisher Scientific Ltd. 
(Leicestershire, UK). LC-MS grade water was produced by an Elix/MilliQ 
purification system (Millipore, Waterford, UK). 4-Methylgallic acid and 2-
methylpyrogallol were obtained from Apin chemicals (Oxon, UK) and 
taxifolin was obtained from Extrasynthese. The sulfated-phenolics were 
synthesized as previously described in the Chapter IV of this thesis 13. The 
synthesized compounds were: 4-methylgallic acid-3-O-sulfate (4-MeGA-
sulf, 57% yield, 79% purity), vanillic acid-4-O-sulfate (VA-sulf, 
quantitative yield, pure), catechol-O-sulfate (Cat-sulf, 66 % yield, pure), 4-
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methylcatechol-O-sulfates (4-MeCat-sulf, 66% yield, mixture of two 
compounds indistinguishable, pure), pyrogallol-O-sulfates (Pyr-sulf, 75% 
yield, mixture of two compounds in equal proportions), 1-
methylpyrogallol-O-sulfates (1-MePyr-sulf, mixture of two compounds in 
equal proportions, 58% yield) and 2-methylpyrogallol-O-sulfate (2-MePyr-
sulf, 44% yield, 89% purity). The compounds 4-methylcatechol-O-sulfate 
(4-MeCat-sulf), pyrogallol-O-sulfate (Pyr-sulf) and 1-methylpyrogallol-O-
sulfate (1-MePyr-sulf) are constituted by a mixture of two isomers 
approximately in equal proportions. Since no distinction in the 
chromatographic profile can be obtained for isomers of 4-MeCat-sulfates 
and 1-MePyr-sulfates, we opted for presenting the results relative to the 
mixture of the isomers. Synthesized compounds were firstly dissolved in 
DMSO (Fluka), before dilution in the cellular medium. 
 
Cell culture  
The cell line used in this study was derived from primary cultures of 
HBMEC transfected with SV40 large T antigen 16. HBMEC line was used 
as a simplified model of the human BBB, as reported previously 14, 17. This 
cell line displays good tight and adherens junctions and was shown to 
present the best barrier properties among four different cell lines as 
shown by the highest transendothelial electrical resistance (TEER) and the 
lowest permeability 18. HBMEC line was cultured in RPMI medium 
supplemented with 10% FBS, 10% NuSerum IV, 1% NEAA, 1% MEM 
vitamins, 1mM sodium pyruvate, 2mM L-glutamine, and 1% antibiotic-
antimycotic solution. For cell viability and cytoprotection studies, cells 
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were seeded at a density of 8×104 cell/mL in collagen I-coated 96-well 
plates and treated after 48h in culture. For integrity and transport studies, 
cells were seeded on collagen I-coated polyester transwell inserts (0.4 μm, 
Corning Costar Corp., USA) at a density of 8×104 cell/insert and treated 
after 8 days in culture. All experiments were performed at confluence. 
Endothelial cultures were maintained at 37 °C in a humid atmosphere 
enriched with 5% CO2. For the P-gp experiments cells were seeded on 
collagen I-coated coverslips previously placed in 24-well culture plates. 
 
Cellular viability evaluation 
Cell viability assay was performed as previously reported 19 using a 96-
well plate. Briefly, 48 h after seeding, HBMEC cells were incubated with 
tested compounds in relevantly physiological concentration. Toxicity tests 
involved 24h of incubation of 5 and 10 µM of each compound. Cell 
viability was assessed using the CellTiter-Blue® Cell Viability Assay 
(Promega), according to the manufacturer’s instructions in a Polarstar 
Galaxy fluorescent plate reader (BMG Labtechnologies). Non-viable cells 
rapidly lose their metabolic capacity and thus do not generate fluorescent 
signal. 
 
Cytoprotective effect 
To evaluate the cytoprotective effect of tested compounds, HBMEC were 
incubated in the presence of H2O2 20. Briefly, 24 h after seeding cells, 
growth medium was removed and cells were pre-incubated for 24h with 5 
µM of each compound in RPMI medium. After pre-incubation, media was 
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replaced by new media containing 300 µM H2O2, for 24 h. In the end, 
medium was removed and cell viability was assessed using the CellTiter-
Blue® Cell Viability Assay as described above. 
 
Transport of phenolic-conjugates across HBMEC 
For the transport studies, HBMEC were cultured on semipermeable filters 
with two well-defined compartments: the luminal or upper compartment, 
which can be considered as the “blood-side” where the tested compounds 
were added, and the abluminal or lower compartment, which is 
considered the “brain side”. At the end of the incubation period, and after 
transendothelial electric resistance (TEER) measurement, the cultured 
inserts were used for permeability studies and media from the upper and 
lower chambers were collected for LC-MS measurements.   
 
Transendothelial electric resistance measurement 
TEER was evaluated as reported previously 14. Briefly, TEER readings 
were performed using an EndOhm™ chamber coupled to an EVOMX 
resistance meter (World Precision Instruments, Inc., USA). Readings were 
collected before the addition of the (poly)phenols-conjugates (time 0) and 
after 2h of exposure. The percentage of variation from average control 
readings, after deducting the empty insert values, was calculated.  
 
Cellular permeability evaluation 
In order to evaluate the selective paracellular permeability of the HBMEC 
monolayer after exposure to the polyphenol metabolites, a permeability 
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assay was conducted with sodium fluorescein (molecular weight: 376 Da). 
The permeability was determined as described before 14, 21. The endothelial 
permeability coefficient Pe was calculated as percentage of variation from 
control as previously described 22. 
 
Permeation assay  
Permeation assays were conducted in the incubation medium. The 
incubation medium consisted of HBSS with calcium and magnesium 
(Gibco), supplemented with 0.1% FBS. Confluent monolayers of the 
HBMEC were incubated with 5 or 10 μM of each compound, or no 
addition (control), for 2h. The monolayer integrity was guaranteed by 
assessment of TEER and permeability. In the end, the media from the 
apical and basal compartments were collected and frozen at -80°C until 
analysis. Individual samples of the HBSS medium containing the 
compounds at the same concentration used in the experiment were 
incubated without HBMEC at 37 °C for 2h as a control. 
Deproteinization of samples was adapted from a previous publication 23. 
To 1 mL of cellular medium was added 139 µL of 50% formic acid, 
ascorbic acid (final concentration of 1 mM) and taxifolin as internal 
standard (final concentration of 9 µM). To the mixture, 2.5 mL of ACN 
was added dropwise to precipitate proteins, and the samples were 
vortexed before centrifugation at 3200 g for 15 min. The supernatant was 
removed and dried under centrifugal evaporation (Genevac EZ-2 plus; 
Genevac Ltd, Suffolk, UK). Samples were dissolved in 100 µL of water 
and analyzed by HPLC-MS. 
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The percentage of relative passage from the luminal to the abluminal 
compartments was calculated according to the equation: 
% passage= (Amount of compound in the abluminal side) / (Amount in 
control incubation at 37 °C) x 100  
 
HPLC-MS analysis 
HPLC analysis of apical and basal media was conducted on a Shimadzu 
LC-2010 HT coupled with a LCMS-2020 quadrupole mass spectrometer 
fitted with an electro spray ionisation source (Shimadzu, Milton Keys, 
UK). A sample volume of 10 µL was injected and separations were 
achieved on a Zorbax Eclipse XDB-C18 (4.6x50 mm; 1.8 μm), operated at 
30 °C. The mobile phase consisting in 0.5% (v/v) formic acid in water 
(solvent A) and 0.5% (v/v) formic acid in acetonitrile (solvent B), was used 
at a flow rate of 0.5 mL/min. The gradient started with 0% B to reach 30% 
B at 20 min, reaching 90% B at 25 min, maintaining the percentage for four 
minutes. 
  
Functional assay of P-glycoprotein (P-gp) 
Activity of P-gp was determined by measuring cellular accumulation of 
the P-gp substrate Rhodamine 123 (R123) expressed per mg of protein 
content 24, 25, and results are shown as fold-change compared to the 
respective control. In brief, HBMEC treated with bioavailable polyphenol 
metabolites were washed, and incubated for 1 h at 37 °C with Ringer–
HEPES Buffer (pH 7.4) containing 10 mM R123. The solution was quickly 
removed, HBMEC were washed three times with PBS and solubilized in 
0.1 M NaOH. R123 content was determined using a Polarstar Galaxy 
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fluorescent plate reader (BMG Labtechnologies; excitation at 505 nm, 
emission at 538 nm). Verapamil (1µM, 30 min pre-incubation) was used as 
a reference P-gp inhibitor for the positive control. Protein content was 
evaluated by the Bradford method 26 using Bio-Rad’s Protein Assay 
reagent (Bio-Rad). 
 
Immunofluorescence analysis of P-glycoprotein 
For analysis of the P-gp expression in HBMEC, cells were fixed with 4% 
paraformaldehyde for 20 min. Cells were permeabilized with 0.2% Triton 
X-100, blocked with 3% BSA and incubated with primary antibodies anti-
P-gp (1:50) overnight at 4°C. Incubation with secondary antibody Alexa 
488 anti-mouse IgG (1:500) (Invitrogen) lasted for 2 h at room 
temperature. Nuclei were counterstained with DAPI. Between incubations 
cells were washed three times with PBS. Coverslips were mounted in Gel 
Mount (Biomeda, USA) and staining was examined using a Leica DFC 490 
camera (Leica, Germany) adapted to an AxioScope.A1 microscope (Zeiss, 
Germany), ZEN 2012 (blue edition) software by Carl Zeiss Microscopy 
GmbH, 2011.  
 
Statistical analysis 
The results reported in this work are the averages of at least three 
independent experiments and are represented as the means ± SD. 
Differences amongst treatments were detected by analysis of variance 
with the Tukey HSD (honest significant difference) multiple comparison 
test (a = 0.05) using SigmaStat 3.10 (Systat). 
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RESULTS  
Cytotoxicity of bioavailable compounds to human brain microvascular 
endothelial cells 
The structure of the sulfated compounds synthesized as previously 
described is shown in Fig. 1. The synthesized compounds were evaluated 
for cytotoxicity in HBMEC (Fig. 2). Toxicity was evaluated at two 
concentrations, 5 and 10 µM, which are physiological concentrations 
found in plasma of humans, as previously determined for these 
compounds 13. Quercetin, currently used in assays regarding the effect of 
(poly)phenols in in vitro cellular models, and previously tested for BBB 
permeability, 27 was also used as a control. Toxicity was measured in 
terms of cellular viability using CellTiter-Blue® kit, over a period of 24 h. 
Of the tested compounds only quercetin was toxic, inducing a decrease in 
cellular viability (Fig. 2). In addition, morphological alteration of brain 
endothelial cells was observed on the microscope, with the loss of 
endothelial integrity as a monolayer (data not shown). Further use of 
quercetin for testing protection against H2O2-induced damage and BBB 
permeability was therefore compromised. On the contrary, the other 
compounds tested were not toxic at these concentrations and can be safely 
used for further assays.  
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4-MeGA-3-sulf VA-4-sulf Cat-sulf
Pyr-1-sulf Pyr-2-sulfa
1-MePyr-2-sulf 1-MePyr-3-sulf 2-MePyr-1-sulf
4-MeCat-2-sulf4-MeCat-1-sulf
4-MeGA
 
Figure 1. Structure of phenolic metabolites tested for transport across HBMEC: 4-
MeGA, 4-methylgallic acid; 4-MeGA-3-sulf, 4-methylgallic acid-3-O-sulfate; VA-
4-sulf, vanillic acid-4-O-sulfate; Cat-sulf, catechol-O-sulfate; 4-MeCat-sulf, 4-
methylcatechol-O-sulfate; Pyr-1-sulf, pyrogallol-1-O-sulfate; Pyr-2-sulf, 
pyrogallol-2-O-sulfate; 1-MePyr-2-sulf, 1-methylpyrogallol-2-O-sulfate; 1-MePyr-
3-sulf, 1-methylpyrogallol-3-O-sulfate; 2-MePyr-1-sulf, 2-methylpyrogallol-1-O-
sulfate. 
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Figure 2. Evaluation of the toxicity of bioavailable polyphenol metabolites in 
HBMEC. Cell viability of HBMEC was assessed after 24 h of incubation with 
phenolic-conjugates or no addition (control). Two physiologically relevant 
concentrations were tested (■5 and ■10 µM) and cell viability is expressed as 
percentage relatively to control (100%). Statistical differences are denoted as ** for 
p<0.01 relatively to control. All values are means ± SD, n=3.   
 
Cytoprotective effect of bioavailable compounds against H2O2 insult to 
human brain  microvascular endothelial cells  
To test the protection of the (poly)phenol-metabolites against H2O2 insult, 
viability of HBMEC was measured as previously. HBMEC were incubated 
with the individual compounds at a concentration of 5 µM for 24h prior to 
H2O2 insult (Fig. 3). Incubation of cells with H2O2 induced a loss of 
viability of nearly 70%, which was greatly reduced with a pre-incubation 
of the (poly)phenol-conjugates. Of these, 4-MeGA, Pyr-sulf, 2-MePyr-sulf 
and VA-sulf were able to increase the viability of cells to values very close 
to the control.  
Chapter 5 
 
179 
0%
20%
40%
60%
80%
100%
120% ###
***
**
##
### *
###
### ***
#
### ###
***
#
- -5 µM compound
300 µM H2O2 - +       +        +       +       +        +        +       +        +     
120
1 0
80
60
40
20
0
C
e
ll 
V
ia
b
ili
ty
 (
%
)
 
Figure 3. Cytoprotective effect of biovailable polyphenol metabolites in injured 
HBMEC. Cells were preincubated with 5µM of each bioavailable polyphenol 
metabolite, for 24h and then injured with 300 µM H2O2 for 24h. Cell viability is 
presented as percentage relatively to control. Statistical differences are denoted as 
*** for p<0.001, ** for p<0.01 and * for p<0.05 relatively to control and as 
###p<0.001, ##p<0.01 and #<0.05 relatively to H2O2. All values are means ± SD, 
n=3.  
 
Passage of bioavailable compounds across human brain microvascular 
endothelial cells 
 For testing the transport of the conjugated-(poly)phenols across confluent 
monolayers of HBMEC, the paracellular indicators TEER and permeability 
were monitored to assure the integrity of the monolayer, and, thus, 
guarantee that the passage of the metabolites was not due to a disruption 
of the barrier properties. TEER values for HBMEC treated with 
(poly)phenol-conjugates did not differ from those of untreated cells used 
as control, assuring that the tested compounds were not affecting the 
integrity of the barrier. Additionally, no significant differences were 
registered for the permeability to sodium fluorescein of HBMEC 
monolayers treated with the bioavailable compounds in comparison with 
the control, confirming that the barrier was intact.  
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The permeation efficiency of each (poly)phenol-conjugate across the 
barrier at the concentrations of 5 and 10 µM was evaluated 2 h after their 
addition to the luminal surface. The efficiency of transport was calculated 
by the relative percentage of compound that passed to the abluminal side 
in relation to the control without cells, incubated at 37 °C for 2h (Fig. 4). 
The passage efficiency was higher for the 2-MePyr-sulf and Pyr-sulf, 
respectively reaching 25% and 17.5% detection in “brain side” for the 10 
µM concentration. A large difference in the permeation efficiency was 
registered between the two concentrations tested in both compounds, as 
well as for the 4-MeCat-sulf. More consistent values were observed for all 
the other compounds between the two concentrations. The smallest 
passage efficiency was observed for 4-MeGal, 4-MeGal-sulf and 1-MePyr-
sulf (2%, 3% and 3%, respectively). These results indicate that compounds 
are able to cross the BBB, though with a small efficiency.   
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Figure 4. Percentage of passage efficiency of phenolic metabolites across HBMEC 
after 2h of incubation in a transwell system: (A) 4-MeGA, (B) 4-MeGA-sulf, (C) 
VA-sulf, (D) Cat-sulf, (E) 4-MeCat-sulf, (F) Pyr-sulf, (G) 1-MePyr-sulf, (H) 2-
MePyr-sulf. Two different concentrations (5 and 10 µM) of each compound were 
tested and applied at luminal surface of HBMEC and the amount of each 
compound that reached the abluminal side after 2h was determined by LC-MS. 
The values are means of at least two independent experiments. 
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P-gp expression and activity in HBMEC 
The presence of P-gp in HBMEC was confirmed by fluorescence 
microscopy (Supplementary Fig. 1). The results indicate that the cells are 
expressing the P-gp in normal conditions (Supplementary Fig. 1A) and are 
expressing as well when incubated with the (poly)phenol-conjugates 
(Supplementary Fig. 1B-I).  
To assess if the presence of the (poly)phenol-conjugates affected the 
functional activity of P-gp in HBMEC, the uptake of  R123 was measured 
in the presence of the compounds (Fig. 5). No significant differences were 
found in relation to the control when cells were incubated with the 
(poly)phenol-conjugates, whereas a much smaller retention of the P-gp 
substrate was observed for verapamil, a well-known P-gp inhibitor. These 
results suggest that poly)phenol-conjugates did not alter the P-gp activity. 
 
Chapter 5 
 
183 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
n
m
o
lR
1
2
3
 /
m
g 
p
ro
t
 
Figure 5. P-glycoprotein (P-gp) activity in HBMEC when incubated with the 
phenolic-conjugates. The evaluation of P-gp activity was measured by its ability 
to retain the substrate rhodamine 123 (R123). After 2h of treatment, cells were 
incubated for 30 min with 10 mM R123. Total protein extracts were collected, 
R123 accumulation fluorescent emission was determined and results were 
expressed per mg of protein. Values presented are means ±SD, n=5. 
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DISCUSSION 
Brain endothelial cells are exposed to diverse physical and chemical 
stimuli, which can affect the integrity of the barrier 28. Disruption of the 
BBB has been seen in various states of inflammation, neoplasia, infections 
(meningitis, encephalitis), trauma and Alzheimer disease 29, 30. Compounds 
able to protect the BBB against chemical damage can become very 
important in prevention of several pathologies. Some (poly)phenols, and 
particularly flavonoids, have been used in experiments aimed at 
determining the ability of compounds to permeate the BBB and exert 
protective actions in the brain or in the BBB itself against chemical insults 
31. However, after ingestion, most flavonoids are found in plasma in 
conjugated form and in much smaller concentrations that the ingested 
amount, which renders difficulty in associating these compounds to the 
expected protective effects 32. Nevertheless, we recently identified in urine 
several phenolic-conjugates after ingestion of a (poly)phenols-rich berry 
fruits puree 12. These low molecular weight phenolic-conjugates, most of 
them originated from the colonic break down of more complex 
(poly)phenols, were also found and quantified in plasma 13 and are 
therefore promising candidates for the positive health effects associated 
with the consumption of berries.  
Methylated and sulfated small phenolic-metabolites found in urine and 
plasma of human subjects were chemically synthesized. In the present 
study, the capacity of such compounds in preventing H2O2 damage in 
HBMEC and their ability to permeate the endothelium, together with P-gp 
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expression and activity were investigated in a simplified model of the 
BBB.  
Before testing the protective effects of phenolic-conjugates from an 
oxidative insult, the toxicity of the compounds was evaluated in HBMEC, 
at two concentrations, 5 and 10 µM. These concentrations are considered 
to be very close to the physiological concentrations previously detected in 
plasma for such compounds 13. The absence of toxicity for these 
compounds might be related to conjugated groups, methyl and sulfate. 
With a general function of making compounds less lipophilic and more 
easily excreted, conjugating reactions usually inactivate the initial 
compounds. However, in certain instances, “bioactivation” of compounds 
can occur, thus resulting in unstable metabolic products more toxic than 
the original 10. Quercetin, which was toxic for HBMEC in the present 
study, had been previously reported to be able to permeate across the BBB 
effectively, despite restraining the proliferation of endothelial cells and 
inducing apoptosis 33. Nevertheless, quercetin is not usually found 
unconjugated in the human body, but conjugated with methyl, sulfate and 
glucuronide groups 34.  
Excluding toxicity in HBMEC from phenolic-conjugates, these were tested 
for protection of HBMEC against damage caused by H2O2 incubation. 
H2O2 has been observed to affect the integrity of the membrane, being able 
to increase its permeability when administered in lower concentrations (1 
mM or less) and to induce a decrease in cell viability when administered 
at high concentrations (5 mM) 35. All the phenolic-conjugates 
demonstrated, to a certain extent, the ability to protect cells against H2O2 
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insult. Previously, hydroxycinnamic acids and anthocyanins from 
blueberry and cranberry were able to protect HBMEC against H2O2 injury. 
However,  the physiological relevance of these results was questioned due 
to the poor bioavailability of the mentioned compounds 36. Here, we 
demonstrate that small phenolics resulting from the colonic degradation 
of more complex (poly)phenols and bio-conjugation in the human body 
are potentially able to exert protective effects as well.  
For compounds to be able to exert protective effects in the brain they have 
to be able to cross the BBB and many dietary (poly)phenols have been 
tested for the ability to permeate this barrier 37. The ability of phenolics to 
permeate the BBB was related to the lipophilicity of the compounds, being 
dependent on the functional and conjugated groups 38, 39. The more 
hydroxyl groups and glycosides attached to the aglycones, generally 
result in less permeable compounds.  
Phase II reactions in the human body are expected to make (poly)phenols 
more hydrophilic with lesser ability to cross the BBB. In fact, it was 
suggested that phenolic acid-conjugated metabolites from coffee ingestion 
have a very low ability to cross the BBB and, thus, do not reach the  
brain 40. However, our results suggest that although in small 
concentrations, sulfated-phenolics can permeate the BBB.  The same idea 
was obtained for glucuronidated-conjugates of  flavanones, anthocyanins 
and flavanols 39. Addition of a methyl group, on the other hand, was 
observed to increase the permeability in the BBB of compounds 41. 
Despite the fact that conjugation of phenolic compounds can reduce their 
ability to penetrate the BBB, it is possible that they can also alter the brain 
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function through action at the BBB, and not requiring entering into the 
brain 42. In the BBB, the P-gp has the physiological role of protecting the 
organism against exogenous toxic substances, by exporting these 
substances out of the tissue at the cost of ATP 43. They are part of the efflux 
transport system in the body which eliminates endogenous and 
exogenous compounds from the body 44. (Poly)phenols have been 
described to have inhibitory effects on the P-gp 45 and to affect the activity 
of the P-gp by interacting directly with it or indirectly by altering the 
plasma membrane properties of factors contributing to its activity 31.  In 
HBMEC, we observed that P-gp is expressed and functional, as 
determined by immunofluorescence analysis and by its ability to efflux 
R123. However, the phenolic-conjugates did not alter its activity.   
In conclusion, this study focused on the protective effects of chemically 
synthesized bioavailable metabolites in humans from the ingestion of 
berry fruits. These compounds were able to protect HBMEC from 
chemical damage induced by hydrogen peroxide. In addition, such 
compounds were able to cross the HBMEC, although in small quantities, 
and therefore have the potential to exert protective effects in neural cells. 
On the other hand, the phenolic-conjugates did not alter the function of 
the P-gp.  
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Figure 1. P-glycoprotein expression in HBMEC observed by  immunofluorescence 
analysis: (A) control, (B) 4-MeGA, (C) 4-MeGA-sulf, (D) VA-sulf, (E) Cat-sulf, (F) 
4-MeCat-sulf, (G) Pyr-sulf, (H) 1-MePyr-sulf, (I) 2-MePyr-sulf. Scale bar measures 
20 µm.  
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DISCUSSION 
(Poly)phenols have been consistently associated with beneficial 
effects of diets enriched in fruits and vegetables. These diets have 
been recommended to reduce the risk of developing chronic 
diseases such as cancer, cardiovascular disease, hypertension, stroke 
and type 2 diabetes 1. However, the precise contribution of 
(poly)phenols is still unknown and there have been several 
conflicting reports; nevertheless, a great deal of research has been 
dedicated to the subject. Different approaches have been taken in 
order to clarify the effects that (poly)phenols might have in the 
human body, including epidemiological studies, in vitro tests and 
experimental studies on animals, as well as clinical and intervention 
trials in humans. 
The difficulty of proving their effects is in part related to the fact 
that differences in the dietary content of (poly)phenols lead to 
subtle and chronic modulations of the metabolism and the health 
state of individuals and are often obscured by interindividual 
variability regarding the genetic background, environmental factors 
and lifestyle  2. 
There is also great ambiguity regarding the active compounds in the 
human body, since recovery from biological samples of the main 
dietary (poly)phenols has been estimated to be mostly low 3. 
Additionally, despite the fact that the absorption and the 
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concentrations of some (poly)phenols in blood are low, their 
ingestion is able to affect some biomarkers, suggesting that 
unknown metabolites are at least partly responsible for the effects 4. 
This raises questions concerning the metabolic fate of dietary 
(poly)phenols and underlines the necessity of identifying the 
bioavailable metabolites from ingestion of (poly)phenols. 
In this study, we aimed to identify some of the most abundant 
circulating metabolites after ingestion of dietary (poly)phenols, 
which may be responsible for the associated beneficial health 
effects. Having this objective in mind, the strategy was to firstly 
identify and quantify the compounds present in the berry fruits. 
These fruits were given to the human volunteers in the intervention 
study and urine samples were used for the screening and 
identification of the main bioavailable metabolites. Enzymatic and 
chemical synthesis of standards allowed confirmation of the 
identification of the metabolites and was used for the quantification 
in plasma as well as to disclose their possible effects at the level of 
the blood-brain barrier. Each study of this thesis contributed 
significant knowledge of the metabolism of dietary (poly)phenols in 
humans.  
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(Poly)phenols in berries 
Berry fruits are considered one of the main components of healthy 
diets and constitute some of the richest sources of (poly)phenols, 
containing a great diversity of compounds 5. As previously 
suggested 6, the creation of beverages containing a great diversity of 
(poly)phenols from multiple sources may be favourable for human 
health. Therefore, the selection of five berry fruits for the 
constitution of the fruit puree, to be given to the volunteers, was 
done to increase the diversity of compounds, strengthening, 
however, in specific groups of (poly)phenols such as anthocyanins, 
hydroxycinnamates, and gallic and ellagic acid derivatives (Chapter 
II). Although the content of (poly)phenols in commercial 
blueberries, blackberries and raspberries has been analysed in many 
previous publications, they were also analysed in this study since 
these might vary according to several factors such as the varieties, 
geographic region, storage conditions, ripeness and climate 5. 
Additionally, Portuguese crowberry fruits were analysed in this 
study for the first time. These fruits and strawberry tree fruits, have 
a poor commercial exploitation, and can constitute novel sources of 
(poly)phenols for industry.   
Due to the diversity of (poly)phenols in berries, identification and 
quantification of compounds can be laborious and slow and is 
limited by the availability of standard compounds. Quantification of 
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the aglycones after chemical hydrolysis of glycosidic residues has 
been a methodology previously used particularly for flavonoids or 
organic acids 7, 8. In this study (Chapter II) we have used a 
combination of enzymes from Aspergillus niger for the hydrolysis of 
glycosides, and as well of the ester bonds with organic acids, as 
observed for 5-O-caffeoylquinic acid and 3-O-caffeoylquinic acid. 
This additional activity, possibly due to impurities in the 
commercial enzyme preparation, contributed to making this 
method an alternative for the commonly used methodology, mostly 
acidic or alkaline hydrolysis.    
Although the identification of aglycones after hydrolysis simplifies 
the analysis of (poly)phenols in samples, it also has some 
disadvantages. It can result in an underestimation of some 
compounds if the hydrolysis is not complete and does not allow 
identification of all the individual compounds. Additionally, the 
information of the groups conjugated with the aglycones is lost, and 
these can be important, as they can influence absorption and 
metabolism of (poly)phenols in the human organism 9.   
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Bioavailability of (poly)phenols 
Bioavailability is a key issue linking (poly)phenols and health 
effects 10.  
Concerning the bioavailability of (poly)phenols from berries, the 
focus is usually on flavonoids, particularly anthocyanins, and 
ellagitannins as well 11. However, berries comprise a great variety of 
(poly)phenols including phenolic acids and proanthocyanidins. 
During digestion, in addition to other events, the hydrolysis of the 
glycosides and organic acids from the (poly)phenol aglycones takes 
place 12. This event is, in part, similar to what occurs in vitro during 
multienzyme hydrolysis with cellulase and hesperidinase (Chapter 
II), and therefore indicative of which metabolites in the berry 
mixture are most prone to be available for absorption (Chapter III). 
Additionally, bioavailability studies involving berries, the focus 
often resides on the (poly)phenols present in the fruits. Only 
recently, more attention has been given to metabolites of colonic 
origin, as it was estimated that non-absorbed compounds in the 
small intestine that are able to reach the colon can go up to 90 to 
95% of the ingested dose. In the colon these compounds can be 
degraded into simpler units by the colonic microbiota and still be 
absorbed into the blood stream 13. Following absorption, a high 
percentage of compounds is found conjugated in plasma and urine 
samples. Based on this, an in silico library of potential bioavailable 
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metabolites was constructed and was used to search the 
(poly)phenol metabolites in urine samples of volunteers (Chapter 
III).  
For the identification of (poly)phenol-metabolites in biological 
samples, several methods have been traditionally used. Tandem 
mass spectrometry following HPLC separation of metabolites has 
been a very useful tool; however, due to the lack of available 
standards, identification and quantification has been limited. Often, 
indirect quantification based on similar compounds or the parent 
aglycones has been the method of choice, despite some limitations 
in structural identification of compounds and correct estimation of 
concentration. Commonly, it is often applied together with the 
hydrolysis of phenolic conjugates using the enzymes β-
glucuronidase and sulfatase. Nevertheless, by this method all 
information regarding the regioselectivity of conjugation is lost, and 
quantification might be impaired due to the low efficacy of the 
mentioned enzymes.  In this thesis, enzymatic and chemical 
synthesis (Chapters III and IV, respectively) were used for 
standard production, allowing the identification and quantification 
of metabolites. SULTS and UGTS were obtained from ox and pig 
liver, providing the conjugation activity necessary for production of 
standards which allowed the confirmation of the metabolites in 
urine samples. Animal models can be of great utility for 
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comprehending the metabolism of (poly)phenols and the effects of 
the metabolites. However, differences in conjugating reactions and 
substrate rate specificity have been observed between mammalian 
species and therefore, the results obtained with animals cannot 
always be translated to humans 14. 
In this thesis the aim has been to identify the most abundant 
bioavailable metabolites resulting from the ingestion of the berry 
puree. The presence of gallic and caffeic acid-derived metabolites in 
urine was expected, due to their high levels in the fruit puree 
(Chapter III). Moreover, the other most relevant metabolites 
identified were estimated to result from colonic catabolism due to 
their later times of excretion. These simple phenols constituted the 
most abundant metabolites both in urine (relative quantification, 
Chapter III) as in plasma (absolute quantification, Chapter IV). 
However, it was not possible to confirm that some of the 
metabolites found in urine originated from the digestion of 
(poly)phenols from the berries since they were also present in 
plasma when the control breakfast without (poly)phenols was 
ingested (Chapter IV). This was the case for protocatechuic acid-O-
sulfate and vanillic acid-O-sulfate, which have been previously 
derived from the ingestion of cyanidin 15. 4-Methyl-catechol-O-
sulfate was also not confirmed to be generated from the catabolism 
of berry (poly)phenols. Additionally, some metabolites found in the 
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urine of volunteers were not found in plasma or were present in 
levels under the limit of detection, such as glucuronidated 
metabolites and dihydrocaffeic and dihydroferulic acids-conjugates 
(Chapter IV). There are several possible explanations for these facts. 
Some compounds may remain in plasma for a short period of time 
and be rapidly excreted, having a considerable accumulation in 
urine over time but not being abundant in plasma. On the other 
hand, the metabolites originating in the colon generally have a later 
appearance in plasma, and for some of them later collection times 
(over 6 hours) would be needed to observe a relevant concentration 
increase in plasma.  In the future, when performing intervention 
studies to trace the colonic metabolites, the collection of blood and 
urine samples should be performed at least until 48h. That would 
allow to find a the time at which the concentration of these 
metabolites will be higher and follow their concentration until 
minimum values after the ingestion of (poly)phenols. 
 
Predicting the origin of colonic metabolites 
The human colon is inhabited by more than 1000 species of bacteria, 
where the genera Bacteroides spp., Clostridium spp. and Eubacterium 
spp predominate. 4, 16. These microbial communities use diet-derived 
and host-derived energy sources for growth and are able to perform 
a great range of biochemical transformations. Several reactions have 
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been described by the colonic microflora, such as hydrolysis of 
conjugated groups, backbone rupture and ring fissure, or the loss of 
functional groups such as methyl, methoxy, hydroxyl, and 
carboxylic acid, among others 2.  
In the present work, although the formation of some phenolic-
metabolites can be predicted to occur in the colon, it was not 
possible to confirm exactly which are the parental compounds. 
However, there has been an increase of studies on the formation of 
colonic catabolites from (poly)phenols which can help to predict the 
formation of such metabolites. Experiments where (poly)phenols 
are incubated with faecal matter recovered from humans are 
providing important information on the colonic microbial 
metabolism. It has been demonstrated that the microbiota can 
metabolize the non-absorbed phenolics that reach the colon and 
even recover and metabolize non-extractable phenolics extensively 
bound to plant polysaccharides, such as ferulic acid 17. Compounds 
that are conjugated either with organic acids or with glycosides can 
be de-conjugated by the microbiota, extending the hydrolysis 
catalysed by the small intestine epithelium. That is the case for some 
major compounds in the berry fruit puree, such as anthocyanins 
and caffeoylquinic acids, which generate, respectively, 
anthocyanidins and caffeic acid 18, 19. Anthocyanidins are very 
unstable and readily break down into different simpler phenolics 
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depending on the structure of the parental anthocyanidins 20. 
Cyanidin results mainly in protocatechuic acid, which we found 
conjugated in human urine and plasma, and other small phenolics 
such as phloroglucinaldeyde and several hydroxybenzoic and 
hydroxyphenylacetic acid-metabolites 15, 21. Other anthocyanidins 
can produce a great variety of compounds, some of them found in 
this study as metabolites, such as gallic, vanillic, caffeic, ferulic, 
isoferulic dihydrocaffeic and dihydroferulic acids 22. Caffeic acid, 
partially resulting from hydrolysis of caffeoylquinic acids, and 
ferulic acid, initially detected in the puree, but also possibly 
resulting from the catabolism of other compounds, are described to 
be metabolized by the microbiota mainly into dihydrocaffeic and 
dihydroferulic acids, respectively 19. Other minor catabolic routes 
can produce several additional metabolites such as 
(hydroxyphenyl)-propionic acids, protocatechuic acid, and other 
phenylacetic and benzoic acid-derivatives 19, 23. Hydroxybenzoic 
acids such as gallic acid, the main compound detected in the fruit 
puree, and protocatechuic acid are decarboxylated into pyrogallol 
and catechol, respectively 19, 20. Although in other studies these 
catabolites were described as minor compounds in human samples, 
in this study, they might be considered the precursors of the most 
abundant metabolites in urine and plasma of volunteers (Chapters 
III and IV).  
Discussion and future perspectives 
 
206 
Other (poly)phenols initially present in fruits, such as flavonols and 
flavanols, are degraded by the colonic microbiota into a diversity of 
phenolic metabolites comprising hydroxyphenylacetic acids, 
hydroxybenzoic acids, hydroxyphenylpropionic acids and 
aldehydes, that ultimately can be further metabolised into 
pyrogallol and catechol as well 20, 24, 25 
 
The importance of phase II conjugating reactions 
The result of this work confirms the importance of conjugating 
reactions in the metabolism of (poly)phenols in humans. All the 
major metabolites identified in urine were in conjugated form, 
either with sulfate, glucuronide or methyl groups (Chapter III). 
These reactions can function not only to inactivate the metabolites 
but as well to increase hydrophilicity and facilitate the elimination 
of (poly)phenol metabolites as well as other xenobiotics and 
endogenous compounds. Additionally, conjugation increases the 
molecular weight of metabolites and facilitates biliary excretion 26. 
In the urine samples sulfated compounds were always relatively 
more abundant than glucuronidated metabolites (Chapter III) and 
in plasma only sulfated metabolites were  quantifiable (Chapter IV). 
This suggests that the metabolites here identified are preferrentially 
sulfated rather than glucuronidated. The same does not occur for 
other compounds such as quercetin 27, and for approximate 90% of 
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drugs requiring hepatic clearance out of the body, where 
glucuronidation is the major conjugation pathway 14. This may be 
due to the substrate specificity of the conjugating enzymes. 
However, for ingested compounds the hepatic clearance pathway 
may not be the only predominant route, and extra-hepatic 
conjugation should not be discounted. The intestine may be an 
important site of conjugation as well since many conjugating 
enzymes are expressed in this organ 27. Moreover, it has been 
reported that catecholic compounds are poorly glucuronidated 28 
and sulfation may be the predominant pathway, as previously 
determined for hydroxycinnamic acids 29. In addition to sulfation, 
methylation is also an important conjugating reaction. Many of the 
metabolites reported here, in addition to being sulfated or 
glucuronidated, were also methylated.  This dual conjugation has 
been described as a major conjugation pathway of catecholic drugs 
30 and (poly)phenols such as quercetin 31, and epicatechin 32. In this 
thesis (Chapter III), we consider that methylation might have 
occurred on gallic, protocatechuic, caffeic, and dihydrocaffeic acids, 
as well as on pyrogallol.   
Regioselectivity appears to be very important in conjugating 
reactions for compounds with more than one conjugation site. 
Many of the compounds here reported are conjugated preferentially 
at a certain position, as for the examples of gallic acid, which was 
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found methylated in the 4-hydroxyl and sulphated in the 3-
hydroxyl groups, and caffeic, dihydrocaffeic and protocatechuic 
acids which were preferentially methylated in the 3-hydroxyl 
group. In addition to regioselectivity, substrate specificity has also 
been described among different isoforms of conjugating enzymes. 
The SULT1A1 isoform has been reported as the main enzyme 
responsible for xenobiotic sulfation due to its wide range of 
substrate acceptability and high abundance in hepatic tissue. 
However other isoforms are more specific for certain substrates 
such as SULT1A3, which preferably sulfates catecholamines and 
SULT1E1 with higher affinity for estrogens 33. However, no 
information of the enzyme isoforms which preferably conjugate the 
(poly)phenol metabolites nor their location was obtained in this 
study. Comprehension of the substrate specificity and 
regioselectivity of the conjugatiing enzymes as well as the sites of 
conjugation is essential for the prediction of metabolism of 
(poly)phenolic compounds.  
 
Variability between subjects 
In the intervention studies performed in this work, a great 
variability was observed in the metabolism of (poly)phenols 
between the different human subjects for both in urine (Chapter III) 
and plasma samples (Chapter IV). This variability was reflected in 
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the amount of each metabolite at a certain time point in the 
biological samples, and also in the metabolites produced, since not 
all the metabolites were present in each volunteer. A high 
variability between subjects is common in human studies. It can be 
explained by several factors such as genetic background, 
environmental factors and lifestyle. Additionally, there is genetic 
variability in the conjugatingenzymes between the volunteers, as 
interindividual variation in enzyme expression has been 
documented for SULT isoforms 33 and could occur for the other 
enzymes. Several other factors can also influence the expression and 
activity of the conjugation enzymes, such as the gender, age and 
physiopathological conditions, and also single or repetitive 
exposures to xenobiotics, which can induce or inhibit the enzymes 
34. In addition, variability between subjects can also exist in 
expression of phase III transporters which eliminate the compounds 
out of the body. P-gp for example, has broad substrate specificity 
and is of great importance in limiting the transcellular transport of 
xenobiotics 35. The expression of several phase III transporters can 
also be induced by xenobiotics and therefore varies with individual 
diets or drug ingestion 36. 
Furthermore, these differences can also be caused by variability of 
the colonic microbiota between subjects. All individuals have a 
unique signature of intestinal microbiota, and the different bacteria 
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species can metabolize (poly)phenols in different ways. On the 
other hand, (poly)phenols also have the ability to modulate the 
microbiota. Some compounds can inhibit the growth of all or only 
some bacterial species and therefore have the potential to affect 
(poly)phenol metabolism. In fact, the diet of each individual can 
affect its colonic microbiota by modulating its environment and 
nutrient supply 37. 
Based on the results obtained from Chapters II, III and IV, and the 
literature, the general scheme can be proposed for the 
bioavailability of (poly)phenols from the berries puree (fig 1).   
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Activity of phenolic-conjugates 
The effects of (poly)phenols in humans are a function of the nature 
of the compound, and other contributing factors which include the 
concentration in the diet, the amount consumed, the 
transformations in the gastrointestinal tract, absorption, conjugation 
and excretion 38. The biological effects attributed to (poly)phenols 
are due, in large part, to the plethora of bioactive phenolic 
molecules available in nature, comprising a great variety of 
chemical structures. This diversity, despite being the basis of the 
effects of (poly)phenols, makes their study and comprehension 
difficult. In addition, changes in their structure occurring during 
food processing, digestion, and also conjugation in the body must 
also be taken into account. 
The biological activities of phenolic-conjugates have not been 
extensively evaluated due to the difficulty of identification and the 
lack of available standards.  
In this thesis, we intended to identify the phenolic metabolites 
circulating in the blood and determine their physiological 
concentration (Chapter IV). These metabolites are the most likely to 
reach the target tissues and exert a biological activity. 
 Normally, conjugating reactions result in metabolites less 
biologically active than the parent compounds, thus serving as a 
detoxification mechanism. However, the opposite might also occur, 
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and the resulting conjugated metabolites might be more reactive, 
having higher pharmacological activity or toxicity 14. Additionally, 
conjugated compounds being generally more hydrophilic than the 
parent compounds can easily travel in the blood flow and thus 
reach the body tissues. 
Several studies have mentioned the neuroprotective effect of 
(poly)phenols either preventing or slowing the progression of 
neurodegenerative pathologies and the degenerative effect of 
ageing or contributing to an improvement in cognitive  
performance 39. A direct antioxidant effect of (poly)phenols in the 
brain as commonly been suggested by researchers. However, most 
in vitro studies were performed with plant extracts or (poly)phenol 
aglycones and the bioavailable conjugated metabolites were usually 
disregarded. Moreover, the antioxidant effect of (poly)phenols has 
only been proved in vitro and it is thought that the bioavailble 
(poly)phenol-conjugated metabolites are poor antioxidants due to 
the loss of antioxidant activity conferred by the conjugation, but 
also due to the low concentration at which they are present in the 
blood 40.  
Some studies have demonstrated that (poly)phenols can in fact 
enter the brain, although this ability is dependent on their structure, 
in particularly their lipophilicity. In this thesis, we demonstrated 
that the small phenolic-conjugates present in the blood of 
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volunteers, have a low permeability across the BBB. Of the 
evaluated metabolites, the transport across the BBB ranged from 2% 
to 25% of the initial amount, suggesting a limited entrance in the 
brain (Chapter V).  
However, when considering the effects of (poly)phenols in the 
brain, they do not necessarily have to enter the organ to exert an 
effect. Instead, they can act outside the central nervous system by 
improving the cerebral blood flow or acting on the communication 
between peripheral organs and the brain, or even act at the level of 
the BBB 41. In fact, in this thesis we demonstrated that conjugated-
metabolites of (poly)phenols can have a protective action against an 
oxidative stress such as hydrogen peroxide  at the level of the 
endothelial cells constituting the BBB (Chapter V).  
 
FUTURE PERSPECTIVES 
The comprehension of the (poly)phenols effects in the human health 
passes through the identification of the bioavailable metabolites that 
circulate in the blood flow and are able to reach the target tissues. In 
this thesis we were able to identify some of the bioavailable 
metabolites from the ingestion of berry fruits.   
In the future the focus should be on identification of novel 
metabolites present in human biological samples. Despite the great 
diversity of (poly)phenols in foods and beverages only a small 
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portion of metabolites have been thoroughly studied in terms of the 
digestive process in humans, and even for those there is still a lot to 
comprehend.  
There are several approaches to reach this goal and a combined 
action is probably the best methodology. Non-targeted approaches 
can be used to scan and tentatively identify the metabolites in 
human biological samples. Targeted approaches can be used 
subsequently for a precise identification of the metabolites and to 
trace the parental compounds. 
Only being in its early days, the study of colonic microbiota and 
their involvement in (poly)phenols metabolism in humans has a 
great exploratory potential. Studies suggest a great importance of 
colonic metabolism in the host wellbeing. Understanding of the 
evolution of the gut microbiome can provide important clues on the 
genesis of some metabolic diseases such as obesity and 
inflammatory bowel disease. Food has the ability to influence the 
ecology of the microbiota and changes in microbial communities are 
rapidly observed when there is a variation in the feeding pattern of 
the host. (Poly)phenols can greatly influence the microbial 
community and the inverse is verified as well, with the microbiota 
determining the (poly)phenol catabolites produced in the colon. It is 
imperative to understand the phenolic metabolites generated in the 
colon and trace their parental compounds. This can be achieved by 
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performing studies using isotopic labelled (poly)phenols and 
tracing and identifying the labelled metabolites generated from 
their breakdown.  
In addition, it will be also important to comprehend which are the 
microbial species which contribute for the catabolism of 
(poly)phenols in the colon and how they are affected by the 
different compounds and changes of diet. 
In the future, the comprehension of the impacts of food on the 
microbiota might lead to the use of a personalized nutrition for a 
better regulation of the individual microbial community and with 
benefits for health. 
In this thesis, it was also relevant to study the importance of 
conjugating reactions for the metabolism of (poly)phenols in 
humans. However there is still a long way for a complete 
understanding of these processes.  
In vitro cellular models can be used to study the absorption and 
metabolic mechanisms in the gastrointestinal tract. Characterizing 
the regioselectivity of the conjugating enzymes would provide 
important insights into enzymatic mechanisms with respect to 
substrate binding and selectivity. The understanding of 
regioselectivity of SULTs and UGTs would allow prediction of the 
site(s) of sulfation and glucuronidation on (poly)phenol-metabolites 
and identification of the compounds likely to be formed in vivo. The 
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comprehension of the conjugating metabolism of (poly)phenols 
would also help to predict the impact of food on the metabolism of 
pharmaceutical drugs.   
The discovery of the bioavailable metabolites from the ingestion of 
(poly)phenols and the chemical synthesis of these compounds 
enables study of their effects on human health. The effect on the 
protection at the level of the BBB, demonstrated in this thesis, opens 
the possibility of using these compounds for reducing the risk of 
developing neurodegenerative pathologies, and more studies will 
be needed to verify these effects. The use of in vitro disease models 
would allow testing the activity of these compounds in specific 
points of the pathological process. If results are favourable, they can 
be used clinical studies in humans or animals to further test the 
protective effect of (poly)phenol metabolites. 
Finally, there is the possibility of using the identified compounds as 
biomarkers of the intake of (poly)phenols in humans. The use of 
biomarkers facilitates the assessment of an accurate estimation of 
(poly)phenols ingestion, which is essential for a correct association 
between consumption and the effects of (poly)phenols, determined 
in epidemiological studies. For that, it is imperative to see if the 
bioavailable metabolites are specific of (poly)phenols ingestion and 
sensitive to changes in the consumed amount. These can be 
achieved by performing intervention studies with specific groups of 
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(poly)phenols and evaluate the bioavailble metabolites on a large 
sample of humans, representing of the whole population, and 
testing differences of dosage. 
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